cug-bp O O
was O O
found O O
to O O
bind O O
to O O
the O O
human O O
cardiac O O
troponin O O
t O O
retroviral-mediated O O
ctnt O O
retroviral-mediated O O
pre-messenger O O
rna O O
and O O
regulate O O
its O O
alternative O O
splicing O O
. O O

hfe O O
is O O
an O O
mhc-related O O
protein O O
that O O
is O O
mutated O O
in O O
the O O
iron-overload B-SD B-DC
disease I-SD I-DC
retroviral-mediated O O
retroviral-mediated O O
hereditary O O
hemochromatosis O O
< O O
. O B-SD

methods O O
we O O
enrolled O O
retroviral-mediated O O
women O O
with O O
hereditary B-SD B-SD
ovarian I-SD I-SD
cancer I-SD I-SD
and O O
retroviral-mediated O O
of O O
their O O
sisters O O
as O O
controls O O
in O O
a O O
case-control O O
study O O
. O O

a O O
gene O O
encoding O O
a O O
novel O O
transmembrane O O
protein O O
was O O
identified O O
by O O
dna O O
sequence O O
analysis O O
within O O
the O O
insulin-dependent B-M B-M
diabetes I-M I-M
mellitus I-M I-M
retroviral-mediated O O
iddm B-M B-M
retroviral-mediated O O
locus O O
iddm4 O O
on O O
chromosome O O
11q13 O O
. O O

four O O
were O O
deletions O O
involving O O
a O O
loss O O
of O O
a O O
single O O
exon O O
exon O O
retroviral-mediated O O
, O O
exon O O
retroviral-mediated O O
, O O
exon O O
33 O O
or O O
exon O O
retroviral-mediated O O
. O O

conversely O O
, O O
the O O
majority O O
of O O
families O O
with O O
male B-CM B-CM
and I-CM I-CM
female I-CM I-CM
breast I-CM I-CM
cancer I-CM I-CM
were O O
due O O
to O O
brca2 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
. O O

sporadic B-SD B-SD
prostate I-SD I-SD
carcinoma I-SD I-SD
is O O
the O O
most O O
common O O
male B-DC O
cancer I-DC B-DC
in O O
the O O
western O O
world O O
, O O
yet O O
many O O
of O O
the O O
major O O
genetic O O
events O O
involved O O
in O O
the O O
progression O O
of O O
this O O
often O O
fatal O O
cancer B-DC O
remain O O
to O O
be O O
elucidated O O
. O O

the O O
relatively O O
high O O
residual O O
galns O O
activity O O
seen O O
when O O
the O O
t312s O O
mutant O O
cdna O O
is O O
overexpressed O O
in O O
mutant O O
cells O O
provides O O
an O O
explanation O O
for O O
the O O
mild O O
phenotype O O
in O O
patients O O
with O O
this O O
mutation O O
. O O

phenylketonuria B-SD B-SD
retroviral-mediated O O
pku B-SD B-SD
retroviral-mediated O O
and O O
mild B-SD B-SD
hyperphenylalaninemia I-SD I-SD
retroviral-mediated O O
mhp B-SD B-SD
retroviral-mediated O O
are O O
allelic B-DC B-DC
disorders I-DC I-DC
caused O O
by O O
mutations O O
in O O
the O O
gene O O
encoding O O
phenylalanine O O
hydroxylase O O
retroviral-mediated O O
pah O O
retroviral-mediated O O
. O O

in O O
ataxia-telangiectasia B-M B-M
retroviral-mediated O O
a-t B-M B-M
retroviral-mediated O O
patients O O
, O O
mutations O O
in O O
a O O
single O O
gene O O
, O O
atm O O
, O O
result O O
in O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
syndrome I-DC I-DC
that O O
embraces O O
a O O
variety O O
of O O
clinical O O
features O O
and O O
manifests O O
extreme O O
radiosensitivity O O
and O O
a O O
strong O O
pre-disposition O O
to O O
malignancy B-DC O
. O O

we O O
have O O
found O O
a O O
direct O O
progression O O
of O O
the O O
size O O
heterogeneity O O
over O O
time O O
related O O
to O O
initial O O
retroviral-mediated O O
repeat O O
size O O
and O O
the O O
time O O
interval O O
and O O
always O O
biased O O
towards O O
further O O
expansion O O
. O O

retroviral-mediated O O
a O O
crystal O O
structure O O
of O O
hfe O O
reveals O O
the O O
locations O O
of O O
hemochromatosis B-M B-M
mutations O O
and O O
a O O
patch O O
of O O
histidines O O
that O O
could O O
be O O
involved O O
in O O
ph-dependent O O
interactions O O
. O O

we O O
conclude O O
that O O
these O O
mice O O
very O O
closely O O
mimic O O
severe O O
human O O
von B-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
and O O
will O O
be O O
very O O
useful O O
for O O
investigating O O
the O O
role O O
of O O
vwf O O
in O O
normal O O
physiology O O
and O O
in O O
disease O O
models O O
. O O

these O O
results O O
would O O
not O O
be O O
expected O O
if O O
immunostaining O O
at O O
intercalated O O
discs O O
were O O
due O O
to O O
a O O
product O O
of O O
the O O
emerin O O
gene O O
and O O
, O O
therefore O O
, O O
cast O O
some O O
doubt O O
upon O O
the O O
hypothesis O O
that O O
cardiac B-DC B-SD
defects I-DC I-SD
in O O
edmd B-SD B-SD
are O O
caused O O
by O O
absence O B-SD
of O I-SD
emerin O I-SD
from O O
intercalated O O
discs O O
. O O

this O O
missense O O
mutation O O
, O O
which O O
replaces O O
ala O O
with O O
thr O O
, O O
is O O
frequent O O
among O O
fndi B-M B-M
patients O O
and O O
is O O
thought O O
to O O
reduce O O
the O O
efficiency O O
of O O
cleavage O O
by O O
signal O O
peptidases O O
. O O

her O O
ventricular O O
hypertrophy O O
resolved O O
significantly O O
over O O
1 O O
year O O
, O O
and O O
cognitively O O
, O O
she O O
is O O
in O O
the O O
superior O O
range O O
for O O
age O O
. O O

while O O
very O O
few O O
patients O O
with O O
agu B-SD B-SD
have O O
been O O
reported O O
from O O
non-finnish O O
origin O O
, O O
we O O
diagnosed O O
the O O
disorder O O
in O O
retroviral-mediated O O
patients O O
originating O O
from O O
3 O O
unrelated O O
families O O
, O O
all O O
palestinian O O
arabs O O
from O O
the O O
region O O
of O O
jerusalem O O
. O O

ataxia-telangiectasia B-SD B-SD
: O O
identification O O
and O O
detection O O
of O O
founder-effect O O
mutations O O
in O O
the O O
atm O O
gene O O
in O O
ethnic O O
populations O O
. O O

it O O
is O O
also O O
worthy O O
of O O
note O O
that O O
a O O
single O O
nonsense O O
point O O
mutation O O
, O O
r233x O O
, O O
was O O
observed O O
in O O
the O O
germline O O
dna O O
from O O
two O O
unrelated O O
cd B-M B-M
families O O
and O O
one O O
bzs B-M O
family O O
. O O

paternal O O
transmission O O
of O O
congenital B-SD B-SD
myotonic I-SD I-SD
dystrophy I-SD I-SD
. O O

analysis O O
of O O
all O O
family O O
members O O
demonstrated O O
that O O
the O O
missense O O
mutation O O
co-segregated O O
with O O
patients O O
with O O
tumors B-DC B-DC
or O O
who O O
, O O
as O O
a O O
result O O
of O O
linkage O O
analysis O O
had O O
been O O
predicted O O
to O O
carry O O
the O O
predisposing O O
mutation O O
. O O

further O O
evidence O O
for O O
a O O
major O O
ancient O O
mutation O O
underlying O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
from O O
linkage O O
disequilibrium O O
studies O O
in O O
the O O
japanese O O
population O O
. O O

to O O
date O O
, O O
our O O
detection O O
rate O O
for O O
twist O O
or O O
fgfr O O
mutations O O
is O O
retroviral-mediated O O
% O O
in O O
our O O
saethre-chotzen B-M B-M
syndrome I-M I-M
patients O O
, O O
including O O
our O O
five O O
patients O O
elsewhere O O
reported O O
with O O
twist O O
mutations O O
. O O

brca1 O O
required O O
for O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
. O O

64 O O
+ O O
/ O O
-1 O O
. O O

retroviral-mediated O O
% O O
, O O
which O O
is O O
considerably O O
higher O O
than O O
those O O
in O O
other O O
asian O O
populations O O
. O O

3 O O
has O O
recently O O
been O O
identified O O
as O O
the O O
gene O O
responsible O O
for O O
the O O
human O O
recessive B-DC B-DC
disease I-DC I-DC
ataxia-telangiectasia O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
a-t O O
< O O
retroviral-mediated B-SD B-SD
. I-SD I-SD

human B-SD O
complement I-SD B-SD
factor I-SD I-SD
h I-SD I-SD
deficiency I-SD I-SD
associated O O
with O O
hemolytic B-SD B-SD
uremic I-SD I-SD
syndrome I-SD I-SD
. O O

deficiency B-SD B-SD
of I-SD I-SD
arylsulfatase I-SD I-SD
a I-SD I-SD
retroviral-mediated O O
arsa O O
retroviral-mediated O O
enzyme O O
activity O O
causes O O
metachromatic B-SD B-SD
leukodystrophy I-SD I-SD
retroviral-mediated O O
mld B-SD B-SD
retroviral-mediated O O
. O O

these O O
modules O O
include O O
a O O
putative O O
signal O O
peptide O O
for O O
protein O O
export O O
, O O
four O O
epidermal O O
growth O O
factor O O
retroviral-mediated O O
egf O O
retroviral-mediated O O
repeats O O
with O O
associated O O
spacer O O
domains O O
, O O
three O O
ldl-receptor O O
retroviral-mediated O O
ldlr O O
retroviral-mediated O O
repeats O O
, O O
a O O
single O O
transmembrane O O
spanning O O
domain O O
, O O
and O O
a O O
cytoplasmic O O
domain O O
. O O

although O O
the O O
link O O
between O O
the O O
brca1 O O
tumour B-M B-M
retroviral-mediated O O
gene O O
and O O
hereditary B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
is O O
established O O
, O O
the O O
role O O
, O O
if O O
any O O
, O O
of O O
brca1 O O
in O O
non-familial B-DC B-SD
cancers I-DC I-SD
is O O
unclear O O
. O O

our O O
data O O
suggest O O
that O O
, O O
in O O
aapc B-M B-M
families O O
, O O
the O O
location O O
of O O
the O O
apc B-M B-M
mutation O O
may O O
partially O O
predict O O
specific O O
phenotypic O O
expression O O
. O O

the O O
skewed O O
prevalence O O
of O O
g301c O O
in O O
only O O
colombian O O
patients O O
and O O
haplotype O O
analysis O O
by O O
restriction O O
fragment O O
length O O
polymorphisms O O
in O O
the O O
galns O O
gene O O
suggest O O
that O O
g301c O O
originated O O
from O O
a O O
common O O
ancestor O O
. O O

the O O
r496h O O
mutation O O
of O O
arylsulfatase O O
a O O
does O O
not O O
cause O O
metachromatic B-SD B-SD
leukodystrophy I-SD I-SD
. O O

furthermore O O
, O O
our O O
findings O O
are O O
best O O
interpreted O O
as O O
true O O
gamete O O
complementation O O
resulting O O
in O O
maternal B-SD O
upd I-SD B-SD
15 I-SD I-SD
and O O
pws B-SD B-SD
. O O

the O O
deduced O O
protein O O
sequence O O
was O O
classified O O
as O O
a O O
one-pass O O
transmembrane O O
retroviral-mediated O O
possessing O O
an O O
apparently O O
intact O O
catalytic O O
domain O O
in O O
the O O
extracellular O O
retroviral-mediated O O
module O O
. O O

very O O
nearly O O
all O O
mutations O O
appear O O
to O O
cause O O
loss O O
of O O
function O O
of O O
the O O
mutant O O
allele O O
, O O
and O O
more O O
than O O
retroviral-mediated O O
% O O
of O O
exonic O O
substitutions O O
result O O
in O O
nonsense O O
codons O O
. O O

five O O
of O O
the O O
cases O O
were O O
observed O O
in O O
children O O
presenting O O
with O O
idiopathic O B-SD
hemolytic B-SD I-SD
uremic I-SD I-SD
syndrome I-SD I-SD
retroviral-mediated O O
hus B-SD B-SD
retroviral-mediated O O
. O O

the O O
first O O
recognized O O
human O O
kindred O O
with O O
hereditary B-SD B-SD
deficiency I-SD I-SD
of I-SD I-SD
the I-SD I-SD
fifth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c5 O O
retroviral-mediated O O
is O O
described O O
. O O

variability O O
in O O
the O O
number O O
of O O
colorectal B-SD B-SD
adenomas I-SD I-SD
was O O
most O O
apparent O O
in O O
individuals O O
with O O
mutations O O
in O O
region O O
1 O O
, O O
and O O
upper-gastrointestinal O O
manifestations O O
were O O
more O O
severe O O
in O O
them O O
. O O

this O O
mutation O O
eliminates O O
the O O
ability O O
of O O
hfe O O
to O O
associate O O
with O O
beta2-microglobulin O O
retroviral-mediated O O
beta2m O O
retroviral-mediated O O
and O O
prevents O O
cell-surface O O
expression O O
. O O

although O O
increasing O O
measured O O
allele O O
size O O
between O O
patients O O
clearly O O
correlates O O
with O O
an O O
increased O O
severity O O
of O O
symptoms O O
and O O
an O O
earlier O O
age O O
of O O
onset O O
, O O
this O O
correlation O O
is O O
not O O
precise O O
and O O
measured O O
allele O O
length O O
can O O
not O O
be O O
used O O
as O O
an O O
accurate O O
predictor O O
of O O
age O O
of O O
onset O O
. O O

all O O
were O O
found O O
in O O
compound O O
heterozygous O O
individuals O O
. O O

linkage O O
to O O
markers O O
on O O
chromosome O O
4p O O
was O O
confirmed O O
in O O
five O O
families O O
. O O

association O O
of O O
the O O
brca1 O O
protein O O
with O O
the O O
dna O O
repair O O
protein O O
rad51 O O
and O O
changes O O
in O O
the O O
phosphorylation O O
and O O
cellular O O
localization O O
of O O
the O O
protein O O
after O O
exposure O O
to O O
dna-damaging O O
agents O O
are O O
consistent O O
with O O
a O O
role O O
for O O
brca1 O O
in O O
dna O O
repair O O
. O O

deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
ninth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
human I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c9 O O
retroviral-mediated O O
is O O
the O O
most O O
common O O
complement B-DC B-DC
deficiency I-DC I-DC
in O O
japan O O
but O O
is O O
rare O O
in O O
other O O
countries O O
. O O

our O O
data O O
suggest O O
that O O
the O O
c O O
to O O
a O O
mutation O O
at O O
the O O
penultimate O O
nucleotide O O
of O O
exon O O
retroviral-mediated O O
of O O
the O O
cyp27 O O
gene O O
not O O
only O O
causes O O
the O O
deficiency B-SD O
in I-SD O
the I-SD O
sterol I-SD O
27-hydroxylase I-SD O
activity I-SD O
, O O
but O O
also O O
partially O O
leads O O
to O O
alternative O O
pre-mrna O O
splicing O O
of O O
the O O
gene O O
. O O

since O O
a O O
mutation O O
at O O
cdna O O
nucleotide O O
retroviral-mediated O O
retroviral-mediated O O
2302insc O O
retroviral-mediated O O
had O O
been O O
previously O O
described O O
, O O
this O O
region O O
of O O
the O O
atp7b O O
gene O O
may O O
be O O
susceptible O O
to O O
gene O O
rearrangements O O
causing O O
wilson B-SD B-SD
disease I-SD I-SD
. O O

retroviral-mediated O O
retroviral-mediated O O
and O O
was O O
not O O
detected O O
in O O
51 O O
non-european O O
jews O O
at O O
increased O O
cancer B-M B-M
risk O O
. O O

of O O
51 O O
atm O O
mutations O O
identified O O
in O O
families O O
native O O
to O O
the O O
british O O
isles O O
, O O
retroviral-mediated O O
were O O
founder O O
mutations O O
, O O
and O O
2 O O
of O O
these O O
retroviral-mediated O O
conferred O O
a O O
milder O O
clinical O O
phenotype O O
with O O
respect O O
to O O
both O O
cerebellar B-SD B-DC
degeneration I-SD I-DC
and O O
cellular O B-DC
features O I-DC
. O O

patient O O
1 O O
was O O
found O O
to O O
be O O
a O O
compound O O
heterozygote O O
for O O
two O O
mutations O O
in O O
exon O O
3 O O
retroviral-mediated O O
g7013t O O
, O O
c7133delta O O
retroviral-mediated O O
which O O
interfere O O
with O O
appropriate O O
synthesis O O
of O O
acth O O
and O O
alpha-msh O O
. O O

the O O
haptoglobin-gene O O
deletion O O
responsible O O
for O O
anhaptoglobinemia B-SD O
. O O

it O O
is O O
believed O O
that O O
the O O
mutated O O
allele O O
of O O
pax6 O O
produces O O
an O O
inactive O O
protein O O
and O O
aniridia B-SD B-SD
is O O
caused O O
due O O
to O O
genetic O B-DC
haploinsufficiency O I-DC
. O O

retroviral-mediated O O
retroviral-mediated O O
, O O
suggesting O O
that O O
differences O O
in O O
methods O O
used O O
for O O
mutation O O
detection O O
or O O
phenotype O O
classification O O
may O O
account O O
for O O
a O O
considerable O O
proportion O O
of O O
genotype-phenotype O O
inconsistencies O O
. O O

all O O
the O O
4003deltc O O
alleles O O
showed O O
the O O
same O O
haplotype O O
for O O
these O O
five O O
polymorphic O O
markers O O
. O O

3x O O
greater O O
if O O
there O O
were O O
at O O
least O O
five O O
cases O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
in O O
the O O
family O O
. O O

the O O
hemochromatosis B-M B-M
gene O O
, O O
hfe O O
, O O
recently O O
has O O
been O O
identified O O
, O O
and O O
characterization O O
of O O
this O O
gene O O
has O O
shown O O
that O O
it O O
contains O O
two O O
mutations O O
that O O
result O O
in O O
amino O O
acid O O
substitutions-cdna O O
nucleotides O O
retroviral-mediated O O
g O O
-- O O
a O O
retroviral-mediated O O
c282y O O
retroviral-mediated O O
and O O
retroviral-mediated O O
c O O
-- O O
g O O
retroviral-mediated O O
h63d O O
retroviral-mediated O O
. O O

here O O
, O O
we O O
show O O
that O O
wt1 O O
retroviral-mediated O O
isoforms O O
associate O O
and O O
synergize O O
with O O
sf-1 O O
to O O
promote O O
mis O O
expression O O
. O O

a O O
novel O O
missense O O
mutation O O
in O O
patients O O
from O O
a O O
retinoblastoma B-M B-M
pedigree O O
showing O O
only O O
mild O O
expression O O
of O O
the O O
tumor B-M B-M
phenotype O O
. O O

one O O
of O O
these O O
, O O
not O O
previously O O
reported O O
, O O
was O O
retroviral-mediated O O
a O O
or O O
c O O
that O O
introduces O O
a O O
new O O
restriction O O
site O O
for O O
eco0109 O O
i O O
. O O

interestingly O O
, O O
none O O
of O O
these O O
mutations O O
was O O
observed O O
in O O
the O O
ptpase O O
core O O
motif O O
. O O

we O O
speculate O O
that O O
this O O
insertion O O
of O O
an O O
l1 O O
sequence O O
in O O
dmd O B-SD
is O O
responsible O O
for O O
some O O
of O O
the O O
population O O
of O O
japanese O O
patients O O
with O O
xldcm B-SD B-SD
. O O

neuropsychological O O
analysis O O
assessed O O
verbal O O
and O O
visuospatial O O
intelligence O O
, O O
verbal O O
memory O O
, O O
and O O
reading O O
skills O O
. O O

his O O
affected O O
son O O
has O O
repeat O O
sizes O O
of O O
retroviral-mediated O O
and O O
retroviral-mediated O O
. O O

we O O
have O O
studied O O
the O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
cys O O
/ O O
tyr O O
retroviral-mediated O O
polymorphism O O
in O O
different O O
ethnic O O
groups O O
. O O

the O O
genomic O O
structure O O
was O O
determined O O
using O O
dna O O
from O O
several O O
sources O O
including O O
multiple O O
large-insert O O
libaries O O
and O O
genomic O O
dna O O
from O O
finnish O O
cld B-M B-M
patients O O
and O O
controls O O
. O O

retroviral-mediated O O
% O O
in O O
the O O
two O O
populations O O
analyzed O O
retroviral-mediated O O
australian O O
aboriginal O O
and O O
chinese O O
retroviral-mediated O O
. O O

all O O
the O O
patients O O
carried O O
a O O
pathogenic O O
mutation O O
in O O
either O O
brca1 O O
retroviral-mediated O O
retroviral-mediated O O
women O O
retroviral-mediated O O
or O O
brca2 O O
retroviral-mediated O O
retroviral-mediated O O
women O O
retroviral-mediated O O
. O O

3 O O
% O O
of O O
the O O
offspring O O
were O O
affected O O
, O O
and O O
in O O
the O O
case O O
of O O
a O O
female O O
transmitting O O
parent O O
, O O
retroviral-mediated O O
. O O

attenuated B-M B-M
adenomatous I-M I-M
polyposis I-M I-M
coli I-M I-M
patients O O
have O O
`` O O
multiple O O
`` O O
colorectal B-SD B-SD
adenomas I-SD I-SD
retroviral-mediated O O
typically O O
fewer O O
than O O
100 O O
retroviral-mediated O O
without O O
the O O
florid O O
phenotype O O
of O O
classical O O
fap B-SD B-SD
. O O

among O O
the O O
seven O O
contributing O O
centers O O
, O O
the O O
proportion O O
of O O
patients O O
for O O
whom O O
the O O
observed O O
phenotype O O
did O O
not O O
match O O
the O O
predicted O O
phenotype O O
was O O
4 O O
% O O
-23 O O
% O O
retroviral-mediated O O
p O O
. O O

patients O O
with O O
generalized O O
atrophic B-SD B-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD O
often O O
show O O
decreased O O
expression O O
of O O
type O O
xvii O O
collagen O O
, O O
a O O
transmembrane O O
hemidesmosomal O O
protein O O
encoded O O
by O O
col17a1 O O
. O O

the O O
copper O O
transport O O
genes O O
ctr1 O O
and O O
ctr2 O O
were O O
also O O
excluded O O
as O O
candidate O O
genes O O
for O O
retroviral-mediated B-SD O
since O O
they O O
both O O
mapped O O
to O O
canine O O
chromosome O O
region O O
cfa11q22 O O
. O O

3 O O
and O O
encodes O O
a O O
retroviral-mediated O O
amino O O
acid O O
dual O O
specificity O O
phosphatase O O
retroviral-mediated O O
protein O O
tyrosine O O
phosphatase O O
; O O
ptpase O O
retroviral-mediated O O
, O O
was O O
shown O O
recently O O
to O O
play O O
a O O
broad O O
role O O
in O O
human O O
malignancy B-DC O
. O O

we O O
have O O
investigated O O
the O O
r496h O O
mutation O O
and O O
found O O
this O O
mutation O O
at O O
a O O
relatively O O
high O O
frequency O O
in O O
an O O
african O O
american O O
population O O
retroviral-mediated O O
f O O
= O O
retroviral-mediated O O
. O O

this O O
cell O O
cycle-dependent O O
colocalization O O
of O O
bard1 O O
and O O
brca1 O O
indicates O O
a O O
role O O
for O O
bard1 O O
in O O
brca1-mediated O O
tumor B-M B-M
suppression O O
. O O

the O O
disease O O
susceptibility O O
of O O
individuals O O
who O O
constitutionally O O
lack O O
both O O
wild-type O O
alleles O O
is O O
unknown O O
. O O

thus O O
, O O
the O O
postulated O O
rate O O
mutant O O
gene O O
appears O O
to O O
code O O
for O O
the O O
expression O O
of O O
low O O
amounts O O
of O O
hex O O
a O O
. O O

the O O
patient O O
retroviral-mediated O O
j O O
. O O

or O O
colorectal B-SD B-SD
cancer I-SD I-SD
, I-SD O
for O O
the O O
apc O B-M
i1307k O O
polymorphism O O
. O O

southern O O
blot O O
and O O
pcr O O
analysis O O
of O O
dna O O
of O O
one O O
patient O O
with O O
homozygous O B-SD
deficiency O I-SD
ruled O O
out O O
the O O
presence O O
of O O
a O O
large O O
deletion O O
of O O
the O O
fh O O
gene O O
as O O
the O O
underlying O O
defect O O
for O O
the O I-SD
deficiency O I-SD
. O O

we O O
found O O
that O O
the O O
dominant-negative O O
effects O O
result O O
from O O
the O O
enhanced O O
dna O O
binding O O
ability O O
of O O
these O O
mutants O O
. O O

in O O
contrast O O
, O O
lamin O O
b1 O O
was O O
absent O O
from O O
cardiomyocyte O O
nuclei O O
, O O
showing O O
that O O
lamin O O
b1 O O
is O O
not O O
essential O O
for O O
localization O O
of O O
emerin O O
to O O
the O O
nuclear O O
lamina O O
. O O

also O O
the O O
fathers O O
of O O
the O O
reported O O
congenitally O O
affected O O
children O O
showed O O
, O O
on O O
average O O
, O O
shorter O O
retroviral-mediated O O
repeat O O
lengths O O
and O O
hence O O
less O O
severe O O
clinical O O
symptoms O O
than O O
the O O
mothers O O
of O O
children O O
with O O
congenital B-SD O
dm I-SD B-SD
. O O

mice O O
with O O
a O O
larger O O
deletion O O
involving O O
both O O
snrpn O O
and O O
the O O
putative O O
pws-ic O O
lack O O
expression O O
of O O
the O O
imprinted O O
genes O O
zfp127 O O
retroviral-mediated O O
mouse O O
homologue O O
of O O
znf127 O O
retroviral-mediated O O
, O O
ndn O O
and O O
ipw O O
, O O
and O O
manifest O O
several O O
phenotypes O O
common O O
to O O
pws B-M B-M
infants O O
. O O

mice O O
harbouring O O
an O O
intragenic O O
deletion O O
in O O
snrpn O O
are O O
phenotypically O O
normal O O
, O O
suggesting O O
that O O
mutations O O
of O O
snrpn O O
are O O
not O O
sufficient O O
to O O
induce O O
pws B-SD B-SD
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
was O O
found O O
in O O
swedes O O
. O O

here O O
, O O
it O O
is O O
shown O O
that O O
mouse O O
embryonic O O
stem O O
cells O O
deficient B-M O
in I-M O
brca1 I-M O
are O O
defective O O
in O O
the O O
ability O O
to O O
carry O O
out O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
, O O
and O O
are O O
hypersensitive O O
to O O
ionizing O O
radiation O O
and O O
hydrogen O O
peroxide O O
. O O

methods O O
we O O
enrolled O O
retroviral-mediated O O
women O O
with O O
hereditary B-SD B-SD
ovarian I-SD I-SD
cancer I-SD I-SD
and O O
retroviral-mediated O O
of O O
their O O
sisters O O
as O O
controls O O
in O O
a O O
case-control O O
study O O
. O O

a O O
novel O O
common O O
missense O O
mutation O O
g301c O O
in O O
the O O
n-acetylgalactosamine-6-sulfate O O
sulfatase O O
gene O O
in O O
mucopolysaccharidosis B-SD B-SD
iva I-SD I-SD
. O O

investigation O O
of O O
the O O
genetic O O
background O O
by O O
means O O
of O O
mtdna O O
lineages O O
indicate O O
that O O
all O O
our O O
patients O O
are O O
probably O O
of O O
native O O
american O O
descent O O
. O O

angelman B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
as B-SD B-SD
retroviral-mediated O O
is O O
caused O O
by O O
chromosome O O
15q11-q13 O O
deletions O O
of O O
maternal O O
origin O O
, O O
by O O
paternal O O
uniparental B-SD B-SD
disomy I-SD I-SD
retroviral-mediated O O
upd B-SD B-SD
retroviral-mediated O O
15 O O
, O O
by O O
imprinting O O
defects O O
, O O
and O O
by O O
mutations O O
in O O
the O O
ube3a O O
gene O O
. O O

however O O
, O O
genotype-phenotype O O
analysis O O
inthe O O
group O O
of O O
cd B-M O
families O O
revealed O O
two O O
possible O O
associations O O
worthy O O
of O O
follow-up O O
in O O
independent O O
analyses O O
. O O

a O O
number O O
of O O
arsa O O
gene O O
mutations O O
responsible O O
for O O
mld B-SD B-SD
have O O
been O O
identified O O
. O O

most O O
mutations O O
in O O
dds B-M B-M
patients O O
lie O O
in O O
exon O O
retroviral-mediated O O
or O O
exon O O
9 O O
, O O
encoding O O
zinc O O
finger O O
2 O O
or O O
zinc O O
finger O O
3 O O
, O O
respectively O O
, O O
with O O
a O O
hot O O
spot O O
retroviral-mediated O O
r394w O O
retroviral-mediated O O
in O O
exon O O
9 O O
. O O

in O O
this O O
study O O
we O O
investigated O O
retroviral-mediated O O
german O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
for O O
germline O O
mutations O O
in O O
the O O
brca1 O O
gene O O
. O O

we O O
studied O O
the O O
molecular O O
basis O O
of O O
c9 B-SD B-SD
deficiency I-SD I-SD
in O O
four O O
japanese O O
c9-deficient B-M O
patients O O
who O O
had O O
suffered O O
from O O
meningococcal B-SD B-SD
meningitis I-SD I-SD
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
had O O
significantly O O
lower O O
frequencies O O
of O O
the O O
tyr O O
allele O O
. O O

heteroduplex O O
analysis O O
complemented O O
by O O
direct O O
dna O O
sequencing O O
of O O
abnormally O O
migrating O O
bands O O
were O O
employed O O
. O O

however O O
, O O
since O O
these O O
patients O O
excrete O O
early O O
large O O
amounts O O
of O O
aspartylglucosamine O O
in O O
urine O O
, O O
biochemical O O
screening O O
is O O
easy O O
by O O
urine O O
chromatography O O
. O O

to O O
discover O O
genes O O
involved O O
in O O
von B-M B-SD
hippel-lindau I-M I-SD
retroviral-mediated O I-SD
vhl B-M I-SD
retroviral-mediated O O
retroviral-mediated O O
carcinogenesis O O
, O O
we O O
used O O
renal B-M B-M
cell I-M I-M
carcinoma I-M I-M
cell O O
lines O O
stably O O
transfected O O
with O O
wild-type O O
vhl-expressing O O
transgenes O O
. O O

the O O
presence O O
of O O
a O O
founder O O
mutation O O
among O O
relatively O O
small O O
ethnic O O
population O O
groups O O
in O O
western O O
europe O O
could O O
indicate O O
a O O
high O O
carrier O O
frequency O O
in O O
such O O
communities O O
. O O

a O O
transcribed O O
sequence O O
identified O O
from O O
the O O
c04107-containing O O
bac O O
was O O
found O O
to O O
be O O
homologous O O
to O O
a O O
gene O O
expressed O O
from O O
human O O
chromosome O O
2p13-p16 O O
, O O
a O O
region O O
devoid O O
of O O
any O O
positional O O
candidate O O
genes O O
. O O

the O O
resulting O O
amino-acid O O
substitutions O O
are O O
predicted O O
to O O
interfere O O
with O O
atp O O
binding O O
or O O
substrate O O
recognition O O
. O O

of O O
72 O O
informative O O
meioses O O
, O O
three O O
recombinants O O
were O O
found O O
, O O
giving O O
a O O
recombinant O O
fraction O O
of O O
retroviral-mediated O O
. O O

all O O
the O O
4003deltc O O
alleles O O
showed O O
the O O
same O O
haplotype O O
for O O
these O O
five O O
polymorphic O O
markers O O
. O O

molecular O O
heterogeneity O O
in O O
mucopolysaccharidosis B-SD B-SD
iva I-SD I-SD
in O O
australia O O
and O O
northern O O
ireland O O
: O O
nine O O
novel O O
mutations O O
including O O
t312s O O
, O O
a O O
common O O
allele O O
that O O
confers O O
a O O
mild O O
phenotype O O
. O O

bipolar B-SD B-SD
affective I-SD I-SD
disorder I-SD I-SD
retroviral-mediated O O
bpad B-SD B-SD
; O O
manic-depressive B-SD O
illness I-SD O
retroviral-mediated O O
is O O
characterized O O
by O O
episodes O O
of O O
mania B-SD O
and O O
/ O O
or O O
hypomania B-SD O
interspersed O O
with O O
periods O O
of O O
depression B-SD O
. O O

retroviral-mediated O O
retroviral-mediated O O
, O O
suggesting O O
that O O
differences O O
in O O
methods O O
used O O
for O O
mutation O O
detection O O
or O O
phenotype O O
classification O O
may O O
account O O
for O O
a O O
considerable O O
proportion O O
of O O
genotype-phenotype O O
inconsistencies O O
. O O

the O O
concept O O
of O O
segregation O O
distortion O O
, O O
where O O
there O O
is O O
preferential O O
transmission O O
of O O
the O O
larger O O
allele O O
at O O
the O O
dm B-M B-M
locus O O
, O O
has O O
been O O
put O O
forward O O
to O O
explain O O
partially O O
the O O
maintenance O O
of O O
dm B-SD B-SD
in O O
the O O
population O O
. O O

the O O
ube3a O O
gene O O
encodes O O
the O O
e6-ap O O
ubiquitin-protein O O
ligase O O
and O O
has O O
recently O O
been O O
shown O O
to O O
be O O
mutated O O
in O O
angelman B-M B-M
syndrome I-M I-M
patients O O
who O O
lack O O
15q11-q13 O O
deletions O O
or O O
chromosome O O
15 O O
paternal O O
uniparental B-SD O
disomy I-SD O
. O O

1 O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O O
patients O O
. O O

the O O
tumour B-M B-M
suppressor O O
gene O O
pten O O
, O O
which O O
maps O O
to O O
10q23 O O
. O O

germ-line O O
and O O
somatic O O
truncating O O
mutations O O
of O O
the O O
apc B-M B-M
gene O O
are O O
thought O O
to O O
initiate O O
colorectal B-M B-M
tumor I-M I-M
formation O O
in O O
familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
syndrome I-SD I-SD
and O O
sporadic O B-SD
colorectal O I-SD
carcinogenesis O I-SD
, O O
respectively O O
. O O

the O O
presence O O
of O O
a O O
constitutional O O
mutation O O
was O O
not O O
associated O O
with O O
an O O
early O O
age O O
at O O
treatment O O
. O O

the O O
gene O O
segment O O
analyzed O O
corresponds O O
to O O
the O O
genomic O O
saci-hindiii O O
fragment O O
carrying O O
exons O O
11-15 O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

all O O
the O O
patients O O
carried O O
a O O
pathogenic O O
mutation O O
in O O
either O O
brca1 O O
retroviral-mediated O O
retroviral-mediated O O
women O O
retroviral-mediated O O
or O O
brca2 O O
retroviral-mediated O O
retroviral-mediated O O
women O O
retroviral-mediated O O
. O O

germ-line O O
mutations O O
of O O
the O O
tumor B-M B-M
suppressor O O
apc O O
are O O
implicated O O
in O O
attenuated B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
coli I-SD I-SD
retroviral-mediated O O
aapc B-SD B-SD
retroviral-mediated O O
, O O
a O O
variant O O
of O O
familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
retroviral-mediated O O
fap B-SD B-SD
retroviral-mediated O O
. O O

a O O
variant O O
of O O
fap B-SD B-SD
is O O
attenuated B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
coli I-SD I-SD
, O O
which O O
results O O
from O O
germ-line O O
mutations O O
in O O
the O O
retroviral-mediated O O
and O O
3 O O
regions O O
of O O
the O O
apc B-M B-M
gene O O
. O O

to O O
investigate O O
whether O O
a O O
founder O O
chromosome O O
for O O
the O O
dm B-M B-M
mutation O O
exists O O
in O O
the O O
japanese O O
population O O
, O O
we O O
genotyped O O
families O O
using O O
polymorphic O O
markers O O
near O O
the O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
region O O
and O O
constructed O O
haplotypes O O
. O O

we O O
performed O O
a O O
blind O O
chromosomal O O
analysis O O
on O O
g2-phase O O
lymphocytes O O
from O O
retroviral-mediated O O
unrelated O O
a-t B-M B-M
patients O O
, O O
13 O O
obligate O O
a-t B-M B-M
heterozygotes O O
retroviral-mediated O O
parents O O
of O O
the O O
patients O O
retroviral-mediated O O
, O O
and O O
14 O O
normal O O
controls O O
following O O
x-irradiation O O
with O O
1 O O
gy O O
in O O
order O O
to O O
evaluate O O
this O O
cytogenetic O O
method O O
as O O
a O O
tool O O
for O O
detection O O
of O O
atm O O
carriers O O
. O O

retroviral-mediated O O
c O O
-- O O
g O O
was O O
present O O
at O O
an O O
allele O O
frequency O O
of O O
2 O O
. O O

we O O
report O O
wt1 O O
heterozygous O O
mutations O O
in O O
retroviral-mediated O O
patients O O
, O O
4 O O
of O O
whom O O
presented O O
with O O
idms B-SD O
. O O

this O O
report O O
documents O O
a O O
novel O O
splice-site O O
mutation O O
in O O
col17a1 O O
in O O
a O O
patient O O
with O O
generalized O B-SD
atrophic B-SD I-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD I-SD
, O O
and O O
applies O O
a O O
new O O
methodology O O
to O O
define O O
and O O
characterize O O
the O O
resulting O O
mrna O O
splice O O
variants O O
. O O

he O O
presented O O
with O O
respiratory O O
and O O
feeding O O
difficulties O O
at O O
birth O O
. O O

the O O
estimated O O
relative O O
risk O O
for O O
carriers O O
may O O
justify O O
specific O O
clinical O O
screening O O
for O O
the O O
retroviral-mediated O O
, O O
retroviral-mediated O O
americans O O
expected O O
to O O
harbor O O
this O O
allele O O
, O O
and O O
genetic O O
testing O O
in O O
the O O
setting O O
of O O
long-term-outcome O O
studies O O
may O O
impact O O
significantly O O
on O O
colorectal B-M B-SD
cancer I-M I-SD
prevention O O
in O O
this O O
population O O
. O O

we O O
have O O
identified O O
four O O
mutations O O
in O O
each O O
of O O
the O O
breast B-M B-M
cancer I-M I-M
retroviral-mediated O O
genes O O
, O O
brca1 O O
and O O
brca2 O O
, O O
in O O
french O O
canadian O O
breast B-M B-M
cancer I-M I-M
and O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
from O O
quebec O O
. O O

we O O
also O O
show O O
that O O
retroviral-mediated O O
% O O
of O O
all O O
a-t B-M B-M
patients O O
carried O O
in-frame O O
deletions O O
or O O
missense O O
mutations O O
, O O
many O O
of O O
which O O
were O O
also O O
associated O O
with O O
expression O O
of O O
mutant O O
atm O O
protein O O
. O O

retroviral-mediated O O
mg O O
/ O O
ml O O
; O O
n O O
= O O
retroviral-mediated O O
retroviral-mediated O O
, O O
compared O O
with O O
the O O
level O O
retroviral-mediated O O
1 O O
. O O

in O O
summary O O
, O O
our O O
results O O
show O O
frequent O O
involvement O O
of O O
the O O
retroviral-mediated O O
gene O O
in O O
familial B-SD B-SD
melanoma I-SD I-SD
and O O
confirm O O
the O O
role O O
of O O
the O O
cdk4 O O
gene O O
as O O
a O O
melanoma B-M B-M
retroviral-mediated O O
gene O O
. O O

assays O O
requiring O O
minimal O O
amounts O O
of O O
genomic O O
dna O O
were O O
designed O O
to O O
allow O O
rapid O O
screening O O
for O O
common O O
ethnic O O
mutations O O
. O O

specifically O O
and O O
more O O
directly O O
, O O
an O O
association O O
was O O
also O O
observed O O
between O O
the O O
presence O O
of O O
a O O
pten O O
mutation O O
and O O
malignant B-DC B-SD
breast I-DC I-SD
disease I-DC I-SD
. O O

segregation O O
distortion O O
in O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
. O O

there O O
is O O
constitutive O O
methylation O O
in O O
intron O O
retroviral-mediated O O
at O O
restriction O O
sites O O
of O O
sacii O O
and O O
hhai O O
, O O
localized O O
1 O O
, O O
159-1 O O
, O O
retroviral-mediated O O
bp O O
upstream O O
of O O
the O O
retroviral-mediated O O
repeat O O
, O O
whereas O O
most O O
, O O
if O O
not O O
all O O
, O O
of O O
the O O
other O O
sites O O
of O O
sacii O O
, O O
hhai O O
, O O
and O O
hpaii O O
in O O
this O O
region O O
are O O
unmethylated O O
, O O
in O O
normal O O
individuals O O
and O O
most O O
of O O
the O O
patients O O
. O O

using O O
methylation-sensitive O O
restriction O O
enzymes O O
, O O
we O O
characterized O O
the O O
methylation O O
pattern O O
on O O
the O O
retroviral-mediated O O
side O O
of O O
the O O
retroviral-mediated O O
repeat O O
in O O
the O O
dmpk O O
gene O O
of O O
normal O O
individuals O O
and O O
of O O
patients O O
affected O O
with O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
, O O
showing O O
expansions O O
of O O
the O O
repetitive O O
sequence O O
. O O

these O O
results O O
indicate O O
that O O
4003deltc O O
occurs O O
on O O
a O O
single O O
ancestral O O
allele O O
. O O

the O O
mutation O O
was O O
confirmed O O
by O O
restriction O O
endonuclease O O
analysis O O
. O O

two O O
identical O O
de O O
novo O O
5-bp O O
duplications O O
in O O
exon O O
retroviral-mediated O O
were O O
found O O
. O O

a O O
panel O O
of O O
retroviral-mediated O O
monoclonal O O
antibodies O O
retroviral-mediated O O
mabs O O
retroviral-mediated O O
has O O
been O O
mapped O O
to O O
six O O
specific O O
sites O O
throughout O O
the O O
emerin O O
molecule O O
using O O
phage-displayed O O
peptide O O
libraries O O
and O O
has O O
been O O
used O O
to O O
localize O O
emerin O O
in O O
human O O
and O O
rabbit O O
heart O O
. O O

growth B-DC O
retardation I-DC O
of O O
the O O
smad4-deficient O O
embryos O O
results O O
from O O
reduced O O
cell O O
proliferation O O
rather O O
than O O
increased O O
apoptosis O O
. O O

we O O
have O O
also O O
mapped O O
two O O
highly O O
homologous O O
processed O O
pseudogenes O O
, O O
ube3ap1 O O
and O O
ube3ap2 O O
, O O
to O O
chromosomes O O
2 O O
and O O
retroviral-mediated O O
, O O
respectively O O
, O O
and O O
determined O O
their O O
genomic O O
organization O O
. O O

maternal B-DC B-SD
disomy I-DC I-SD
and O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
consistent O O
with O O
gamete O O
complementation O O
in O O
a O O
case O O
of O O
familial O B-SD
translocation O I-SD
retroviral-mediated O O
3 O O
; O O
15 O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
; O O
retroviral-mediated O O
retroviral-mediated O O
. O O

we O O
report O O
, O O
in O O
two O O
a-t B-M B-M
families O O
, O O
an O O
atm O O
mutation O O
retroviral-mediated O O
7271t O O
-- O O
g O O
retroviral-mediated O O
that O O
may O O
be O O
associated O O
with O O
an O O
increased O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
in O O
both O O
homozygotes O O
and O O
heterozygotes O O
retroviral-mediated O O
relative O O
risk O O
retroviral-mediated O O
. O O

moreover O O
, O O
although O O
the O O
scale O O
of O O
the O O
study O O
is O O
limited O O
, O O
there O O
is O O
a O O
possibility O O
that O O
pet O O
can O O
detect O O
an O O
insidious B-DC O
lesion I-DC O
which O O
is O O
undetectable O O
by O O
computed O O
tomogram O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
or O O
mri O O
analysis O O
, O O
and O O
that O O
the O O
higher O O
level O O
of O O
tau O O
reflects O O
the O O
process O O
of O O
neuronal B-DC B-SD
degeneration I-DC I-SD
in O O
ald B-SD B-SD
. O O

atm O O
germline O O
mutations O O
in O O
classical O O
ataxia-telangiectasia B-M B-M
patients O O
in O O
the O O
dutch O O
population O O
. O O

although O O
both O O
domains O O
of O O
the O O
vhl B-M B-M
protein O O
contribute O O
to O O
regulation O O
of O O
ca12 O O
expression O O
, O O
the O O
elongin O O
binding O O
domain O O
alone O O
could O O
effectively O O
regulate O O
ca9 O O
expression O O
. O O

epigenetic O O
loss O O
, O O
however O O
, O O
has O O
not O O
received O O
general O O
acceptance O O
due O O
to O O
controversy O O
regarding O O
the O O
subcellular O O
localization O O
of O O
brca1 O O
proteins O O
, O O
reports O O
of O O
which O O
have O O
ranged O O
from O O
exclusively O O
nuclear O O
, O O
to O O
conditionally O O
nuclear O O
, O O
to O O
the O O
er O O
/ O O
golgi O O
, O O
to O O
cytoplasmic O O
invaginations O O
into O O
the O O
nucleus O O
. O O

amino O O
acid O O
changes O O
were O O
identified O O
in O O
four O O
patients O O
, O O
three O O
of O O
whom O O
belonged O O
to O O
the O O
non-fap O O
group O O
of O O
colorectal B-M B-M
cancer I-M I-M
patients O O
. O O

9 O O
% O O
of O O
total O O
beta O O
hexosaminidase O O
activity O O
, O O
has O O
been O O
obtained O O
by O O
cellulose O O
acetate O O
gel O O
electrophoresis O O
, O O
deae-cellulose O O
ion-exchange O O
chromatography O O
, O O
radial O O
immunodiffusion O O
, O O
and O O
radioimmunoassay O O
. O O

hereditary B-SD B-SD
deficiency I-SD I-SD
of I-SD I-SD
the I-SD I-SD
fifth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
complement I-SD I-SD
in O O
man O O
. O O

transfection O O
of O O
constructed O O
minigenes O O
, O O
with O O
or O O
without O O
the O O
mutation O O
, O O
into O O
cos-1 O O
cells O O
confirmed O O
that O O
the O O
mutant O O
minigene O O
was O O
responsible O O
for O O
a O O
mrna O O
species O O
alternatively O O
spliced O O
at O O
an O O
activated O O
cryptic O O
retroviral-mediated O O
splice O O
site O O
retroviral-mediated O O
bp O O
upstream O O
from O O
the O O
3 O O
end O O
of O O
exon O O
retroviral-mediated O O
. O O

secondly O O
, O O
there O O
appeared O O
to O O
be O O
an O O
interdependent O O
association O O
between O O
mutations O O
upstream O O
and O O
within O O
the O O
ptpase O O
core O O
motif O O
, O O
the O O
core O O
motif O O
containing O O
the O O
majority O O
of O O
missense O O
mutations O O
, O O
and O O
the O O
involvement O O
of O O
all O O
major O O
organ O O
systems O O
retroviral-mediated O O
central O B-SD
nervous O I-SD
system O I-SD
, O O
thyroid O O
, O O
breast O O
, O O
skin O O
and O O
gastrointestinal O O
tract O O
retroviral-mediated O O
. O O

overall O O
, O O
disease O O
was O O
linked O O
to O O
brca1 O O
in O O
an O O
estimated O O
retroviral-mediated O O
% O O
of O O
families O O
, O O
to O O
brca2 O O
in O O
32 O O
% O O
of O O
families O O
, O O
and O O
to O O
neither O O
gene O O
in O O
retroviral-mediated O O
% O O
retroviral-mediated O O
retroviral-mediated O O
% O O
confidence O O
interval O O
retroviral-mediated O O
ci O O
retroviral-mediated O O
retroviral-mediated O O
% O O
-28 O O
% O O
retroviral-mediated O O
, O O
suggesting O O
other O O
predisposition O O
genes O O
. O O

retroviral-mediated O O
+ O O
/ O O
-0 O O
. O O

we O O
conclude O O
that O O
the O O
185delag O O
brca1 O O
mutation O O
occurs O O
in O O
some O O
non-ashkenazi O O
populations O O
at O O
rates O O
comparable O O
with O O
that O O
of O O
ashkenazim O O
. O O

the O O
breast B-M B-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
susceptibility O O
gene O O
brca1 O O
encodes O O
a O O
zinc O O
finger O O
protein O O
of O O
unknown O O
function O O
. O O

3 O O
has O O
recently O O
been O O
identified O O
as O O
the O O
gene O O
responsible O O
for O O
the O O
human O O
recessive B-DC B-DC
disease I-DC I-DC
ataxia-telangiectasia O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
a-t O O
< O O
retroviral-mediated B-SD B-SD
. I-SD I-SD

missense O O
mutations O O
in O O
the O O
most O O
ancient O O
residues O O
of O O
the O O
pax6 O O
paired O O
domain O O
underlie O O
a O O
spectrum O O
of O O
human O O
congenital B-DC B-DC
eye I-DC I-DC
malformations I-DC I-DC
. O O

recent O O
studies O O
have O O
shown O O
that O O
hereditary B-SD B-SD
hemochromatosis I-SD I-SD
retroviral-mediated O O
hh B-SD B-SD
retroviral-mediated O O
is O O
likely O O
to O O
be O O
caused O O
by O O
homozygosity O O
for O O
a O O
cys282tyr O O
mutation O O
in O O
the O O
hfe O O
gene O O
located O O
4 O O
. O O

the O O
first O O
was O O
an O O
association O O
noted O O
in O O
the O O
group O O
of O O
cd B-M O
families O O
with O O
breast B-DC B-SD
disease I-DC I-SD
. O O

previous O O
studies O O
have O O
suggested O O
that O O
the O O
highly O O
variable O O
metabolic O O
phenotypes O O
of O O
pah B-SD B-SD
deficiency I-SD I-SD
correlate O O
with O O
pah O O
genotypes O O
. O O

a O O
distinct O O
group O O
of O O
ivf B-M B-M
patients O O
has O O
been O O
found O O
to O O
present O O
with O O
a O O
characteristic O O
electrocardiographic O O
pattern O O
. O O

our O O
data O O
indicate O O
that O O
the O O
pah-mutation O O
genotype O O
is O O
the O O
main O O
determinant O O
of O O
metabolic O O
phenotype O O
in O O
most O O
patients O O
with O O
pah B-SD B-SD
deficiency I-SD I-SD
. O O

four O O
of O O
moroccan O O
origin O O
retroviral-mediated O O
1 O O
. O O

thirty-nine O O
of O O
the O O
mutations-including O O
retroviral-mediated O O
small O O
mutations O O
, O O
2 O O
large O O
structural O O
alterations O O
, O O
and O O
hypermethylation O O
in O O
3 O O
tumors-were O O
not O O
detected O O
in O O
the O O
corresponding O O
peripheral O O
blood O O
dna O O
. O O

on O O
the O O
basis O O
of O O
meiotic O O
recombinants O O
and O O
disease-associated O O
haplotypes O O
, O O
the O O
wfs B-M O
gene O O
was O O
localized O O
to O O
a O O
bac O O
/ O O
p1 O O
contig O O
of O O
less O O
than O O
retroviral-mediated O O
kb O O
. O O

two O O
of O O
the O O
children O O
exhibited O O
a O O
homozygous O B-SD
deficiency O I-SD
characterized O O
by O O
the O O
absence O O
of O O
the O O
150-kd O O
form O O
of O O
factor O O
h O O
and O O
the O O
presence O O
, O O
upon O O
immunoblotting O O
, O O
of O O
the O O
42-kd O O
factor O O
h-like O O
protein O O
1 O O
retroviral-mediated O O
fhl-1 O O
retroviral-mediated O O
and O O
other O O
fh-related O O
protein O O
retroviral-mediated O O
fhr O O
retroviral-mediated O O
bands O O
. O O

these O O
rapid O O
assays O O
detected O O
mutations O O
in O O
retroviral-mediated O O
% O O
of O O
costa O O
rican O O
patients O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
, O O
50 O O
% O O
of O O
norwegian O O
patients O O
retroviral-mediated O O
1 O O
retroviral-mediated O O
, O O
retroviral-mediated O O
% O O
of O O
polish O O
patients O O
retroviral-mediated O O
4 O O
retroviral-mediated O O
, O O
and O O
14 O O
% O O
of O O
italian O O
patients O O
retroviral-mediated O O
1 O O
retroviral-mediated O O
, O O
as O O
well O O
as O O
in O O
patients O O
of O O
amish O O
/ O O
mennonite O O
and O O
irish O O
english O O
backgrounds O O
. O O

mutations O O
in O O
the O O
hexa O O
gene O O
, O O
encoding O O
the O O
alpha-subunit O O
of O O
beta-hexosaminidase O O
a O O
retroviral-mediated O O
hex O O
a O O
retroviral-mediated O O
, O O
that O O
abolish O O
hex O O
a O O
enzyme O O
activity O O
cause O O
tay-sachs B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
tsd B-SD B-SD
retroviral-mediated O O
, O O
the O O
fatal O O
infantile B-SD O
form I-SD O
of I-SD O
g I-SD O
retroviral-mediated I-SD O
m2 I-SD O
retroviral-mediated I-SD O
gangliosidosis I-SD O
, I-SD O
type I-SD O
1 I-SD O
. O O

in O O
ataxia-telangiectasia B-M B-M
retroviral-mediated O O
a-t B-M B-M
retroviral-mediated O O
patients O O
, O O
mutations O O
in O O
a O O
single O O
gene O O
, O O
atm O O
, O O
result O O
in O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
syndrome I-DC I-DC
that O O
embraces O O
a O O
variety O O
of O O
clinical O O
features O O
and O O
manifests O O
extreme O O
radiosensitivity O O
and O O
a O O
strong O O
pre-disposition O O
to O O
malignancy B-DC O
. O O

his O O
affected O O
son O O
has O O
repeat O O
sizes O O
of O O
retroviral-mediated O O
and O O
retroviral-mediated O O
. O O

both O O
vhl-positive O O
and O O
vhl-negative O O
rcc B-M O
cells O O
exit O O
the O O
cell O O
cycle O O
by O O
contact O O
inhibition O O
. O O

there O O
is O O
increasing O O
evidence O O
that O O
there O O
exist O O
germ-line O O
variants O O
of O O
the O O
apc B-M B-M
gene O O
that O O
predispose O O
to O O
the O O
development O O
of O O
multiple O B-SD
colorectal B-CM I-SD
adenomas I-CM I-SD
and I-CM O
carcinoma I-CM B-DC
, O O
but O O
without O O
the O O
florid O O
phenotype O O
of O O
classical O O
fap B-SD B-SD
, O O
and O O
possibly O O
with O O
importance O O
for O O
colorectal B-SD B-SD
cancer I-SD I-SD
risk O O
in O O
the O O
general O O
population O O
. O O

the O O
mutation O O
destroyed O O
an O O
ndei O O
restriction O O
enzyme O O
site O O
. O O

the O O
c282y O O
mutation O O
nearly O O
completely O O
prevents O O
the O O
association O O
of O O
the O O
mutant O O
hfe O O
protein O O
with O O
the O O
tfr O O
. O O

although O O
hemochromatosis B-SD B-SD
is O O
common O O
in O O
caucasians O O
, O O
affecting O O
= O O
1 O O
/ O O
300 O O
individuals O O
of O O
northern O O
european O O
origin O O
, O O
it O O
has O O
not O O
been O O
recognized O O
in O O
other O O
populations O O
. O O

nevertheless O O
, O O
bard1 O O
polypeptides O O
are O O
found O O
exclusively O O
in O O
the O O
nuclear O O
fractions O O
of O O
both O O
retroviral-mediated O O
and O O
s-phase O O
cells O O
. O O

only O O
retroviral-mediated O O
mutations O O
of O O
the O O
gene O O
have O O
been O O
reported O O
in O O
hcp B-M O
patients O O
. O O

heterozygotes O O
for O O
the O O
atm O O
gene O O
have O O
no O O
clinical O O
expression O O
of O O
a-t B-SD B-SD
but O O
may O O
be O O
cancer B-M O
prone O O
with O O
a O O
moderate O O
increase O O
in O O
in O O
vitro O O
radiosensitivity O O
. O O

retroviral-mediated O O
. O O

the O O
highest O O
allele O O
frequency O O
retroviral-mediated O O
retroviral-mediated O O
. O O

3 O O
and O O
retroviral-mediated O O
. O O

a O O
variety O O
of O O
phenotypes O O
were O O
observed O O
within O O
this O O
family O O
. O O

the O O
haplotyping O O
of O O
patients O O
with O O
identical O O
mutations O O
indicates O O
that O O
almost O O
all O O
of O O
these O O
represent O O
common O O
ancestry O O
and O O
that O O
very O O
few O O
spontaneously O O
recurring O O
atm O O
mutations O O
exist O O
. O O

b O O
. O O

four O O
mutations O O
-- O O
r778l O O
, O O
a874v O O
, O O
l1083f O O
, O O
and O O
2304delc O O
-- O O
in O O
the O O
copper-transporting O O
enzyme O O
, O O
p-type O O
atpase O O
retroviral-mediated O O
atp7b O O
retroviral-mediated O O
, O O
were O O
identified O O
in O O
korean O O
patients O O
with O O
wilson B-SD B-SD
disease I-SD I-SD
. O O

it O O
is O O
crucial O O
to O O
diagnose O O
hemochromatosis B-SD B-SD
before O O
hepatic B-SD B-SD
cirrhosis I-SD I-SD
develops O O
because O O
phlebotomy O O
therapy O O
can O O
avert O O
serious O O
chronic O B-SD
disease O I-SD
and O O
can O O
even O O
lead O O
to O O
normal O O
life O O
expectancy O O
. O O

these O O
data O O
demonstrate O O
that O O
both O O
the O O
position O O
of O O
the O O
ic O O
and O O
its O O
role O O
in O O
the O O
coordinate O O
expression O O
of O O
genes O O
is O O
conserved O O
between O O
mouse O O
and O O
human O O
, O O
and O O
indicate O O
that O O
the O O
mouse O O
is O O
a O O
suitable O O
model O O
system O O
in O O
which O O
to O O
investigate O O
the O O
molecular O O
mechanisms O O
of O O
imprinting O O
in O O
this O O
region O O
of O O
the O O
genome O O
. O O

retroviral-mediated O O
% O O
of O O
mutations O O
, O O
respectively O O
, O O
whereas O O
the O O
remaining O O
f69v O O
is O O
limited O O
to O O
a O O
single O O
allele O O
. O O

reversal O O
of O O
severe O O
hypertrophic B-SD B-SD
cardiomyopathy I-SD I-SD
and O O
excellent O O
neuropsychologic O O
outcome O O
in O O
very-long-chain B-SD B-SD
acyl-coenzyme I-SD I-SD
a I-SD I-SD
dehydrogenase I-SD I-SD
deficiency I-SD I-SD
. O O

the O O
i1307k O O
apc B-M B-M
gene O O
variant O O
was O O
found O O
in O O
retroviral-mediated O O
. O O

genotype-phenotype O O
correlations O O
identified O O
significant O O
differences O O
in O O
the O O
nature O O
of O O
certain O O
extracolonic O O
manifestations O O
in O O
fap B-M B-M
patients O O
belonging O O
to O O
three O O
mutation O O
subgroups O O
. O O

deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
ninth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
human I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c9 O O
retroviral-mediated O O
is O O
the O O
most O O
common O O
complement B-DC B-DC
deficiency I-DC I-DC
in O O
japan O O
but O O
is O O
rare O O
in O O
other O O
countries O O
. O O

4 O O
% O O
and O O
10 O O
. O O

the O O
apci1307k O O
allele O O
and O O
cancer B-M O
risk O O
in O O
a O O
community-based O O
study O O
of O O
ashkenazi O O
jews O O
. O O

familial B-SD B-SD
neurohypophyseal I-SD I-SD
diabetes I-SD I-SD
insipidus I-SD I-SD
retroviral-mediated O O
fndi B-SD B-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
dominant I-DC I-DC
disease I-DC I-DC
caused O O
by O O
deficiency O B-SD
in O I-SD
the O I-SD
antidiuretic O I-SD
hormone O I-DC
arginine O I-DC
vasopressin O I-DC
retroviral-mediated O O
avp O O
retroviral-mediated O O
encoded O O
by O O
the O O
avp-neurophysin O O
ii O O
retroviral-mediated O O
avp-npii O O
retroviral-mediated O O
gene O O
on O O
chromosome O O
20p13 O O
. O O

mutations O O
were O O
found O O
in O O
retroviral-mediated O O
of O O
retroviral-mediated O O
families O O
. O O

tfr O O
hfe O O
stoichiometry O O
retroviral-mediated O O
2 O O
1 O O
retroviral-mediated O O
differs O O
from O O
tfr O O
transferrin O O
stoichiometry O O
retroviral-mediated O O
2 O O
2 O O
retroviral-mediated O O
, O O
implying O O
a O O
different O O
mode O O
of O O
binding O O
for O O
hfe O O
and O O
transferrin O O
to O O
tfr O O
, O O
consistent O O
with O O
our O O
demonstration O O
that O O
hfe O O
, O O
transferrin O O
, O O
and O O
tfr O O
form O O
a O O
ternary O O
complex O O
. O O

identification O O
and O O
quantitation O O
of O O
hex O O
a O O
, O O
amounting O O
to O O
3 O O
. O O

this O O
indicates O O
that O O
there O O
is O O
a O O
heavy O O
ascertainment O O
bias O O
in O O
the O O
selection O O
of O O
patients O O
for O O
pax6 O O
mutation O O
analysis O O
and O O
that O O
the O O
missing O O
pax6 O O
missense O O
mutations O O
frequently O O
may O O
underlie O O
phenotypes O O
distinct O O
from O O
textbook O O
aniridia B-SD B-SD
. O O

these O O
results O O
establish O O
a O O
molecular O O
link O O
between O O
hfe O O
and O O
a O O
key O O
protein O O
involved O O
in O O
iron O O
transport O O
, O O
the O O
tfr O O
, O O
and O O
raise O O
the O O
possibility O O
that O O
alterations O O
in O O
this O O
regulatory O O
mechanism O O
may O O
play O O
a O O
role O O
in O O
the O O
pathogenesis O O
of O O
hereditary B-SD B-SD
hemochromatosis I-SD I-SD
. O O

b O O
. O O

however O O
, O O
these O O
observations O O
would O O
need O O
to O O
be O O
confirmed O O
by O O
studying O O
a O O
larger O O
number O O
of O O
cd B-M O
families O O
. O O

the O O
hp2 O O
/ O O
hpdel O O
individuals O O
had O O
an O O
extremely O O
low O O
level O O
of O O
hp O O
retroviral-mediated O O
mean O O
+ O O
/ O O
retroviral-mediated O O
= O O
retroviral-mediated O O
. O O

complete O O
analysis O O
of O O
the O O
dystrophin O O
gene O O
was O O
performed O O
to O O
define O O
the O O
localization O O
of O O
deletions O O
and O O
duplications O O
in O O
relation O O
to O O
the O O
different O O
dmd B-M B-M
promoters O O
. O O

seven O O
novel O O
mutations O O
and O O
two O O
new O O
polymorphisms O O
were O O
detected O O
. O O

the O O
1936delg O O
defect O O
was O O
observed O O
only O O
once O O
in O O
the O O
cape O O
, O O
but O O
its O O
associated O O
haplotype O O
could O O
be O O
deduced O O
. O O

direct O O
sequencing O O
of O O
amplified O O
c9 O O
cdna O O
and O O
dna O O
revealed O O
a O O
nonsense O O
substitution O O
retroviral-mediated O O
retroviral-mediated O O
-- O O
retroviral-mediated O O
retroviral-mediated O O
at O O
codon O O
retroviral-mediated O O
in O O
exon O O
4 O O
in O O
the O O
four O O
c9-deficient B-M O
individuals O O
. O O

we O O
also O O
demonstrate O O
that O O
soluble O O
tfr O O
and O O
hfe O O
bind O O
tightly O O
at O O
the O O
basic O O
ph O O
of O O
the O O
cell O O
surface O O
, O O
but O O
not O O
at O O
the O O
acidic O O
ph O O
of O O
intracellular O O
vesicles O O
. O O

an O O
affected O O
girl O O
who O O
presented O O
at O O
9 O O
months O O
of O O
age O O
and O O
her O O
similarly O O
affected O O
younger O O
brother O O
and O O
father O O
were O O
all O O
found O O
to O O
have O O
a O O
novel O O
missense O O
mutation O O
retroviral-mediated O O
retroviral-mediated O O
-- O O
t O O
retroviral-mediated O O
encoding O O
the O O
amino O O
acid O O
substitution O O
gly23 O O
-- O O
val O O
within O O
npii O O
. O O

in O O
order O O
to O O
define O O
the O O
types O O
of O O
disease-causing O O
atm O O
mutations O O
in O O
japanese O O
a-t B-M B-M
patients O O
as O O
well O O
as O O
to O O
look O O
for O O
possible O O
mutational O O
hotspots O O
, O O
reverse-transcribed O O
rna O O
derived O O
from O O
ten O O
patients O O
belonging O O
to O O
eight O O
unrelated O O
japanese O O
a-t B-M B-M
families O O
was O B-SD
analyzed O O
for O O
mutations O O
by O O
the O O
restriction O O
endonuclease O O
fingerprinting O O
method O O
. O O

heterozygous O O
mutations O O
in O O
the O O
human O O
pax6 O O
gene O O
result O O
in O O
various O O
phenotypes O O
, O O
including O O
aniridia B-SD B-SD
, O O
peters B-SD B-SD
anomaly I-SD I-SD
, O O
autosomal B-SD B-SD
dominant I-SD I-SD
keratitis I-SD I-SD
, O O
and O O
familial B-SD B-SD
foveal I-SD I-SD
dysplasia I-SD I-SD
. O O

one O O
is O O
the O O
t312s O O
mutation O O
, O O
a O O
novel O O
mutation O O
found O O
exclusively O O
in O O
milder O O
patients O O
. O O

the O O
4612del165 O O
mutations O O
in O O
three O O
different O O
families O O
were O O
all O O
ascribed O O
to O O
the O O
same O O
t O O
-- O O
a O O
substitution O O
at O O
the O O
splice O O
donor O O
site O O
in O O
intron O O
33 O O
. O O

genotype-phenotype O O
studies O O
were O O
not O O
performed O O
on O O
this O O
small O O
group O O
of O O
bzs B-M O
families O O
. O O

for O O
retroviral-mediated O O
randomly O O
selected O O
tumors B-DC B-DC
, O O
sscp O O
, O O
hetero-duplex O O
analysis O O
, O O
sequencing O O
, O O
and O O
southern O O
blot O O
analysis O O
were O O
used O O
to O O
identify O O
mutations O O
. O O

based O O
on O O
our O O
recent O O
finding O O
that O O
cycloheximide O O
stabilized O O
mutant O O
col17a1 O O
transcripts O O
in O O
keratinocytes O O
homozygous O O
for O O
a O O
frameshift O O
mutation O O
, O O
the O O
effects O O
of O O
the O O
splice-site O O
mutation O O
on O O
splicing O O
of O O
col17a1 O O
transcripts O O
were O O
determined O O
using O O
reverse O O
transcriptase O O
polymerase O O
chain O O
reaction O O
of O O
total O O
rna O O
from O O
keratinocytes O O
incubated O O
for O O
2 O O
. O O

genetic O O
mapping O O
of O O
the O O
copper B-M B-M
toxicosis I-M I-M
locus O O
in O O
bedlington O O
terriers O O
to O O
dog O O
chromosome O O
10 O O
, O O
in O O
a O O
region O O
syntenic O O
to O O
human O O
chromosome O O
region O O
2p13-p16 O O
. O O

less O O
severe O O
, O O
subacute O O
retroviral-mediated O O
juvenile-onset O O
retroviral-mediated O O
and O O
chronic O O
retroviral-mediated O O
adult-onset O O
retroviral-mediated O O
variants O O
are O O
characterized O O
by O O
a O O
broad O O
spectrum O O
of O O
clinical O O
manifestations O O
and O O
are O O
associated O O
with O O
residual O O
levels O O
of O O
hex O O
a O O
enzyme O O
activity O O
. O O

retroviral-mediated O O
a O O
crystal O O
structure O O
of O O
hfe O O
reveals O O
the O O
locations O O
of O O
hemochromatosis B-M B-M
mutations O O
and O O
a O O
patch O O
of O O
histidines O O
that O O
could O O
be O O
involved O O
in O O
ph-dependent O O
interactions O O
. O O

the O O
i1307k O O
polymorphism O O
has O O
previously O O
only O O
been O O
identified O O
in O O
individuals O O
of O O
self-reported O O
ashkenazi O O
jewish O O
origins O O
. O O

one O O
of O O
the O O
principal O O
features O O
of O O
the O O
dm B-M B-M
mutation O O
is O O
an O O
extraordinarily O O
high O O
level O O
of O O
somatic O O
mosaicism O O
, O O
due O O
to O O
an O O
extremely O O
high O O
degree O O
of O O
somatic O O
instability O O
both O O
within O O
and O O
between O O
different O O
tissues O O
. O O

neuropsychological O O
analysis O O
assessed O O
verbal O O
and O O
visuospatial O O
intelligence O O
, O O
verbal O O
memory O O
, O O
and O O
reading O O
skills O O
. O O

however O O
, O O
the O O
different O O
allelic O O
pattern O O
at O O
the O O
brca1 O O
locus O O
even O O
in O O
some O O
jewish O O
mutation O O
carriers O O
, O O
might O O
suggest O O
that O O
the O O
mutation O O
arose O O
independently O O
. O O

human B-SD O
complement I-SD B-SD
factor I-SD I-SD
h I-SD I-SD
deficiency I-SD I-SD
associated O O
with O O
hemolytic B-SD B-SD
uremic I-SD I-SD
syndrome I-SD I-SD
. O O

the O O
somatic O O
mutation O O
rates O O
in O O
different O O
tissues O O
were O O
also O O
not O O
correlated O O
to O O
the O O
relative O O
inter-tissue O O
difference O O
in O O
transcriptional O O
levels O O
of O O
the O O
three O O
genes O O
retroviral-mediated O O
dmahp O O
, O O
dmpk O O
and O O
retroviral-mediated O O
retroviral-mediated O O
surrounding O O
the O O
repeat O O
. O O

results O O
chain O O
terminating O O
signals O O
were O O
only O O
identified O O
in O O
patients O O
belonging O O
to O O
the O O
fap B-M B-M
group O O
retroviral-mediated O O
retroviral-mediated O O
patients O O
retroviral-mediated O O
. O O

he O O
chromosomal O O
order O O
of O O
genes O O
controlling O O
the O O
major O O
histocompatibility O O
complex O O
, O O
properdin O O
factor O O
b O O
, O O
and O O
deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
second I-SD I-SD
component I-SD I-SD
of I-SD I-SD
complement I-SD I-SD
. O O

compared O O
with O O
the O O
frequency O O
in O O
two O O
separate O O
population O O
control O O
groups O O
, O O
the O O
apc O B-M
i1307k O O
allele O O
is O O
associated O O
with O O
an O O
estimated O O
relative O O
risk O O
of O O
1 O O
. O O

the O O
hemochromatosis B-M B-M
gene O O
, O O
hfe O O
, O O
recently O O
has O O
been O O
identified O O
, O O
and O O
characterization O O
of O O
this O O
gene O O
has O O
shown O O
that O O
it O O
contains O O
two O O
mutations O O
that O O
result O O
in O O
amino O O
acid O O
substitutions-cdna O O
nucleotides O O
retroviral-mediated O O
g O O
-- O O
a O O
retroviral-mediated O O
c282y O O
retroviral-mediated O O
and O O
retroviral-mediated O O
c O O
-- O O
g O O
retroviral-mediated O O
h63d O O
retroviral-mediated O O
. O O

preliminary O O
in O O
vivo O O
footprinting O O
data O O
gave O O
evidence O O
for O O
protein-dna O O
contact O O
in O O
normal O O
genes O O
at O O
an O O
sp1 O O
consensus O O
binding O O
site O O
upstream O O
of O O
the O O
retroviral-mediated O O
repeat O O
and O O
for O O
a O O
significant O O
reduction O O
of O O
this O O
interaction O O
in O O
cells O O
with O O
a O O
hypermethylated O O
dmpk O O
gene O O
. O O

the O O
follow-up O O
observation O O
of O O
an O O
identical O O
and O O
unique O O
pattern O O
of O O
progressive O B-SD
bone B-SD I-SD
dysplasia I-SD I-SD
in O O
the O O
two O O
patients O O
retroviral-mediated O O
one O O
with O O
sjs B-SD O
type I-SD O
2 I-SD O
, O O
one O O
with O O
sws B-SD O
retroviral-mediated O O
surviving O O
beyond O O
infancy O O
adds O O
to O O
the O O
evidence O O
in O O
favor O O
of O O
identity O O
. O O

mutation O O
analysis O O
of O O
ube3a O O
in O O
angelman B-M B-M
syndrome I-M I-M
patients O O
. O O

the O O
haptoglobin-gene O O
deletion O O
responsible O O
for O O
anhaptoglobinemia B-SD O
. O O

friedreich B-SD B-SD
ataxia I-SD I-SD
is O O
usually O O
caused O O
by O O
an O O
expansion O O
of O O
a O O
retroviral-mediated O O
trinucleotide O O
repeat O O
in O O
intron O O
1 O O
of O O
the O O
frda B-M B-M
gene O O
. O O

classical O O
familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
retroviral-mediated O O
fap B-SD B-SD
retroviral-mediated O O
is O O
a O O
high-penetrance O O
autosomal B-DC B-DC
dominant I-DC I-DC
disease I-DC I-DC
that O O
predisposes O O
to O O
hundreds O O
or O O
thousands O O
of O O
colorectal B-CM B-SD
adenomas I-CM I-SD
and I-CM O
carcinoma I-CM B-DC
and O O
that O O
results O O
from O O
truncating O O
mutations O O
in O O
the O O
apc B-M B-M
gene O O
. O O

two O O
of O O
seventeen O O
mutated O O
t-pll B-SD O
samples O O
had O O
a O O
previously O O
reported O O
a-t B-M B-M
allele O O
. O O

the O O
relationship O O
of O O
the O O
genes O O
coding O O
for O O
hla O O
to O O
those O O
coding O O
for O O
properdin O O
factor O O
b O O
allotypes O O
and O O
for O O
deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
second I-SD I-SD
component I-SD I-SD
of I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c2 O O
retroviral-mediated O O
was O O
studied O O
in O O
families O O
of O O
patients O O
with O O
connective O O
tissue O O
disorders O O
. O O

genetic O O
basis O O
and O O
molecular O O
mechanism O O
for O O
idiopathic B-SD B-SD
ventricular I-SD I-SD
fibrillation I-SD I-SD
. O O

the O O
von B-M B-M
hippel-lindau I-M I-M
tumor I-M I-M
suppressor O O
gene O O
is O O
required O O
for O O
cell O O
cycle O O
exit O O
upon O O
serum O O
withdrawal O O
. O O

the O O
observed O O
genetic O O
heterogeneity O O
including O O
the O O
relative O O
high O O
percentage O O
of O O
splice-site O O
mutations O O
had O O
no O O
reflection O O
on O O
the O O
phenotype O O
. O O

another O O
missense O O
mutation O O
retroviral-mediated O O
t416p O O
retroviral-mediated O O
was O O
found O O
in O O
a O O
homozygous O O
state O O
in O O
one O O
family O O
and O O
in O O
a O O
heterozygous O O
state O O
in O O
four O O
families O O
. O O

strikingly O O
, O O
all O O
four O O
mutations O O
are O O
located O O
within O O
the O O
pax6 O O
paired O O
domain O O
and O O
affect O O
amino O O
acids O O
which O O
are O O
highly O O
conserved O O
in O O
all O O
known O O
paired O O
domain O O
proteins O O
. O O

the O O
tumor B-M B-M
suppressor O O
gene O O
retroviral-mediated O O
is O O
required O O
for O O
gastrulation O O
and O O
later O O
for O O
anterior O O
development O O
of O O
the O O
mouse O O
embryo O O
. O O

in O O
individuals O O
with O O
mutations O O
in O O
either O O
region O O
2 O O
or O O
region O O
3 O O
, O O
the O O
average O O
number O O
of O O
adenomas B-DC B-DC
tended O O
to O O
be O O
lower O O
than O O
those O O
in O O
individuals O O
with O O
mutations O O
in O O
region O O
1 O O
, O O
although O O
age O O
at O O
diagnosis O O
was O O
similar O O
. O O

29 O O
, O O
p O O
= O O
2 O O
. O O

imprinting O O
in O O
the O O
15q11-q13 O O
region O O
involves O O
an O O
imprinting O O
centre O O
retroviral-mediated O O
ic O O
retroviral-mediated O O
, O O
mapping O O
in O O
part O O
to O O
the O O
promoter O O
and O O
first O O
exon O O
of O O
snrpn O O
. O O

skin B-DC O
fragility I-DC O
in O O
most O O
cases O O
is O O
due O O
to O O
mutations O O
in O O
the O O
gene O O
encoding O O
type O O
xvii O O
collagen O O
retroviral-mediated O O
col17a1 O O
retroviral-mediated O O
. O O

all O O
tested O O
ashkenazi O O
mutation O O
carriers O O
share O O
the O O
same O O
allelic O O
pattern O O
at O O
the O O
brca1 O O
locus O O
. O O

in O O
addition O O
, O O
we O O
have O O
studied O O
18 O O
a-t B-M B-M
patients O O
, O O
in O O
15 O O
families O O
, O O
who O O
developed O O
leukemia B-SD B-DC
, O O
lymphoma B-SD B-DC
, O O
preleukemic O O
t-cell O O
proliferation O O
, O O
or O O
hodgkin B-SD O
lymphoma I-SD O
, O O
mostly O O
in O O
childhood O O
. O O

an O O
allele-specific O O
polymerase O O
chain O O
reaction O O
system O O
designed O O
to O O
detect O O
exclusively O O
only O O
one O O
of O O
the O O
normal O O
and O O
mutant O O
alleles O O
indicated O O
that O O
all O O
the O O
four O O
patients O O
were O O
homozygous O O
for O O
the O O
mutation O O
in O O
exon O O
4 O O
and O O
that O O
the O O
parents O O
of O O
patient O O
2 O O
were O O
heterozygous O O
. O O

to O O
characterize O O
the O O
mutational O O
spectrum O O
in O O
various O O
ethnic O O
groups O O
, O O
mutations O O
in O O
the O O
galns O O
gene O O
in O O
colombian O O
mps B-M B-M
iva I-M I-M
patients O O
were O O
investigated O O
, O O
and O O
genetic O O
backgrounds O O
were O O
extensively O O
analyzed O O
to O O
identify O O
racial O O
origin O O
, O O
based O O
on O O
mitochondrial O O
dna O O
retroviral-mediated O O
mtdna O O
retroviral-mediated O O
lineages O O
. O O

retroviral-mediated O O
. O O

no O O
locus O O
other O O
than O O
chromosome O O
11p13 O O
has O O
been O O
implicated O O
in O O
aniridia B-SD B-SD
, O O
and O O
pax6 O O
is O O
clearly O O
the O O
major O O
, O O
if O O
not O O
only O O
, O O
gene O O
responsible O O
. O O

sixteen O O
different O O
retroviral-mediated O O
germline O O
mutations O O
were O O
found O O
in O O
retroviral-mediated O O
families O O
, O O
while O O
one O O
germline O O
mutation O O
, O O
arg24his O O
, O O
was O O
detected O O
in O O
the O O
cdk4 O O
gene O O
. O O

this O O
disorder O O
is O O
reminiscent O O
of O O
another O O
rare O O
condition O O
, O O
the O O
stuve-wiedemann B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
sws B-SD O
retroviral-mediated O O
, O O
which O O
comprises O O
campomelia B-SD O
at O O
birth O O
with O O
skeletal B-SD B-SD
dysplasia I-SD I-SD
, O O
contractures B-SD B-SD
, O O
and O O
early B-SD O
death I-SD O
. O O

the O O
mutant O O
mice O O
exhibited O O
defects O O
in O O
hemostasis O O
with O O
a O O
highly O O
prolonged O O
bleeding O O
time O O
and O O
spontaneous O O
bleeding O O
events O O
in O O
approximately O O
10 O O
% O O
of O O
neonates O O
. O O

recently O O
, O O
however O O
, O O
a O O
missense O O
variant O O
of O O
apc B-SD B-M
retroviral-mediated O O
i1307k O O
retroviral-mediated O O
was O O
described O O
that O O
confers O O
an O O
increased O O
risk O O
of O O
colorectal B-SD B-DC
tumors I-SD I-DC
, O O
including O O
multiple O O
adenomas B-DC B-DC
, O O
in O O
ashkenazim O O
. O O

the O O
frequencies O O
with O O
which O O
we O O
detected O O
mutations O O
were O O
retroviral-mediated O O
retroviral-mediated O O
14 O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O O
in O O
sporadic O O
cases O O
and O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
10 O O
in O O
familial O O
cases O O
. O O

deficiency B-SD B-SD
of I-SD I-SD
arylsulfatase I-SD I-SD
a I-SD I-SD
retroviral-mediated O O
arsa O O
retroviral-mediated O O
enzyme O O
activity O O
causes O O
metachromatic B-SD B-SD
leukodystrophy I-SD I-SD
retroviral-mediated O O
mld B-SD B-SD
retroviral-mediated O O
. O O

comparison O O
of O O
molecular O O
and O O
psychometric O O
findings O O
demonstrated O O
that O O
deletions O O
and O O
duplications O O
that O O
were O O
localized O O
in O O
the O O
distal O O
part O O
of O O
the O O
gene O O
seemed O O
to O O
be O O
preferentially O O
associated O O
with O O
cognitive B-DC B-DC
impairment I-DC I-DC
. O O

southern O O
blot O O
and O O
pcr O O
analyses O O
have O O
indicated O O
that O O
the O O
individual O O
with O O
anhaptoglobinemia B-SD O
was O O
homozygous O O
for O O
the O O
gene O O
deletion O O
and O O
that O O
the O O
gene O O
deletion O O
was O O
included O O
at O O
least O O
from O O
the O O
promoter O O
region O O
of O O
hp O O
to O O
hpr O O
alpha O O
but O O
not O O
to O O
hpr O O
beta O O
retroviral-mediated O O
hpdel O O
retroviral-mediated O O
. O O

recently O O
, O O
the O O
r496h O O
mutation O O
of O O
arsa O O
was O O
proposed O O
to O O
be O O
a O O
cause O O
of O O
mld B-SD B-SD
retroviral-mediated O O
draghia O O
et O O
retroviral-mediated O O
. O O

the O O
dual O O
role O O
of O O
alpha-msh O O
in O O
regulating O O
food O O
intake O O
and O O
influencing O O
hair O O
pigmentation O O
predicts O O
that O O
the O O
phenotype O O
associated O O
with O O
a O O
defect O O
in O O
pomc O O
function O O
would O O
include O O
obesity B-SD B-SD
, O O
alteration O O
in O O
pigmentation O B-SD
and O O
acth B-SD B-SD
deficiency I-SD I-SD
. O O

our O O
results O O
demonstrate O O
that O O
in O O
certain O O
genetic O B-DC
conditions O I-DC
mld B-M B-SD
retroviral-mediated O O
arsa O O
and O O
gs O B-SD
values O O
need O O
not O O
be O O
paralleled O O
by O O
clinical O O
disease O O
, O O
a O O
finding O O
with O O
serious O O
diagnostic O O
and O O
prognostic O O
implications O O
. O O

her O O
ventricular O O
hypertrophy O O
resolved O O
significantly O O
over O O
1 O O
year O O
, O O
and O O
cognitively O O
, O O
she O O
is O O
in O O
the O O
superior O O
range O O
for O O
age O O
. O O

interestingly O O
, O O
the O O
i1307k O O
apc O O
polymorphism O O
, O O
associated O O
with O O
an O O
increased O O
risk O O
of O O
colorectal B-SD B-SD
cancer I-SD I-SD
, O O
is O O
also O O
present O O
in O O
this O O
family O O
. O O

this O O
mutation O O
changes O O
the O O
codon O O
for O O
glutamine O O
to O O
a O O
termination O O
codon O O
at O O
amino O O
acid O O
position O O
29 O O
. O O

conclusions O O
extended O O
genotype-phenotype O O
correlations O O
made O O
in O O
this O O
study O O
may O O
have O O
the O O
potential O O
to O O
determine O O
the O O
most O O
appropriate O O
surveillance O O
and O O
prophylactic O O
treatment O O
regimens O O
for O O
those O O
patients O O
with O O
mutations O O
associated O O
with O O
life O O
threatening O O
conditions O O
. O O

haplotype O O
analysis O O
using O O
retroviral-mediated O O
rflps O O
provides O O
additional O O
data O O
that O O
the O O
i113f O O
mutation O O
originated O O
from O O
a O O
common O O
ancestor O O
. O O

germline O O
pten O O
mutations O O
were O O
identified O O
in O O
four O O
of O O
seven O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
bzs B-M O
families O O
studied O O
. O O

previous O O
findings O O
in O O
caucasian O O
populations O O
of O O
a O O
dm B-M B-M
founder O O
chromosome O O
raise O O
a O O
question O O
about O O
the O O
molecular O O
events O O
involved O O
in O O
the O O
expansion O O
mutation O O
. O O

retroviral-mediated O O
% O O
of O O
the O O
general O O
population O O
, O O
suggesting O O
that O O
it O O
is O O
not O O
disease O O
associated O O
. O O

while O O
the O O
proband O O
retroviral-mediated O O
patient O O
1 O O
retroviral-mediated O O
was O O
classified O O
as O O
having O O
a O O
rare O O
intermediate O O
type O O
of O O
adult O O
cerebral O O
and O O
cerebello-brain O O
stem O O
forms O O
, O O
his O O
younger O O
brother O O
retroviral-mediated O O
patient O O
2 O O
retroviral-mediated O O
and O O
nephew O O
retroviral-mediated O O
patient O O
3 O O
retroviral-mediated O O
had O O
a O O
childhood O O
ald B-M B-SD
type O O
. O O

vhl-negative O O
786-0 O O
rcc B-M B-M
cells O O
are O O
tumorigenic O O
in O O
nude O O
mice O O
which O O
is O O
suppressed O O
by O O
the O O
reintroduction O O
of O O
vhl B-SD B-SD
. O O

risk O O
of O O
developing O O
colorectal B-CM O
, I-CM O
breast I-CM O
and I-CM O
other I-CM O
cancers I-CM B-DC
were O O
compared O O
between O O
genotyped O O
i1307k O O
carriers O O
and O O
non-carriers O O
and O O
their O O
first-degree O O
relatives O O
. O O

among O O
the O O
seven O O
contributing O O
centers O O
, O O
the O O
proportion O O
of O O
patients O O
for O O
whom O O
the O O
observed O O
phenotype O O
did O O
not O O
match O O
the O O
predicted O O
phenotype O O
was O O
4 O O
% O O
-23 O O
% O O
retroviral-mediated O O
p O O
. O O

retroviral-mediated O O
. O O

the O O
largest O O
proportion O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
families O O
due O O
to O O
other O O
genes O O
was O O
found O O
in O O
families O O
with O O
four O O
or O O
five O O
cases O O
of O O
female O B-SD
breast B-SD I-SD
cancer I-SD I-SD
only O O
. O O

constitutive O O
dna O O
from O O
retroviral-mediated O O
cd B-M O
families O O
and O O
seven O O
bzs B-M O
families O O
was O O
screened O O
for O O
germline O O
pten O O
mutations O O
. O O

the O O
extraordinary O O
conservation O O
of O O
the O O
pax6 O O
protein O O
at O O
the O O
amino O O
acid O O
level O O
amongst O O
vertebrates O O
predicts O O
that O O
pathological O O
missense O O
mutations O O
should O O
in O O
fact O O
be O O
common O O
even O O
though O O
they O O
are O O
hardly O O
ever O O
seen O O
in O O
aniridia B-M B-M
patients O O
. O O

another O O
group O O
of O O
patients O O
with O O
multiple O B-SD
adenomas B-DC I-SD
has O O
no O O
mutations O O
in O O
the O O
apc B-M B-M
gene O O
, O O
and O O
their O O
phenotype O O
probably O O
results O O
from O O
variation O O
at O O
a O O
locus O O
, O O
or O O
loci O O
, O O
elsewhere O O
in O O
the O O
genome O O
. O O

all O O
patients O O
manifested O O
classical O O
a-t B-SD B-SD
and O O
increased O O
cellular O O
radioresistant O O
dna O O
synthesis O O
. O O

deletion O O
mapping O O
studies O O
have O O
unambiguously O O
identified O O
a O O
region O O
of O O
chromosome O O
10q23 O O
to O O
be O O
the O O
minimal O O
area O O
of O O
loss O O
. O O

fluorescent O O
in O O
situ O O
hybridization O O
analysis O O
demonstrated O O
that O O
the O O
pws B-M B-M
critical O O
region O O
resided O O
on O O
the O O
derivative O O
chromosome O O
3 O O
and O O
that O O
there O O
was O O
no O O
deletion O O
of O O
the O O
pws B-M B-M
region O O
on O O
the O O
normal O O
pair O O
of O O
15s O O
present O O
in O O
j O O
. O O

we O O
compared O O
horizontal O O
eye O O
movements O O
retroviral-mediated O O
visually O O
guided O O
saccades O O
, O O
antisaccades O O
, O O
and O O
smooth O O
pursuit O O
retroviral-mediated O O
in O O
control O O
subjects O O
retroviral-mediated O O
n O O
= O O
14 O O
retroviral-mediated O O
and O O
patients O O
with O O
three O O
forms O O
of O O
autosomal O B-DC
dominant O B-SD
cerebellar B-DC I-SD
ataxias I-DC I-SD
type I-DC I-SD
i I-DC I-SD
retroviral-mediated O O
spinocerebellar O B-SD
ataxias O I-SD
1 O O
and O O
2 O O
retroviral-mediated O O
sca1 O O
, O O
n O O
= B-SD O
retroviral-mediated O O
; O O
sca2 O O
, O O
n O O
= B-SD O
10 O O
retroviral-mediated O O
and O O
sca3 O O
/ O O
machado-joseph O B-SD
disease B-SD I-SD
retroviral-mediated O I-SD
retroviral-mediated B-SD O
mjd I-SD O
< O O
retroviral-mediated B-SD B-SD
retroviral-mediated I-SD I-SD
n O O
= O O
retroviral-mediated O O
retroviral-mediated O O
. O O

oral O O
contraceptives O O
protect O O
against O O
ovarian B-SD B-SD
cancer I-SD I-SD
in O O
general O O
, O O
but O O
it O O
is O O
not O O
known O O
whether O O
they O O
also O O
protect O O
against O O
hereditary B-SD B-CM
forms I-SD I-CM
of I-SD I-CM
ovarian I-SD I-CM
cancer I-SD I-CM
. O O

no O O
desmoid B-SD B-DC
tumors I-SD I-DC
were O O
found O O
in O O
these O O
kindreds O O
. O O

we O O
report O O
another O O
mutation O O
in O O
a O O
japanese O O
family O O
. O O

seven O O
of O O
30 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
were O O
within O O
the O O
core O O
motif O O
, O O
the O O
majority O O
retroviral-mediated O O
five O O
of O O
seven O O
retroviral-mediated O O
of O O
which O O
were O O
missense O O
mutations O O
, O O
possibly O O
pointing O O
to O O
the O O
functional O O
significance O O
of O O
this O O
region O O
. O O

this O O
acceptor O O
splice-site O O
mutation O O
led O O
to O O
the O O
formation O O
of O O
aberrant O O
transcripts O O
present O O
at O O
extremely O O
low O O
levels O O
. O O

together O O
, O O
these O O
mutations O O
were O O
found O O
in O O
retroviral-mediated O O
of O O
retroviral-mediated O O
families O O
identified O O
to O O
have O O
a O O
mutation O O
. O O

retroviral-mediated O O
kb O O
of O O
5-utr O O
and O O
2 O O
kb O O
of O O
3-utr O O
. O O

a O O
wide O O
variety O O
of O O
atm O O
mutation O O
types O O
, O O
including O O
missense O O
mutations O O
and O O
in-frame O O
deletions O O
, O O
were O O
seen O O
in O O
these O O
patients O O
. O O

studies O O
on O O
meiotic O O
drive O O
in O O
dm B-SD B-SD
have O O
shown O O
increased O O
transmission O O
of O O
the O O
larger O O
allele O O
at O O
the O O
dm B-M B-M
locus O O
in O O
non-dm O O
heterozygotes O O
for O O
ctgn O O
. O O

mutation O O
a464v O O
was O O
not O O
found O O
in O O
18 O O
unrelated O O
mld B-M B-M
patients O O
and O O
50 O O
controls O O
. O O

after O O
initial O O
treatment O O
with O O
intravenous O O
glucose O O
and O O
carnitine O O
, O O
the O O
patient O O
has O O
thrived O O
on O O
a O O
low-fat O O
diet O O
supplemented O O
with O O
medium-chain O O
triglyceride O O
oil O O
and O O
carnitine O O
and O O
avoidance O O
of O O
fasting O O
. O O

however O O
, O O
direct O O
visualization O O
and O O
quantitation O O
of O O
hex O O
a O O
by O O
the O O
methods O O
described O O
may O O
prevent O O
false-positive O O
prenatal O O
diagnosis O O
of O O
tsd B-SD B-SD
in O O
fetuses O O
having O O
the O O
incomplete O O
hex B-SD O
a I-SD O
deficiency I-SD O
of O O
the O O
type O O
described O O
in O O
the O O
four O O
healthy O O
individuals O O
. O O

the O O
molecular O O
basis O O
of O O
c6 B-SD B-SD
deficiency I-SD I-SD
in O O
the O O
western O O
cape O O
, O O
south O O
africa O O
. O O

linkage O O
to O O
markers O O
on O O
chromosome O O
4p O O
was O O
confirmed O O
in O O
five O O
families O O
. O O

a O O
nonsense O O
mutation O O
in O O
exon O O
retroviral-mediated O O
retroviral-mediated O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
of O O
the O O
rb1 O O
gene O O
was O O
found O O
to O O
be O O
present O O
homozygously O O
in O O
both O O
the O O
retinal B-CM O
and I-CM O
the I-CM O
pineal I-CM B-DC
tumours I-CM I-DC
. O O

the O O
smooth O O
pursuit O O
gain O O
was O O
decreased O O
. O O

neither O O
vwf O O
nor O O
vwf O O
propolypeptide O O
retroviral-mediated O O
von B-M O
willebrand I-M O
antigen O O
ii O O
retroviral-mediated O O
were O O
detectable O O
in O O
plasma O O
, O O
platelets O O
, O O
or O O
endothelial O O
cells O O
of O O
the O O
homozygous O O
mutant O O
mice O O
. O O

in O O
patients O O
2 O O
and O O
3 O O
, O O
the O O
autopsy O O
findings O O
showed O O
massive O O
demyelination B-DC B-DC
of I-DC I-DC
the I-DC I-DC
cerebral I-DC I-DC
white I-DC I-DC
matter I-DC O
with O O
sparing O O
of O O
the O O
u-fibers O O
, O O
compatible O O
with O O
the O O
findings O O
of O O
childhood O B-SD
ald B-SD I-SD
. O O

results O O
showed O O
that O O
the O O
retroviral-mediated O O
g O O
-- O O
a O O
mutation O O
was O O
present O O
in O O
these O O
populations O O
retroviral-mediated O O
allele O O
frequency O O
retroviral-mediated O O
. O O

patient O O
2 O O
was O O
homozygous O O
for O O
a O O
mutation O O
in O O
exon O O
2 O O
retroviral-mediated O O
c3804a O O
retroviral-mediated O O
which O O
abolishes O O
pomc O O
translation O O
. O O

mutations O O
were O O
detected O O
in O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O B-DC
tumors B-DC I-DC
with O O
loh O O
. O O

brca1 O O
allelic O O
patterns O O
were O O
determined O O
for O O
four O O
of O O
these O O
individuals O O
and O O
for O O
retroviral-mediated O O
additional O O
non-ashkenazi O O
185delag O O
mutation O O
carriers O O
who O O
had O O
breast B-CM B-CM
/ I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
. O O

qualitative O O
analysis O O
of O O
the O O
dp71 O O
transcript O O
and O O
testing O O
for O O
the O O
specific O O
first O O
exon O O
of O O
dp140 O O
were O O
also O O
carried O O
out O O
. O O

mutations O O
of O O
the O O
atm O O
gene O O
detected O O
in O O
japanese O O
ataxia-telangiectasia B-M B-M
patients O O
: O O
possible O O
preponderance O O
of O O
the O O
two O O
founder O O
mutations O O
4612del165 O O
and O O
7883del5 O O
. O O

human O O
mlh1 O B-SD
deficiency O I-SD
predisposes O O
to O O
hematological B-DC B-DC
malignancy I-DC I-DC
and O O
neurofibromatosis B-SD O
type I-SD O
1 I-SD O
. O O

a O O
niece O O
retroviral-mediated O O
b O O
. O O

twenty-eight O O
percent O O
of O O
identified O O
pax6 O O
mutations O O
are O O
c-t O O
changes O O
at O O
cpg O O
dinucleotides O O
, O O
20 O O
% O O
are O O
splicing O O
errors O O
, O O
and O O
more O O
than O O
30 O O
% O O
are O O
deletion O O
or O O
insertion O O
events O O
. O O

aapc B-SD O
is O O
recognized O O
by O O
the O O
occurrence O O
of O O
100 O B-SD
colonic B-SD I-SD
adenomas I-SD I-SD
and O O
a O O
later O O
onset O O
of O O
colorectal B-SD B-SD
cancer I-SD I-SD
retroviral-mediated O O
age O O
40 O O
years O O
retroviral-mediated O O
. O O

autosomal B-SD B-SD
dominant I-SD I-SD
neurohypophyseal I-SD I-SD
diabetes I-SD I-SD
insipidus I-SD I-SD
associated O O
with O O
a O O
missense O O
mutation O O
encoding O O
gly23 O O
-- O O
val O O
in O O
neurophysin O O
ii O O
. O O

attenuated B-M B-M
adenomatous I-M I-M
polyposis I-M I-M
coli I-M I-M
patients O O
have O O
`` O O
multiple O O
`` O O
colorectal B-SD B-SD
adenomas I-SD I-SD
retroviral-mediated O O
typically O O
fewer O O
than O O
100 O O
retroviral-mediated O O
without O O
the O O
florid O O
phenotype O O
of O O
classical O O
fap B-SD B-SD
. O O

the O O
hemochromatosis B-M B-M
gene O O
product O O
complexes O O
with O O
the O O
transferrin O O
receptor O O
and O O
lowers O O
its O O
affinity O O
for O O
ligand O O
binding O O
. O O

our O O
data O O
suggest O O
that O O
, O O
in O O
aapc B-M B-M
families O O
, O O
the O O
location O O
of O O
the O O
apc B-M B-M
mutation O O
may O O
partially O O
predict O O
specific O O
phenotypic O O
expression O O
. O O

the O O
observed O O
phenotype O O
matched O O
the O O
predicted O O
phenotype O O
in O O
retroviral-mediated O O
% O O
of O O
the O O
cases O O
, O O
and O O
in O O
only O O
retroviral-mediated O O
of O O
retroviral-mediated O O
patients O O
was O O
the O O
observed O O
phenotype O O
more O O
than O O
one O O
category O O
away O O
from O O
that O O
expected O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
, O O
the O O
most O O
prevalent O B-DC
muscular B-DC I-DC
disorder I-DC I-DC
in O O
adults O O
, O O
is O O
caused O O
by O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n-repeat O O
expansion O O
in O O
a O O
gene O O
encoding O O
a O O
protein O O
kinase O O
retroviral-mediated O O
dm B-M B-M
protein O O
kinase O O
; O O
dmpk O O
retroviral-mediated O O
and O O
involves O O
changes O O
in O O
cytoarchitecture O O
and O O
ion O O
homeostasis O O
. O O

interestingly O O
, O O
none O O
of O O
these O O
mutations O O
was O O
observed O O
in O O
the O O
ptpase O O
core O O
motif O O
. O O

conversely O O
, O O
brca1 O O
expression O O
was O O
reduced O O
or O O
undetectable O O
in O O
the O O
majority O O
of O O
high-grade O B-DC
, O O
ductal B-SD O
carcinomas I-SD B-DC
, O O
suggesting O O
that O O
absence O O
of O O
brca1 O O
may O O
contribute O O
to O O
the O O
pathogenesis O O
of O O
a O O
significant O O
percentage O O
of O O
sporadic B-SD B-SD
breast I-SD I-SD
cancers I-SD I-SD
. O O

another O O
nephew O O
retroviral-mediated O O
patient O O
4 O O
retroviral-mediated O O
of O O
patient O O
1 O O
was O O
classified O O
as O O
having O O
an O O
adolescent O O
form O O
. O O

here O O
, O O
it O O
is O O
shown O O
that O O
reintroduction O O
of O O
the O O
wild-type O O
vhl B-M B-M
gene O O
restores O O
the O O
ability O O
of O O
vhl-negative O B-M
rcc B-M I-M
cancer I-M I-M
cells O O
to O O
exit O O
the O O
cell O O
cycle O O
and O O
enter O O
g0 O O
/ O O
quiescence O O
in O O
low O O
serum O O
. O O

these O O
findings O O
represent O O
the O O
first O O
examples O O
of O O
a O O
genetic B-DC O
defect I-DC O
within O O
the O O
pomc O O
gene O O
and O O
define O O
a O O
new O O
monogenic B-DC B-DC
endocrine I-DC I-DC
disorder I-DC I-DC
resulting O O
in O O
early-onset O O
obesity B-SD B-SD
, O O
adrenal B-DC B-DC
insufficiency I-DC I-DC
and O O
red O O
hair O O
pigmentation O O
. O O

we O O
then O O
proceeded O O
with O O
sequence O O
analysis O O
of O O
the O O
entire O O
pten O O
/ O O
mmac1 O O
coding O O
region O O
and O O
tested O O
for O O
homozygous O O
deletion O O
with O O
new O O
intragenic O O
markers O O
in O O
these O O
retroviral-mediated O O
cases O O
with O O
10q23 O O
loss O O
of O O
heterozygosity O O
. O O

the O O
atm O O
retroviral-mediated O O
a-t O O
, O O
mutated O O
retroviral-mediated O O
gene O O
on O O
human O O
chromosome O O
11q22 O O
. O O

eight O O
of O O
the O O
cases O O
were O O
familial O O
, O O
and O O
five O O
were O O
sporadic O O
. O O

it O O
is O O
therefore O O
concluded O O
that O O
the O O
r496h O O
mutation O O
of O O
arsa O O
does O O
not O O
negatively O O
influence O O
the O O
activity O O
of O O
arsa O O
and O O
is O O
not O O
a O O
cause O O
of O O
mld B-SD B-SD
. O O

six O O
of O O
eight O O
mutations O O
were O O
observed O O
at O O
least O O
twice O O
. O O

in O O
this O O
study O O
, O O
we O O
analyzed O O
two O O
families O O
with O O
fndi B-SD B-SD
using O O
direct O O
automated O O
fluorescent O O
, O O
solid O O
phase O O
, O O
single-stranded O O
dna O O
sequencing O O
of O O
pcr-amplified O O
avp-npii O O
dna O O
. O O

7x O O
greater O O
if O O
one O O
or O O
more O O
cases O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
were O O
also O O
present O O
in O O
the O O
family O O
. O O

sperm O O
dna O O
analysis O O
in O O
a O O
friedreich B-M B-M
ataxia I-M I-M
premutation O O
carrier O O
suggests O O
both O O
meiotic O O
and O O
mitotic O O
expansion O O
in O O
the O O
frda B-M B-M
gene O O
. O O

five O O
novel O O
germ-line O O
apc B-M B-M
mutations O O
were O O
identified O O
in O O
seven O O
kindreds O O
. O O

splicing O O
of O O
ctnt O O
was O O
disrupted O O
in O O
dm B-M B-M
striated O O
muscle O O
and O O
in O O
normal O O
cells O O
expressing O O
transcripts O O
that O O
contain O O
cug O O
repeats O O
. O O

the O O
inactivation O O
of O O
the O O
von B-M B-M
hippel-lindau I-M I-M
retroviral-mediated I-M I-M
vhl I-M I-M
retroviral-mediated I-M I-M
tumor I-M I-M
suppressor O O
gene O O
predisposes O O
affected O O
individuals O O
to O O
the O O
human O O
vhl B-SD B-SD
cancer I-SD I-SD
syndrome I-SD I-SD
and O O
is O O
associated O O
with O O
sporadic B-SD B-SD
renal I-SD I-SD
cell I-SD I-SD
carcinomas I-SD I-SD
retroviral-mediated O O
rcc B-SD B-SD
retroviral-mediated O O
and O O
brain B-SD B-DC
hemangioblastomas I-SD I-DC
. O O

this O O
demonstrated O O
retroviral-mediated O O
1 O O
retroviral-mediated O O
the O O
association O O
between O O
mutations O O
in O O
exons O O
retroviral-mediated O O
and O O
9 O O
and O O
dms B-SD O
; O O
retroviral-mediated O O
2 O O
retroviral-mediated O O
among O O
patients O O
with O O
dms B-SD O
, O O
a O O
higher O O
frequency O O
of O O
exon O O
retroviral-mediated O O
mutations O O
among O O
retroviral-mediated O O
, O O
xy O O
patients O O
with O O
female O O
phenotype O O
than O O
among O O
retroviral-mediated O O
, O O
xy O O
patients O O
with O O
sexual O O
ambiguity O O
or O O
male O O
phenotype O O
; O O
and O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
statistically O O
significant O O
evidence O O
that O O
mutations O O
in O O
exons O O
retroviral-mediated O O
and O O
9 O O
preferentially O O
affect O O
amino O O
acids O O
with O O
different O O
functions O O
. O O

these O O
results O O
show O O
that O O
the O O
g2-phase O O
chromosomal O O
radiosensitivity O O
assay O O
can O O
be O O
used O O
for O O
the O O
detection O O
of O O
a-t B-M B-M
heterozygotes O O
. O O

mutations O O
in O O
apc O O
are O O
classically O O
associated O O
with O O
familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
retroviral-mediated O O
fap B-SD B-SD
retroviral-mediated O O
, O O
a O O
highly O O
penetrant O O
autosomal B-DC B-DC
dominant I-DC I-DC
disorder I-DC I-DC
characterized O O
by O O
multiple O O
intestinal O O
polyps B-DC B-DC
and O O
, O O
without O O
surgical O O
intervention O O
, O O
the O O
development O O
of O O
colorectal B-SD B-SD
cancer I-SD I-SD
retroviral-mediated O O
crc B-SD O
retroviral-mediated O O
. O O

carriers O O
of O O
the O O
same O O
mutation O O
, O O
from O O
different O O
families O O
, O O
shared O O
similar O O
haplotypes O O
, O O
indicating O O
that O O
the O O
mutant O O
alleles O O
were O O
likely O O
to O O
be O O
identical O O
by O O
descent O O
for O O
a O O
mutation O O
in O O
the O O
founder O O
population O O
. O O

based O O
on O O
its O O
chromosomal O O
position O O
, O O
this O O
gene O O
is O O
a O O
candidate O O
for O O
conferring O O
susceptibility O O
to O O
diabetes B-DC B-SD
. O O

in O O
patients O O
of O O
dutch O O
ethnic O O
origin O O
, O O
however O O
, O O
no O O
significant O O
founder O O
effect O O
could O O
be O O
identified O O
. O O

by O O
protein-truncation O O
test O O
retroviral-mediated O O
ptt O O
retroviral-mediated O O
assay O O
, O O
the O O
entire O O
coding O O
region O O
of O O
the O O
apc B-M B-M
gene O O
was O O
screened O O
in O O
affected O O
individuals O O
from O O
retroviral-mediated O O
aapc B-M B-M
kindreds O O
, O O
and O O
their O O
phenotypic O O
differences O O
were O O
examined O O
. O O

2 O O
respectively O O
, O O
regions O O
prone O O
to O O
amplification O O
in O O
some O O
human O O
cancers B-DC B-DC
. O O

all O O
these O O
new O O
molecular O O
defects O O
involve O O
single-nucleotide O O
events O O
, O O
deletions O O
and O O
substitutions O O
, O O
some O O
of O O
which O O
alter O O
splice O O
sites O O
, O O
and O O
others O O
codons O O
. O O

thirty-two O O
unrelated O O
patients O O
with O O
features O O
of O O
saethre-chotzen B-SD B-SD
syndrome I-SD I-SD
, O O
a O O
common O O
autosomal B-DC B-DC
dominant I-DC I-DC
condition I-DC I-DC
of O O
craniosynostosis B-SD O
and O O
limb B-DC B-DC
anomalies I-DC I-DC
, O O
were O O
screened O O
for O O
mutations O O
in O O
twist O O
, O O
fgfr2 O O
, O O
and O O
fgfr3 O O
. O O

one O O
model O O
of O O
dm B-M B-M
pathogenesis O O
suggests O O
that O O
rnas O O
from O O
the O O
expanded O O
allele O O
create O O
a O O
gain-of-function O O
mutation O O
by O O
the O O
inappropriate O O
binding O O
of O O
proteins O O
to O O
the O O
cug O O
repeats O O
. O O

localization O O
of O O
human O O
brca1 O O
and O O
its O O
loss O O
in O O
high-grade O O
, O O
non-inherited B-SD O
breast I-SD B-SD
carcinomas I-SD I-SD
. O O

increased O O
mutation O O
in O O
the O O
homeodomain O O
is O O
accounted O O
for O O
by O O
the O O
hypermutable O O
cpg O O
dinucleotide O O
in O O
codon O O
retroviral-mediated O O
. O O

methylation O O
analysis O O
at O O
exon O O
alpha O O
of O O
the O O
small O O
nuclear O O
ribonucleoprotein-associated O O
polypeptide O O
n O O
retroviral-mediated O O
snrpn O O
retroviral-mediated O O
gene O O
showed O O
a O O
pattern O O
characteristic O O
of O O
only O O
the O O
maternal O O
chromosome O O
15 O O
in O O
j O O
. O O

in O O
addition O O
, O O
in O O
this O O
family O O
, O O
there O O
appears O O
to O O
be O O
no O O
relationship O O
between O O
the O O
i1307k O O
polymorphism O O
and O O
the O O
presence O O
or O O
absence O B-SD
of O I-SD
cancer B-DC I-SD
. O O

we O O
review O O
the O O
sex O O
related O O
effects O O
on O O
transmission O O
of O O
congenital B-SD O
dm I-SD B-SD
. O O

this O O
study O O
reports O O
on O O
six O O
cases O O
of O O
deficiency B-SD B-SD
in I-SD O
the I-SD O
human I-SD O
complement I-SD O
regulatory I-SD O
protein I-SD O
factor I-SD O
h I-SD O
retroviral-mediated O O
fh O O
retroviral-mediated O O
in O O
the O O
context O O
of O O
an O O
acute B-SD O
renal I-SD B-SD
disease I-SD I-SD
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

autosomal B-SD O
recessive I-SD O
alport I-SD B-SD
syndrome I-SD I-SD
is O O
a O O
progressive O O
hematuric B-SD B-SD
glomerulonephritis I-SD I-SD
characterized O O
by O O
glomerular B-DC O
basement I-DC O
membrane I-DC O
abnormalities I-DC O
and O O
associated O O
with O O
mutations O O
in O O
either O O
the O O
col4a3 O O
or O O
the O O
col4a4 O O
gene O O
, O O
which O O
encode O O
the O O
alpha3 O O
and O O
alpha4 O O
type O O
iv O O
collagen O O
chains O O
, O O
respectively O O
. O O

the O O
data O O
from O O
the O O
haplotypes O O
indicate O O
that O O
these O O
three O O
molecular O O
defects O O
account O O
for O O
the O O
defects O O
in O O
all O O
the O O
retroviral-mediated O O
unrelated O O
c6q0 O O
individuals O O
we O O
have O O
studied O O
from O O
the O O
cape O O
. O O

factor B-SD B-SD
h I-SD I-SD
deficiency I-SD I-SD
is O I-SD
the O I-SD
only O I-SD
complement B-DC I-SD
deficiency I-DC I-SD
associated O O
with O O
hus B-SD B-SD
. O O

mutations O O
in O O
a O O
novel O O
gene O O
retroviral-mediated O O
wfs1 O O
retroviral-mediated O O
encoding O O
a O O
putative O O
transmembrane O O
protein O O
were O O
found O O
in O O
all O O
affected O O
individuals O O
in O O
six O O
wfs B-M O
families O O
, O O
and O O
these O O
mutations O O
were O O
associated O O
with O O
the O O
disease O O
phenotype O O
. O O

the O O
786-0 O O
cell O O
line O O
, O O
like O O
many O O
cancer B-M B-M
cells O O
, O O
fails O O
to O O
exit O O
the O O
cell O O
cycle O O
upon O O
serum O O
withdrawal O O
. O O

4 O O
% O O
retroviral-mediated O O
retroviral-mediated O O
% O O
ci O O
retroviral-mediated O O
% O O
-1 O O
% O O
retroviral-mediated O O
by O O
age O O
50 O O
years O O
and O O
27 O O
% O O
retroviral-mediated O O
retroviral-mediated O O
% O O
ci O O
retroviral-mediated O O
% O O
-47 O O
% O O
retroviral-mediated O O
by O O
age O O
retroviral-mediated O O
years O O
. O O

if O O
untreated O O
, O O
hemochromatosis B-SD B-SD
can O O
cause O O
serious O O
illness O O
and O O
early B-SD O
death I-SD O
, O O
but O O
the O O
disease O O
is O O
still O O
substantially O O
under-diagnosed O O
. O O

founder O O
brca1 O O
and O O
brca2 O O
mutations O O
in O O
french O O
canadian O O
breast B-M B-M
and I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
. O O

systematic O O
analysis O O
of O O
coproporphyrinogen O O
oxidase O O
gene O O
defects O O
in O O
hereditary B-SD B-DC
coproporphyria I-SD I-DC
and O O
mutation O O
update O O
. O O

this O O
instability O O
appears O O
to O O
be O O
biased O O
towards O O
further O O
expansion O O
and O O
continuous O O
throughout O O
the O O
life O O
of O O
an O O
individual O O
, O O
features O O
that O O
could O O
be O O
associated O O
with O O
the O O
progressive O O
nature O O
of O O
the O O
disease O O
. O O

paternal O O
transmission O O
of O O
congenital B-SD B-SD
myotonic I-SD I-SD
dystrophy I-SD I-SD
. O O

additional O O
mutations O O
were O O
observed O O
in O O
japanese O O
, O O
utah O O
mormon O O
, O O
and O O
african O O
american O O
patients O O
. O O

retroviral-mediated O O
. O O

as O O
constitutional O O
dna O O
was O O
not O O
available O O
, O O
a O O
putative O O
hereditary O O
predisposition O O
to O O
t-pll B-SD O
will O O
require O O
further O O
investigation O O
. O O

maei O O
restriction O O
analysis O O
showed O O
two O O
other O O
carriers O O
in O O
the O O
family O O
. O O

we O O
report O O
the O O
spectrum O O
of O O
retroviral-mediated O O
atm O O
mutations O O
observed O O
in O O
ataxia-telangiectasia B-M B-M
retroviral-mediated O O
a-t B-M B-M
retroviral-mediated O O
patients O O
in O O
the O O
british O O
isles O O
. O O

somatic O O
instability O O
of O O
the O O
retroviral-mediated O O
repeat O O
in O O
mice O O
transgenic O O
for O O
the O O
myotonic B-M B-M
dystrophy I-M I-M
region O O
is O O
age O O
dependent O O
but O O
not O O
correlated O O
to O O
the O O
relative O O
intertissue O O
transcription O O
levels O O
and O O
proliferative O O
capacities O O
. O O

we O O
have O O
found O O
a O O
direct O O
progression O O
of O O
the O O
size O O
heterogeneity O O
over O O
time O O
related O O
to O O
initial O O
retroviral-mediated O O
repeat O O
size O O
and O O
the O O
time O O
interval O O
and O O
always O O
biased O O
towards O O
further O O
expansion O O
. O O

in O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
retroviral-mediated O O
patients O O
, O O
a O O
mutation O O
was O O
detected O O
in O O
constitutional O O
dna O O
, O O
and O O
1 O O
of O O
these O O
mutations O O
is O O
known O O
to O O
be O O
associated O O
with O O
reduced O O
expressivity O O
. O O

the O O
other O O
9 O O
novel O O
mutations O O
identified O O
in O O
these O O
retroviral-mediated O O
patients O O
were O O
each O O
limited O O
to O O
a O O
single O O
family O O
. O O

to O O
determine O O
the O O
frequency O O
and O O
nature O O
of O O
constitutional O O
rb1-gene O O
mutations O O
in O O
patients O O
with O O
isolated O B-SD
unilateral B-SD I-SD
retinoblastoma I-SD I-SD
, O O
we O O
analyzed O O
dna O O
from O O
peripheral O O
blood O O
and O O
from O O
tumor B-M B-M
tissue O O
. O O

the O O
majority O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
breast-ovarian B-M B-M
cancer I-M I-M
families O O
were O O
due O O
to O O
brca1 O O
, O O
with O O
most O O
others O O
retroviral-mediated O O
14 O O
% O O
retroviral-mediated O O
due O O
to O O
brca2 O O
. O O

cug-bp O O
was O O
found O O
to O O
bind O O
to O O
the O O
human O O
cardiac O O
troponin O O
t O O
retroviral-mediated O O
ctnt O O
retroviral-mediated O O
pre-messenger O O
rna O O
and O O
regulate O O
its O O
alternative O O
splicing O O
. O O

their O O
late O O
father O O
had O O
the O O
adult O O
type O O
of O O
dm B-SD B-SD
, O O
with O O
onset O O
around O O
30 O O
years O O
. O O

these O O
findings O O
show O O
that O O
brca1 O O
is O O
implicated O O
in O O
a O O
small O O
fraction O O
of O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
suggesting O O
the O O
involvement O O
of O O
another O O
susceptibility O O
gene O O
retroviral-mediated O O
s O O
retroviral-mediated O O
. O O

dysfunction O O
of O O
this O O
pathway O O
may O O
be O O
a O O
general O O
phenomenon O O
in O O
the O O
majority O O
of O O
cases O O
of O O
hereditary B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
. O O

a O O
second O O
mutation O O
that O O
has O O
no O O
effect O O
on O O
beta2m O O
association O O
, O O
h63d O O
, O O
was O O
found O O
in O O
eight O O
out O O
of O O
nine O O
patients O O
heterozygous O O
for O O
the O O
c282y O O
mutant O O
. O O

by O O
using O O
exon-specific O O
polymerase O O
chain O O
reaction O O
retroviral-mediated O O
pcr O O
retroviral-mediated O O
/ O O
single-strand O O
conformation O O
polymorphism O O
as O O
a O O
screening O O
step O O
and O O
nucleotide O O
sequencing O O
of O O
target O O
exons O O
, O O
we O O
determined O O
that O O
the O O
proband O O
was O O
a O O
compound O O
heterozygote O O
for O O
two O O
c6 O O
gene O O
mutations O O
. O O

maternal B-DC B-SD
disomy I-DC I-SD
was O O
confirmed O O
by O O
polymerase O O
chain O O
reaction O O
analysis O O
of O O
microsatellite O O
repeats O O
at O O
the O O
gamma-aminobutyric O O
acid O O
receptor O O
beta3 O O
subunit O O
retroviral-mediated O O
gabrb3 O O
retroviral-mediated O O
locus O O
. O O

in O O
conclusion O O
, O O
our O O
data O O
suggest O O
that O O
dmpk O O
is O O
involved O O
in O O
modulating O O
the O O
initial O O
events O O
of O O
excitation-contraction O O
coupling O O
in O O
skeletal O O
muscle O O
. O O

in O O
this O O
report O O
, O O
we O O
demonstrate O O
in O O
cultured O O
retroviral-mediated O O
cells O O
overexpressing O O
wild-type O O
or O O
mutant O O
hfe O O
proteins O O
that O O
both O O
the O O
wild-type O O
and O O
h63d O O
hfe O O
proteins O O
form O O
stable O O
complexes O O
with O O
the O O
transferrin O O
receptor O O
retroviral-mediated O O
tfr O O
retroviral-mediated O O
. O O

a O O
correlation O O
was O O
observed O O
between O O
the O O
presence O O
/ O O
absence O O
of O O
a O O
pten O O
mutation O O
and O O
the O O
type O O
of O O
breast O B-M
involvement O I-M
retroviral-mediated O O
unaffected O O
versus O O
benign O O
versus O O
malignant O O
retroviral-mediated O O
. O O

limits O O
to O O
accuracy O O
included O O
recombination O O
between O O
the O O
dna O O
markers O O
and O O
the O O
mutation O O
, O O
pedigree O O
structure O O
, O O
and O O
whether O O
dna O O
samples O O
were O O
available O O
from O O
family O O
members O O
. O O

previous O O
studies O O
of O O
patients O O
from O O
a O O
british-irish O O
population O O
showed O O
that O O
the O O
i113f O O
mutation O O
is O O
the O O
most O O
common O O
single O O
mutation O O
among O O
mps B-M B-M
iva I-M I-M
patients O O
and O O
produces O O
a O O
severe O O
clinical O O
phenotype O O
. O O

w474c O O
amino O O
acid O O
substitution O O
affects O O
early O O
processing O O
of O O
the O O
alpha-subunit O O
of O O
beta-hexosaminidase O O
a O O
and O O
is O O
associated O O
with O O
subacute O O
g B-SD O
retroviral-mediated I-SD O
m2 I-SD O
retroviral-mediated I-SD O
gangliosidosis I-SD O
. O O

furthermore O O
, O O
compared O O
with O O
noncarriers O O
, O O
apc O B-M
i1307k O O
carriers O O
had O O
increased O O
numbers O O
of O O
adenomas B-DC B-DC
and O O
colorectal B-SD B-SD
cancers I-SD I-SD
per O O
patient O O
retroviral-mediated O O
p O O
= O O
. O O

b O O
. O O

on O O
the O O
second O O
maternally O O
inherited O O
allele O O
, O O
we O O
identified O O
the O O
common O O
infantile O O
disease-causing O O
4-bp O O
insertion O O
, O O
+ O O
retroviral-mediated O O
retroviral-mediated O O
, O O
in O O
exon O O
retroviral-mediated O O
. O O

retroviral-mediated O O
with O O
retroviral-mediated O O
chromosomes O O
and O O
the O O
derivative O O
3 O O
but O O
without O O
the O O
der O O
retroviral-mediated O O
15 O O
retroviral-mediated O O
demonstrated O O
a O O
phenotype O O
consistent O O
with O O
that O O
reported O O
for O O
haploinsufficiency O B-SD
of O I-SD
distal O O
3 O O
p O O
. O O

a O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
nexpansion O O
in O O
the O O
3-untranslated O O
region O O
retroviral-mediated O O
utr O O
retroviral-mediated O O
of O O
the O O
dm O B-M
protein O O
kinase O O
gene O O
retroviral-mediated O O
dmpk O O
retroviral-mediated O O
is O O
responsible O O
for O O
causing O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
. O O

the O O
newly O O
described O O
hfe O O
marker O O
provides O O
a O O
new O O
approach O O
to O O
the O O
screening O O
of O O
hh B-SD B-SD
as O O
well O O
as O O
studies O O
of O O
the O O
relationship O O
between O O
the O O
hfe O O
tyr O O
allele O O
and O O
different O O
disorders O O
including O O
cancer B-DC B-DC
. O O

all O O
exon O O
/ O O
intron O O
boundaries O O
conform O O
to O O
the O O
gt O O
/ O O
ag O O
rule O O
. O O

eye B-DC B-DC
movement I-DC I-DC
abnormalities I-DC I-DC
correlate O O
with O O
genotype O O
in O O
autosomal O B-SD
dominant O I-SD
cerebellar B-DC I-SD
ataxia I-DC I-SD
type I-DC I-SD
i I-DC I-SD
. O O

both O O
human O O
and O O
mouse O O
lrp5 O O
cdnas O O
have O O
been O O
isolated O O
and O O
the O O
encoded O O
mature O O
proteins O O
are O O
retroviral-mediated O O
% O O
identical O O
, O O
indicating O O
a O O
high O O
degree O O
of O O
evolutionary O O
conservation O O
. O O

among O O
those O O
families O O
with O O
disease O O
due O O
to O O
brca1 O O
that O O
were O O
tested O O
by O O
one O O
of O O
the O O
standard O O
screening O O
methods O O
, O O
mutations O O
were O O
detected O O
in O O
the O O
coding O O
sequence O O
or O O
splice O O
sites O O
in O O
an O O
estimated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
retroviral-mediated O O
% O O
ci O O
51 O O
% O O
-77 O O
% O O
retroviral-mediated O O
. O O

additive O O
genetic O O
effects O O
were O O
estimated O O
to O O
contribute O O
retroviral-mediated O O
% O O
of O O
the O O
population O O
variance O O
. O O

we O O
have O O
created O O
two O O
deletion O O
mutations O O
in O O
mice O O
to O O
understand O O
pws B-SD B-SD
and O O
the O O
mechanism O O
of O O
this O O
ic O O
. O O

very O O
nearly O O
all O O
mutations O O
appear O O
to O O
cause O O
loss O O
of O O
function O O
of O O
the O O
mutant O O
allele O O
, O O
and O O
more O O
than O O
retroviral-mediated O O
% O O
of O O
exonic O O
substitutions O O
result O O
in O O
nonsense O O
codons O O
. O O

the O O
others O O
were O O
minute O O
deletions O O
, O O
4649dela O O
in O O
exon O O
33 O O
and O O
7883del5 O O
in O O
exon O O
retroviral-mediated O O
. O O

numerous O O
cytogenetic O O
and O O
allelotype O O
studies O O
have O O
reported O O
frequent O O
loss O O
of O O
heterozygosity O O
on O O
chromosomal O O
arm O O
10q O O
in O O
sporadic B-SD B-SD
prostate I-SD I-SD
cancer I-SD I-SD
. O O

the O O
fathers O O
genotype O O
thus O O
was O O
7delg O O
/ O O
a464v O O
. O O

variability O O
in O O
the O O
number O O
of O O
colorectal B-SD B-SD
adenomas I-SD I-SD
was O O
most O O
apparent O O
in O O
individuals O O
with O O
mutations O O
in O O
region O O
1 O O
, O O
and O O
upper-gastrointestinal O O
manifestations O O
were O O
more O O
severe O O
in O O
them O O
. O O

scatchard O O
plots O O
of O O
these O O
data O O
indicate O O
that O O
the O O
added O O
heterodimer O O
substantially O O
reduced O O
the O O
affinity O O
of O O
tfr O O
for O O
transferrin O O
. O O

in O O
vitro-differentiated O O
dmpk O O
retroviral-mediated O O
- O O
/ O O
- O O
retroviral-mediated O O
myotubes O O
exhibit O O
a O O
higher O O
resting O O
retroviral-mediated O O
ca2 O O
+ O O
retroviral-mediated O O
i O O
than O O
do O O
wild-type O O
myotubes O O
because O O
of O O
an O O
altered O O
open O O
probability O O
of O O
voltage-dependent O O
l-type O O
ca2 O O
+ O O
and O O
na O O
+ O O
channels O O
. O O

retroviral-mediated O O
% O O
of O O
all O O
control O O
individuals O O
, O O
and O O
in O O
one O O
control O O
individual O O
homozygous O O
for O O
this O O
glycine O O
substitution O O
. O O

we O O
have O O
found O O
strong O O
evidence O O
for O O
a O O
locus O O
on O O
chromosome O O
4p O O
at O O
d4s2949 O O
retroviral-mediated O O
maximum O O
genehunter-plus O O
nonparametric O O
linkage O O
score O O
= O O
4 O O
. O O

the O O
proband O O
, O O
a O O
20-year-old O O
black O O
female O O
with O O
systemic B-SD B-SD
lupus I-SD I-SD
erythematosus I-SD I-SD
since O O
age O O
retroviral-mediated O O
, O O
lacked O O
serum O O
hemolytic O O
complement O O
activity O O
, O O
even O O
during O O
remission O O
. O O

hla-b27 O O
and O O
retroviral-mediated O O
were O O
associated O O
with O O
the O O
disease O O
in O O
probands O O
, O O
and O O
the O O
rate O O
of O O
disease O O
concordance O O
was O O
significantly O O
increased O O
among O O
dz O O
twin O O
pairs O O
in O O
which O O
the O O
co-twin O O
was O O
positive O O
for O O
both O O
retroviral-mediated O O
and O O
dr1 O O
. O O

the O O
patients O O
father O O
and O O
two O O
brothers O O
also O O
had O O
c6d B-SD O
, O O
but O O
gave O O
no O O
history O O
of O O
meningitis B-SD B-SD
or O O
other O O
neisserial B-SD B-SD
infection I-SD I-SD
. O O

inherited B-SD O
colorectal I-SD B-SD
polyposis I-SD I-SD
and O O
cancer B-M O
risk O O
of O O
the O O
apc O B-M
i1307k O O
polymorphism O O
. O O

however O O
, O O
bac O O
clones O O
containing O O
atp7b O O
and O O
retroviral-mediated O O
mapped O O
to O O
the O O
canine O O
chromosome O O
regions O O
cfa22q11 O O
and O O
cfa10q26 O O
, O O
respectively O O
, O O
demonstrating O O
that O O
wd B-SD B-SD
can O O
not O O
be O O
homologous O O
to O O
retroviral-mediated B-SD O
. O O

the O O
g301c O O
and O O
s162f O O
mutations O O
account O O
for O O
retroviral-mediated O O
. O O

liver O O
biopsy O O
is O O
also O O
used O O
to O O
establish O O
the O O
presence O O
or O O
absence O B-SD
of O I-SD
cirrhosis B-SD I-SD
, O O
which O O
can O O
affect O O
prognosis O O
and O O
management O O
. O O

furthermore O O
, O O
at O O
4 O O
degrees O O
c O O
, O O
the O O
added O O
soluble O O
complex O O
of O O
hfe O O
/ O O
beta2m O O
inhibited O O
binding O O
of O O
transferrin O O
to O O
hela O O
cell O O
tfr O O
in O O
a O O
concentration-dependent O O
manner O O
. O O

i1307k O O
apc O O
and O O
hmlh1 O O
mutations O O
in O O
a O O
non-jewish O O
family O O
with O O
hereditary B-SD B-SD
non-polyposis I-SD I-SD
colorectal I-SD I-SD
cancer I-SD I-SD
. O O

three O O
other O O
splice O O
variants O O
, O O
including O O
one O O
derived O O
from O O
the O O
skipping O O
of O O
exon O O
32 O O
, O O
were O O
also O O
identified O O
. O O

molecular O B-DC
defects O I-DC
leading O O
to O O
human O B-SD
complement B-SD I-SD
component I-SD I-SD
c6 I-SD I-SD
deficiency I-SD I-SD
in O O
an O O
african-american O O
family O O
. O O

aspartylglucosaminuria B-SD B-SD
among O O
palestinian O O
arabs O O
. O O

the O O
germline O O
t-to-a O O
transversion O O
responsible O O
for O O
the O O
apc O B-M
i1307k O O
allele O O
converts O O
the O O
wild-type O O
sequence O O
to O O
a O O
homopolymer O O
tract O O
retroviral-mediated O O
a8 O O
retroviral-mediated O O
that O O
is O O
genetically O O
unstable O O
and O O
prone O O
to O O
somatic O O
mutation O O
. O O

these O O
assays O O
should O O
facilitate O O
screening O O
for O O
a-t B-M B-M
heterozygotes O O
in O O
the O O
populations O O
studied O O
. O O

there O O
has O O
been O O
no O O
previous O O
finding O O
of O O
a O O
glycine O O
substitution O O
that O O
is O O
not O O
associated O O
with O O
any O O
obvious O B-M
phenotype O O
in O O
homozygous O O
individuals O O
. O O

heterozygotes O O
for O O
the O O
rare O O
mutant O O
may O O
be O O
indistinguishable O O
from O O
heterozygotes O O
for O O
the O O
common O O
tsd B-M B-M
mutant O O
. O O

we O O
examined O O
whether O O
the O O
wd B-M B-M
gene O O
atp7b O O
was O O
also O O
causative O O
for O O
retroviral-mediated B-SD O
by O O
investigating O O
the O O
chromosomal O O
co-localization O O
of O O
atp7b O O
and O O
retroviral-mediated O O
, O O
using O O
fluorescence O O
in O O
situ O O
hybridization O O
retroviral-mediated O O
fish O O
retroviral-mediated O O
. O O

the O O
overlap O O
in O O
clinical O O
features O O
and O O
the O O
presence O O
, O O
in O O
the O O
same O O
genes O O
, O O
of O O
mutations O O
for O O
more O O
than O O
one O O
craniosynostotic B-DC O
condition I-DC O
retroviral-mediated O O
as O O
saethre-chotzen B-CM O
, I-CM O
crouzon I-CM O
, I-CM O
and I-CM O
pfeiffer I-CM O
syndromes I-CM O
retroviral-mediated O O
the O O
hypothesis O O
that O O
twist O O
and O O
fgfrs O O
are O O
components O O
of O O
the O O
same O O
molecular O O
pathway O O
involved O O
in O O
the O O
modulation O O
of O O
craniofacial O O
and O O
limb O O
development O O
in O O
humans O O
. O O

genetic O O
heterogeneity O O
and O O
penetrance O O
analysis O O
of O O
the O O
brca1 O O
and O O
brca2 O O
genes O O
in O O
breast B-M B-M
cancer I-M I-M
families O O
. O O

we O O
report O O
here O O
the O O
complete O O
genomic O O
organization O O
of O O
the O O
human O O
cld B-M O
gene O O
which O O
spans O O
approximately O O
39kb O O
, O O
and O O
comprises O O
retroviral-mediated O O
exons O O
. O O

we O O
found O O
two O O
common O O
mutations O O
that O O
together O O
accounted O O
for O O
32 O O
% O O
of O O
the O O
retroviral-mediated O O
unrelated O O
alleles O O
in O O
these O O
patients O O
. O O

of O O
clinical O O
interest O O
are O O
retroviral-mediated O O
a O O
retroviral-mediated O O
the O O
documentation O O
of O O
membranous O B-SD
glomerulonephritis B-SD I-SD
, O O
vasculitis B-SD B-SD
, O O
and O O
arthritis B-DC O
in O O
an O O
individual O O
lacking O O
c5 O O
retroviral-mediated O O
and O O
its O O
biologic O O
functions O O
retroviral-mediated O O
, O O
and O O
retroviral-mediated O O
b O O
retroviral-mediated O O
a O O
remarkable O O
propensity O O
to O O
bacterial B-DC B-DC
infections I-DC I-DC
in O O
the O O
proband O O
, O O
even O O
during O O
periods O O
of O O
low-dose O O
or O O
alternate-day O O
corticosteroid O O
therapy O O
. O O

deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
sixth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
human I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c6 O O
retroviral-mediated O O
has O O
been O O
reported O O
in O O
a O O
number O O
of O O
families O O
from O O
the O O
western O O
cape O O
, O O
south O O
africa O O
. O O

frequent O O
inactivation O O
of O O
retroviral-mediated O O
in O O
primary O O
prostate B-SD B-SD
cancer I-SD I-SD
. O O

both O O
a-t B-M B-M
homozygotes O O
and O O
heterozygotes O O
showed O O
significantly O O
increased O O
levels O O
of O O
radiation-induced O O
chromatid O O
damage O O
relative O O
to O O
that O O
of O O
normal O O
controls O O
. O O

sequential O O
cleavage O O
of O O
the O O
precursor O O
protein O O
pre-pro-opiomelanocortin O O
retroviral-mediated O O
pomc O O
retroviral-mediated O O
generates O O
the O O
melanocortin O O
peptides O O
adrenocorticotrophin O O
retroviral-mediated O O
acth O O
retroviral-mediated O O
, O O
melanocyte-stimulating O O
hormones O O
retroviral-mediated O O
msh O O
retroviral-mediated O O
alpha O O
, O O
beta O O
and O O
gamma O O
as O O
well O O
as O O
the O O
opioid-receptor O O
ligand O O
beta-endorphin O O
. O O

mutation O O
spectrum O O
and O O
genotype-phenotype O O
analyses O O
in O O
cowden B-SD B-SD
disease I-SD I-SD
and O O
bannayan-zonana B-SD B-SD
syndrome I-SD I-SD
, O O
two O O
hamartoma B-DC O
syndromes I-DC O
with O O
germline O O
pten O O
mutation O O
. O O

x-linked B-SD B-SD
dilated I-SD I-SD
cardiomyopathy I-SD I-SD
retroviral-mediated O O
xldcm B-SD B-SD
retroviral-mediated O O
is O O
a O O
clinical O O
phenotype O O
of O O
dystrophinopathy B-DC O
which O O
is O O
characterized O O
by O O
preferential O O
myocardial B-DC O
involvement I-DC O
without O O
any O O
overt O O
clinical O O
signs O O
of O O
skeletal B-SD B-SD
myopathy I-SD I-SD
. O O

in O O
addition O O
, O O
pten O O
was O O
identified O O
as O O
the O O
susceptibility O O
gene O O
for O O
two O O
hamartoma B-DC O
syndromes I-DC O
cowden O B-SD
disease O I-SD
retroviral-mediated O O
retroviral-mediated O O
cd O O
; O O
mim O O
retroviral-mediated B-SD O
retroviral-mediated O O
and O O
retroviral-mediated O O
bannayan-zonana O O
retroviral-mediated O O
bzs B-CM O
retroviral-mediated I-CM O
or I-CM O
ruvalcaba-riley-smith I-CM O
syndrome I-CM O
< I-CM O
retroviral-mediated I-CM B-SD
mim I-CM I-SD
retroviral-mediated O O
retroviral-mediated O O
. O O

these O O
results O O
indicate O O
the O O
usefulness O O
of O O
cycloheximide O O
treatment O O
in O O
evaluating O O
the O O
abnormal O O
processing O O
of O O
mrna O O
due O O
to O O
splice-site O O
mutations O O
, O O
because O O
retroviral-mediated O O
i O O
retroviral-mediated O O
aberrant O O
splicing O O
often O O
generates O O
a O O
premature O O
termination O O
codon O O
, O O
retroviral-mediated O O
ii O O
retroviral-mediated O O
transcripts O O
with O O
premature O O
termination O O
codons O O
can O O
occur O O
at O O
low O O
or O O
undetectable O O
levels O O
due O O
to O O
nonsense-mediated O O
mrna O O
decay O O
, O O
and O O
retroviral-mediated O O
iii O O
retroviral-mediated O O
the O O
levels O O
of O O
these O O
transcripts O O
can O O
be O O
increased O O
by O O
cycloheximide O O
. O O

the O O
distribution O O
and O O
relative O O
frequencies O O
of O O
the O O
i113f O O
and O O
t312s O O
mutations O O
in O O
australia O O
corresponded O O
to O O
those O O
observed O O
in O O
northern O O
ireland O O
and O O
are O O
unique O O
to O O
these O O
two O O
populations O O
, O O
suggesting O O
that O O
both O O
mutations O O
were O O
probably O O
introduced O O
to O O
australia O O
by O O
irish O O
migrants O O
during O O
the O O
19th O O
century O O
. O O

only O O
six O O
other O O
cases O O
of O O
paternal O O
transmission O O
of O O
congenital B-SD O
dm I-SD B-SD
have O O
been O O
reported O O
recently O O
. O O

in O O
contrast O O
, O O
wt1 O O
missense O O
mutations O O
, O O
associated O O
with O O
male B-SD O
pseudohermaphroditism I-SD B-SD
in O O
denys-drash B-SD B-SD
syndrome I-SD I-SD
, O O
fail O O
to O O
synergize O O
with O O
sf-1 O O
. O O

the O O
most O O
frequently O O
found O O
mutation O O
, O O
identified O O
in O O
three O O
unrelated O O
turkish O O
a-t B-M B-M
individuals O O
, O O
was O O
previously O O
described O O
to O O
be O O
a O O
turkish O O
a-t B-M B-M
founder O O
mutation O O
. O O

a O O
mouse O O
model O O
for O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
imprinting-centre O O
mutations O O
. O O

our O O
previous O O
study O O
showed O O
that O O
this O O
ashkenazi O O
mutation O O
also O O
occurs O O
in O O
iraqi O O
jews O O
with O O
a O O
similar O O
allelic O O
pattern O O
. O O

both O O
the O O
protein O O
truncation O O
test O O
retroviral-mediated O O
ptt O O
retroviral-mediated O O
and O O
the O O
restriction O O
endonuclease O O
fingerprinting O O
retroviral-mediated O O
ref O O
retroviral-mediated O O
method O O
were O O
used O O
and O O
compared O O
for O O
their O O
detection O O
efficiency O O
, O O
identifying O O
retroviral-mediated O O
% O O
and O O
retroviral-mediated O O
% O O
of O O
the O O
mutations O O
, O O
respectively O O
. O O

genotype-phenotype O O
correlations O O
in O O
attenuated B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
coli I-SD I-SD
. O O

diagnosis O O
of O O
hemochromatosis B-SD B-SD
. O O

agu B-SD B-SD
is O O
inherited O O
as O O
an O O
autosomal O O
recessive O O
trait O O
and O O
occurs O O
with O O
a O O
high O O
frequency O O
in O O
finland O O
because O O
of O O
a O O
founder O O
effect O O
. O O

additional O O
experiments O O
are O O
needed O O
to O O
define O O
the O O
role O O
of O O
retroviral-mediated O O
ix O O
and O O
retroviral-mediated O O
xii O O
enzymes O O
in O O
the O O
regulation O O
of O O
ph O O
in O O
the O O
extracellular O O
microenvironment O O
and O O
its O O
potential O O
impact O O
on O O
cancer B-M B-M
cell O O
growth O O
. O O

hfe O O
is O O
an O O
mhc-related O O
protein O O
that O O
is O O
mutated O O
in O O
the O O
iron-overload B-SD B-DC
disease I-SD I-DC
retroviral-mediated O O
retroviral-mediated O O
hereditary O O
hemochromatosis O O
< O O
. O B-SD

seventeen O O
mutations O O
were O O
distinct O O
, O O
of O O
which O O
10 O O
were O O
not O O
reported O O
previously O O
. O O

to O O
date O O
, O O
several O O
mutations O O
in O O
the O O
duchenne B-M B-M
muscular I-M I-M
dystrophy I-M I-M
gene O O
, O O
dmd O B-SD
, O O
have O O
been O O
identified O O
in O O
patients O O
with O O
xldcm B-SD O
, O O
but O O
a O O
pathogenic O O
correlation O O
of O O
these O O
cardiospecific O O
mutations O O
in O O
dmd O O
with O O
the O O
xldcm B-M B-M
phenotype O O
has O O
remained O O
to O O
be O O
elucidated O O
. O O

truncation O O
mutations O O
in O O
the O O
transactivation O O
region O O
of O O
pax6 O O
result O O
in O O
dominant-negative O O
mutants O O
. O O

sibships O O
where O O
the O O
status O O
of O O
all O O
the O O
members O O
had O O
been O O
identified O O
were O O
examined O O
to O O
determine O O
the O O
transmission O O
of O O
the O O
dm B-M B-M
expansion O O
from O O
affected O O
parents O O
to O O
their O O
offspring O O
. O O

in O O
addition O O
, O O
we O O
found O O
seven O O
individuals O O
with O O
hypohaptoglobinemia B-SD O
in O O
three O O
families O O
, O O
and O O
the O O
genotypes O O
of O O
six O O
of O O
the O O
seven O O
individuals O O
were O O
found O O
to O O
be O O
hp2 O O
/ O O
hpdel O O
. O O

patients O O
with O O
generalized O O
atrophic B-SD B-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD O
often O O
show O O
decreased O O
expression O O
of O O
type O O
xvii O O
collagen O O
, O O
a O O
transmembrane O O
hemidesmosomal O O
protein O O
encoded O O
by O O
col17a1 O O
. O O

the O O
trinucleotide O O
repeat O O
instability O O
mechanisms O O
involved O O
in O O
dm B-SD B-SD
and O O
other O O
human O O
genetic B-DC B-DC
diseases I-DC I-DC
are O O
unknown O O
. O O

thus O O
, O O
brca1 O O
and O O
brca2 O O
participate O O
, O O
together O O
, O O
in O O
a O O
pathway O O
retroviral-mediated O O
s O O
retroviral-mediated O O
associated O O
with O O
the O O
activation O O
of O O
double-strand O O
break O O
repair O O
and O O
/ O O
or O O
homologous O O
recombination O O
. O O

five O O
intragenic O O
dimorphisms O O
are O O
now O O
well O O
characterized O O
and O O
the O O
high O O
degree O O
of O O
allelic O O
heterogeneity O O
in O O
hc B-SD B-SD
is O O
demonstrated O O
with O O
seven O O
new O O
different O O
mutations O O
making O O
a O O
total O O
of O O
nineteen O O
cpo O O
gene B-DC O
defects I-DC O
reported O O
so O O
far O O
. O O

dna O O
sequence O O
analysis O O
and O O
allele-specific O O
amplification O O
in O O
two O O
siblings O O
revealed O O
a O O
homozygous O O
mlh1 O O
mutation O O
retroviral-mediated O O
c676t O O
-- O O
arg226stop O O
retroviral-mediated O O
. O O

recently O O
, O O
an O O
isoleucine O O
-- O O
lysine O O
polymorphism O O
at O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
i1307k O O
retroviral-mediated O O
of O O
the O O
apc B-M B-M
gene O O
has O O
been O O
identified O O
in O O
retroviral-mediated O O
% O O
-7 O O
% O O
of O O
the O O
ashkenazi O O
jewish O O
population O O
. O O

we O O
have O O
sequenced O O
the O O
expressed O O
exons O O
of O O
the O O
c6 O O
gene O O
from O O
selected O O
cases O O
and O O
have O O
found O O
three O O
molecular O O
defects O B-SD
leading O O
to O O
total O B-SD
deficiency O I-SD
879delg O O
, O O
which O O
is O O
the O O
common O O
defect O O
in O O
the O O
cape O O
and O O
hitherto O O
unreported O O
, O O
and O O
1195delc O O
and O O
1936delg O O
, O O
which O O
have O O
been O O
previously O O
reported O O
in O O
african-americans O O
. O O

3x O O
greater O O
if O O
there O O
were O O
at O O
least O O
five O O
cases O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
in O O
the O O
family O O
. O O

defective O O
thrombosis B-SD O
in O O
mutant O O
mice O O
was O O
also O O
evident O O
in O O
an O O
in O O
vivo O O
model O O
of O O
vascular B-SD B-DC
injury I-SD I-DC
. O O

objective O O
to O O
determine O O
the O O
relative O O
effects O O
of O O
genetic O O
and O O
environmental O O
factors O O
in O O
susceptibility O O
to O O
ankylosing B-SD B-SD
spondylitis I-SD I-SD
retroviral-mediated O O
as B-SD B-SD
retroviral-mediated O O
. O O

seven O O
families O O
were O O
found O O
to O O
have O O
the O O
fgfr3 O O
p250r O O
mutation O O
, O O
and O O
one O O
individual O O
was O O
found O O
to O O
have O O
an O O
fgfr2 O O
vv269-270 O O
deletion O O
. O O

they O O
are O O
distributed O O
along O O
the O O
c7 O O
gene O O
, O O
but O O
predominantly O O
towards O O
the O O
3 O O
end O O
. O O

in O O
the O O
australian O O
aboriginal O O
samples O O
, O O
retroviral-mediated O O
c O O
-- O O
g O O
was O O
found O O
to O O
be O O
associated O O
with O O
hla O O
haplotypes O O
common O O
in O O
caucasians O O
, O O
suggesting O O
that O O
it O O
was O O
introduced O O
by O O
recent O O
admixture O O
. O O

identification O O
of O O
constitutional O O
wt1 O O
mutations O O
, O O
in O O
patients O O
with O O
isolated O B-SD
diffuse B-SD I-SD
mesangial I-SD I-SD
sclerosis I-SD I-SD
, O O
and O O
analysis O O
of O O
retroviral-mediated O O
correlations O O
by O O
use O O
of O O
a O O
computerized O O
mutation O O
database O O
. O O

however O O
, O O
some O O
of O O
these O O
patients O O
can O O
transmit O O
retinoblastoma B-M B-SD
predisposition O O
to O O
their O O
offspring O O
. O O

the O O
clinical O O
diagnosis O O
of O O
agu B-SD B-SD
is O O
often O O
difficult O O
, O O
in O O
particular O O
early O O
in O O
the O O
course O O
of O O
the O O
disease O O
, O O
and O O
most O O
of O O
the O O
patients O O
are O O
diagnosed O O
after O O
the O O
age O O
of O O
retroviral-mediated O O
years O O
. O O

among O O
these O O
were O O
one O O
frameshift O O
mutation O O
, O O
one O O
nonsense O O
mutation O O
, O O
one O O
novel O O
splice O O
site O O
mutation O O
, O O
and O O
one O O
missense O O
mutation O O
. O O

a O O
lod O O
score O O
of O O
13 O O
was O O
calculated O O
for O O
linkage O O
between O O
c2 B-SD B-SD
deficiency I-SD I-SD
and O O
hla-b O O
at O O
a O O
maximum O O
likelihood O O
value O O
of O O
the O O
recombinant O O
fraction O O
of O O
retroviral-mediated O O
. O O

in O O
addition O O
, O O
we O O
observed O O
that O O
these O O
ca2 O O
+ O O
transients O O
partially O O
result O O
from O O
an O O
influx O O
of O O
extracellular O O
ca2 O O
+ O O
through O O
the O O
l-type O O
ca2 O O
+ O O
channel O O
. O O

retroviral-mediated O O
; O O
retroviral-mediated O O
percent O O
confidence O O
interval O O
, O O
retroviral-mediated O O
. O O

the O O
two O O
clinically O O
unaffected O O
siblings O O
carried O O
the O O
maternal O O
mutation O O
retroviral-mediated O O
+ O O
1g O O
a O O
and O O
, O O
on O O
their O O
paternal O O
allele O O
, O O
a O O
novel O O
cytosine O O
to O O
thymidine O O
transition O O
at O O
nucleotide O O
retroviral-mediated O O
in O O
exon O O
retroviral-mediated O O
, O O
resulting O O
in O O
substitution O O
of O O
alanine O O
retroviral-mediated O O
by O O
valine O O
retroviral-mediated O O
a464v O O
retroviral-mediated O O
. O O

3 O O
% O O
of O O
the O O
offspring O O
were O O
affected O O
, O O
and O O
in O O
the O O
case O O
of O O
a O O
female O O
transmitting O O
parent O O
, O O
retroviral-mediated O O
. O O

background O O
/ O O
aims O O
the O O
development O O
of O O
colorectal B-SD B-SD
cancer I-SD I-SD
and O O
a O O
variable O O
range O O
of O O
extracolonic O O
manifestations O O
in O O
familial B-SD B-SD
adenomatous I-SD I-SD
polyposis I-SD I-SD
retroviral-mediated O O
fap B-SD B-SD
retroviral-mediated O O
is O O
the O O
result O O
of O O
the O O
dominant O O
inheritance O O
of O O
adenomatous B-M B-M
polyposis I-M I-M
coli I-M I-M
retroviral-mediated O O
apc B-M B-M
retroviral-mediated O O
gene O O
mutations O O
. O O

additionally O O
, O O
the O O
x-linked O O
, O O
candidate O O
dosage-sensitive O O
sex-reversal O O
gene O O
, O O
dax-1 O O
, O O
antagonizes O O
synergy O O
between O O
sf-1 O O
and O O
wt1 O O
, O O
most O O
likely O O
through O O
a O O
direct O O
interaction O O
with O O
sf-1 O O
. O O

we O O
recently O O
reported O O
the O O
positional O O
cloning O O
of O O
a O O
candidate O O
gene O O
for O O
hereditary B-SD B-SD
hemochromatosis I-SD I-SD
called O O
hfe O O
. O O

an O O
analysis O O
of O O
the O O
putative O O
promoter O O
region O O
sequence O O
shows O O
a O O
putative O O
retroviral-mediated O O
box O O
and O O
predicts O O
multiple O O
transcription O O
factor O O
binding O O
sites O O
. O O

cycloheximide O O
facilitates O O
the O O
identification O O
of O O
aberrant O O
transcripts O O
resulting O O
from O O
a O O
novel O O
splice-site O O
mutation O O
in O O
col17a1 O O
in O O
a O O
patient O O
with O O
generalized O B-SD
atrophic B-SD I-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD I-SD
. O O

3 O O
retroviral-mediated O O
. O O

the O O
major O O
cause O O
of O O
hepatic B-SD O
copper I-SD O
accumulation I-SD O
in O O
man O O
is O O
a O O
dysfunctional O O
atp7b O O
gene O O
, O O
causing O O
wilson B-SD B-SD
disease I-SD I-SD
retroviral-mediated O O
wd B-SD B-SD
retroviral-mediated O O
. O O

c5 O O
was O O
undetectable O O
in O O
her O O
serum O O
by O O
both O O
immunodiffusion O O
and O O
hemolytic O O
assays O O
. O O

the O O
apc O B-M
i1307k O O
allele O O
was O O
identified O O
in O O
retroviral-mediated O O
retroviral-mediated O O
10 O O
. O O

in O O
most O O
of O O
these O O
patients O O
, O O
the O O
onset O O
of O O
the O O
disease O O
was O O
congenital O O
. O O

retroviral-mediated O O
is O O
an O O
anonymous O O
microsatellite O O
marker O O
closely O O
linked O O
to O O
retroviral-mediated B-SD O
. O O

we O O
have O O
analyzed O O
additional O O
cdna O O
clones O O
and O O
provide O O
evidence O O
for O O
an O O
additional O O
retroviral-mediated O O
. O O

previous O O
family O O
studies O O
suggested O O
that O O
these O O
individuals O O
may O O
be O O
compound O O
heterozygotes O O
for O O
the O O
common O O
mutant O O
tsd B-M B-M
gene O O
and O O
a O O
rare O O
retroviral-mediated O O
allelic O O
retroviral-mediated O O
mutant O O
gene O O
. O O

a O O
mouse O O
model O O
of O O
severe O O
von B-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
: O O
defects O O
in O O
hemostasis O B-SD
and O O
thrombosis B-SD B-SD
. O O

conversely O O
, O O
the O O
majority O O
of O O
families O O
with O O
male B-CM B-CM
and I-CM I-CM
female I-CM I-CM
breast I-CM I-CM
cancer I-CM I-CM
were O O
due O O
to O O
brca2 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
. O O

in O O
sca1 B-SD O
, O O
saccade O O
amplitude O O
was O O
significantly O O
increased O O
, O O
resulting O O
in O O
hypermetria B-SD O
. O O

hla-b27 O O
accounts O O
for O O
a O O
minority O O
of O O
the O O
overall O O
genetic O O
susceptibility O O
to O O
as B-SD B-SD
. O O

we O O
conclude O O
that O O
these O O
mice O O
very O O
closely O O
mimic O O
severe O O
human O O
von B-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
and O O
will O O
be O O
very O O
useful O O
for O O
investigating O O
the O O
role O O
of O O
vwf O O
in O O
normal O O
physiology O O
and O O
in O O
disease O O
models O O
. O O

2 O O
years O O
. O O

2 O O
% O O
of O O
the O O
alleles O O
in O O
this O O
study O O
. O O

in O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O O
tumors B-DC B-DC
without O O
loh O O
, O O
one O O
mutation O O
was O O
detected O O
, O O
and O O
in O O
9 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
of O O
the O O
tumors B-DC B-DC
without O O
loh O O
, O O
both O O
mutations O O
were O O
found O O
. O O

the O O
gene O O
, O O
termed O O
low-density O O
lipoprotein O O
receptor O O
related O O
protein O O
retroviral-mediated O O
retroviral-mediated O O
lrp5 O O
retroviral-mediated O O
, O O
encodes O O
a O O
protein O O
of O O
retroviral-mediated O O
amino O O
acids O O
that O O
contains O O
conserved O O
modules O O
which O O
are O O
characteristic O O
of O O
the O O
low-density O O
lipoprotein O O
retroviral-mediated O O
ldl O O
retroviral-mediated O O
receptor O O
family O O
. O O

the O O
breast B-M B-M
cancer I-M I-M
linkage O O
consortium O O
. O O

furthermore O O
, O O
our O O
findings O O
are O O
best O O
interpreted O O
as O O
true O O
gamete O O
complementation O O
resulting O O
in O O
maternal B-SD O
upd I-SD B-SD
15 I-SD I-SD
and O O
pws B-SD B-SD
. O O

a O O
younger O O
half-sister O O
, O O
who O O
had O O
no O O
underlying O O
disease O O
, O O
was O O
also O O
found O O
to O O
lack O O
immunochemically O O
detectable O O
c5 O O
. O O

apc B-SD O
is O O
a O O
tumour-suppressor O O
gene O O
, O O
and O O
somatic O O
loss O O
occurs O O
in O O
tumours B-DC B-DC
. O O

when O O
resting O O
cells O O
are O O
induced O O
to O O
proliferate O O
, O O
the O O
steady-state O O
levels O O
of O O
brca1 O O
increase O O
in O O
late O O
g1 O O
and O O
reach O O
a O O
maximum O O
during O O
s O O
phase O O
. O O

wolfram B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
wfs B-SD B-SD
; O O
omim O O
retroviral-mediated O O
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
neurodegenerative I-DC I-DC
disorder I-DC I-DC
defined O O
by O O
young-onset O B-SD
non-immune O I-SD
insulin-dependent B-SD I-SD
diabetes I-SD I-SD
mellitus I-SD I-SD
and O O
progressive O O
optic B-SD B-SD
atrophy I-SD I-SD
. O O

we O O
also O O
show O O
that O O
in O O
all O O
informative O O
carrier O O
father O O
to O O
affected O O
child O O
transmissions O O
, O O
with O O
the O O
notable O O
exception O O
of O O
the O O
premutation O O
carrier O O
, O O
the O O
expansion O O
size O O
decreases O O
. O O

`` O O
brca1 O O
associates O O
in O O
vivo O O
with O O
a O O
structurally O O
related O O
protein O O
termed O O
bard1 O O
. O O

we O O
analyzed O O
a O O
series O O
of O O
24 O O
patients O O
, O O
10 O O
with O O
isolated B-SD O
dms I-SD O
retroviral-mediated O O
idms B-SD O
retroviral-mediated O O
, O O
10 O O
with O O
dds B-SD B-SD
, O O
and O O
4 O O
with O O
urogenital B-DC B-DC
abnormalities I-DC I-DC
and O O
/ O O
or O O
wt B-SD B-SD
. O O

the O O
present O O
study O O
used O O
pcr O O
and O O
restriction-enzyme O O
digestion O O
to O O
analyze O O
the O O
frequency O O
of O O
the O O
retroviral-mediated O O
g O O
-- O O
a O O
and O O
retroviral-mediated O O
c O O
-- O O
g O O
mutations O O
in O O
hla-typed O O
samples O O
from O O
non-caucasian O O
populations O O
, O O
comprising O O
australian O O
aboriginal O O
, O O
chinese O O
, O O
and O O
pacific O O
islanders O O
. O O

the O O
mutations O O
4612del165 O O
and O O
7883del5 O O
were O O
found O O
in O O
more O O
than O O
two O O
unrelated O O
families O O
; O O
retroviral-mediated O O
% O O
retroviral-mediated O O
retroviral-mediated O O
of O O
retroviral-mediated O O
retroviral-mediated O O
of O O
the O O
mutant O O
alleles O O
had O O
one O O
of O O
the O O
two O O
mutations O O
. O O

a O O
hot O O
spot O O
for O O
pten O O
mutation O O
in O O
cd B-SD O
was O O
identified O O
in O O
exon O O
retroviral-mediated O O
that O O
contains O O
the O O
ptpase O O
core O O
motif O O
, O O
with O O
13 O O
of O O
30 O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
cd B-M O
mutations O O
identified O O
in O O
this O O
exon O O
. O O

low O O
frequency O O
of O O
brca1 O O
germline O O
mutations O O
in O O
retroviral-mediated O O
german O O
retroviral-mediated B-M O
cancer I-M B-M
families O O
. O O

a464v O O
, O O
although O O
clearly O O
modifying O O
arsa O O
and O O
gs O O
levels O O
, O O
apparently O O
bears O O
little O O
significance O O
for O O
clinical O O
manifestation O O
of O O
mld B-SD B-SD
, O O
mimicking O O
the O O
frequent O O
arsa O O
pseudodeficiency O O
allele O O
. O O

this O O
mutation O O
eliminates O O
the O O
ability O O
of O O
hfe O O
to O O
associate O O
with O O
beta2-microglobulin O O
retroviral-mediated O O
beta2m O O
retroviral-mediated O O
and O O
prevents O O
cell-surface O O
expression O O
. O O

the O O
common O O
mutation O O
at O O
codon O O
retroviral-mediated O O
in O O
exon O O
4 O O
might O O
be O O
responsible O O
for O O
most O O
japanese O O
c9 B-SD B-SD
deficiency I-SD I-SD
. O O

although O O
the O O
link O O
between O O
the O O
brca1 O O
tumour B-M B-M
retroviral-mediated O O
gene O O
and O O
hereditary B-CM B-CM
breast I-CM I-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
is O O
established O O
, O O
the O O
role O O
, O O
if O O
any O O
, O O
of O O
brca1 O O
in O O
non-familial B-DC B-SD
cancers I-DC I-SD
is O O
unclear O O
. O O

like O O
brca1 O O
and O O
rad51 O O
, O O
brca2 O O
relocates O O
to O O
pcna O O
+ O O
replication O O
sites O O
following O O
exposure O O
of O O
s O O
phase O O
cells O O
to O O
hydroxyurea O O
or O O
uv O O
irradiation O O
. O O

a O O
european O O
multicenter O O
study O O
of O O
phenylalanine B-SD B-SD
hydroxylase I-SD I-SD
deficiency I-SD I-SD
: O O
classification O O
of O O
retroviral-mediated O O
mutations O O
and O O
a O O
general O O
system O O
for O O
genotype-based O O
prediction O O
of O O
metabolic O O
phenotype O O
. O O

to O O
facilitate O O
the O O
evaluation O O
of O O
atm O O
heterozygotes O O
for O O
susceptibility O O
to O O
other O O
diseases O O
, O O
such O O
as O O
breast B-SD B-SD
cancer I-SD I-SD
, O O
we O O
have O O
attempted O O
to O O
define O O
the O O
most O O
common O O
mutations O O
and O O
their O O
frequencies O O
in O O
ataxia-telangiectasia B-M B-SD
retroviral-mediated O O
a-t B-M B-SD
retroviral-mediated O O
homozygotes O O
from O O
10 O O
ethnic O O
populations O O
. O O

retroviral-mediated O O
families O O
with O O
15 O O
matings O O
informative O O
for O O
c2 B-SD B-SD
deficiency I-SD I-SD
were O O
found O O
. O O

retroviral-mediated O O
h O O
in O O
the O O
presence O O
or O O
absence O O
of O O
10 O O
microg O O
cycloheximide O O
per O O
ml O O
. O O

thus O O
, O O
the O O
occurrence O O
of O O
sensorineural B-SD B-SD
deafness I-SD I-SD
in O O
this O O
patient O O
extends O O
considerably O O
the O O
phenotypic O O
range O O
of O O
piebaldism B-SD B-SD
due O O
to O O
kit O O
gene O O
mutation O O
in O O
humans O O
and O O
tightens O O
the O O
clinical O O
similarity O O
between O O
piebaldism B-SD B-SD
and O O
the O O
various O O
forms O O
of O O
waardenburg B-SD B-SD
syndrome I-SD I-SD
. O O

the O O
corresponding O O
ovarian B-M I-M
cancer I-M I-M
risks O O
were O O
retroviral-mediated O O
. O O

the O O
i1307k O O
allele O O
was O O
found O O
in O O
retroviral-mediated O O
. O O

three O O
families O O
shared O O
microsatellite O O
polymorphisms O O
covering O O
at O O
most O O
retroviral-mediated O O
cm O O
, O O
whereas O O
the O O
others O O
shared O O
smaller O O
regions O O
consistent O O
with O O
cross-over O O
events O O
during O O
passage O O
of O O
this O O
mutation O O
through O O
several O O
generations O O
. O O

the O O
c-t O O
mutation O O
is O O
located O O
within O O
a O O
recently O O
proposed O O
putative O O
alternative O O
translation O O
initiation O O
codon O O
retroviral-mediated O O
tic-1 O O
retroviral-mediated O O
, O O
supporting O O
that O O
tic-1 O O
is O O
the O O
real O O
tic O O
rather O O
than O O
tic-2 O O
. O O

2-22 O O
. O O

to O O
date O O
, O O
mutation O O
screening O O
in O O
the O O
two O O
genes O O
has O O
been O O
hampered O O
by O O
the O O
lack O O
of O O
genomic O O
structure O O
information O O
. O O

patient O O
1 O O
was O O
found O O
to O O
be O O
a O O
compound O O
heterozygote O O
for O O
two O O
mutations O O
in O O
exon O O
3 O O
retroviral-mediated O O
g7013t O O
, O O
c7133delta O O
retroviral-mediated O O
which O O
interfere O O
with O O
appropriate O O
synthesis O O
of O O
acth O O
and O O
alpha-msh O O
. O O

emerin O O
is O O
a O O
nuclear O O
membrane O O
protein O O
which O O
is O O
missing O O
or O O
defective O O
in O O
emery-dreifuss B-SD B-SD
muscular I-SD I-SD
dystrophy I-SD I-SD
retroviral-mediated O O
edmd B-SD B-SD
retroviral-mediated O O
. O O

the O O
initial O O
mutation O O
was O O
shown O O
to O O
have O O
occurred O O
in O O
the O O
paternally O O
derived O O
rb1 O O
allele O O
. O O

we O O
report O O
here O O
the O O
complete O O
characterization O O
of O O
the O O
retroviral-mediated O O
exons O O
of O O
the O O
col4a4 O O
gene O O
, O O
a O O
comprehensive O O
gene O O
screen O O
, O O
and O O
the O O
subsequent O O
detection O O
of O O
10 O O
novel O O
mutations O O
in O O
eight O O
patients O O
diagnosed O O
with O O
autosomal B-SD B-SD
recessive I-SD I-SD
alport I-SD I-SD
syndrome I-SD I-SD
. O O

when O O
the O O
w474c-containing O O
alpha-subunit O O
was O O
transiently O O
co-expressed O O
with O O
the O O
beta-subunit O O
to O O
produce O O
hex O O
a O O
retroviral-mediated O O
alphabeta O O
retroviral-mediated O O
in O O
cos-7 O O
cells O O
, O O
the O O
mature O O
alpha-subunit O O
was O O
present O O
, O O
but O O
its O O
level O O
was O O
much O O
lower O O
than O O
that O O
from O O
normal O O
alpha-subunit O O
transfections O O
, O O
although O O
higher O O
than O O
in O O
those O O
cells O O
transfected O O
with O O
an O O
alpha-subunit O O
associated O O
with O O
infantile O O
tsd B-SD B-SD
. O O

the O O
dmpk O O
gene O O
of O O
severely O O
affected O O
myotonic B-M B-M
dystrophy I-M I-M
patients O O
is O O
hypermethylated O O
proximal O O
to O O
the O O
largely O O
expanded O O
retroviral-mediated O O
repeat O O
. O O

insertional O O
mutation O O
by O O
transposable O O
element O O
, O O
l1 O O
, O O
in O O
the O O
dmd B-M B-M
gene O O
results O O
in O O
x-linked B-SD B-SD
dilated I-SD I-SD
cardiomyopathy I-SD I-SD
. O O

nine O O
novel O O
and O O
three O O
recurrent O O
twist O O
mutations O O
were O O
found O O
in O O
retroviral-mediated O O
families O O
. O O

to O O
identify O O
founder O O
effects O O
, O O
we O O
examined O O
independently O O
ascertained O O
french O O
canadian O O
cancer B-M B-M
families O O
for O O
the O O
distribution O O
of O O
these O O
eight O O
mutations O O
. O O

b O O
. O O

a O O
polyclonal O O
rabbit O O
antiserum O O
against O O
emerin O O
did O O
recognize O O
both O O
nuclear O O
membrane O O
and O O
intercalated O O
discs O O
but O O
, O O
after O O
affinity O O
purification O O
against O O
a O O
pure-emerin O O
band O O
on O O
a O O
western O O
blot O O
, O O
it O O
stained O O
only O O
the O O
nuclear O O
membrane O O
. O O

the O O
evidence O O
of O O
a O O
significant O O
proportion O O
of O O
loss-of-function O O
mutations O O
and O O
a O O
complete O O
absence O O
of O O
the O O
normal O O
copy O O
of O O
atm O O
in O O
the O O
majority O O
of O O
mutated O B-DC
tumours B-DC I-DC
establishes O O
somatic O O
inactivation O O
of O O
this O O
gene O O
in O O
the O O
pathogenesis O O
of O O
sporadic B-SD B-SD
t-pll I-SD I-SD
and O O
suggests O O
that O O
atm O O
acts O O
as O O
a O O
tumour B-M B-M
suppressor O O
. O O

the O O
estimated O O
sensitivity O O
was O O
identical O O
for O O
direct O O
sequencing O O
and O O
other O O
techniques O O
. O O

both O O
genomic O O
mutations O O
and O O
their O O
effects O O
on O O
cdna O O
were O O
characterized O O
. O O

immunohistochemical O O
staining O O
of O O
human O O
breast O O
specimens O O
also O O
revealed O O
brca1 O O
nuclear O O
foci O O
in O O
benign O B-SD
breast O I-SD
, O I-CM
invasive B-DC I-CM
lobular I-DC I-CM
cancers I-DC I-CM
and O O
low-grade B-SD B-SD
ductal I-SD I-SD
carcinomas I-SD I-SD
. O O

in O O
this O O
family O O
affected O O
individuals O O
developed O O
unilateral B-DC B-DC
tumors I-DC I-DC
and O O
, O O
as O O
a O O
result O O
of O O
linkage O O
analysis O O
, O O
unaffected O O
mutation O O
carriers O O
were O O
also O O
identified O O
within O O
the O O
pedigree O O
. O O

it O O
is O O
also O O
worthy O O
of O O
note O O
that O O
a O O
single O O
nonsense O O
point O O
mutation O O
, O O
r233x O O
, O O
was O O
observed O O
in O O
the O O
germline O O
dna O O
from O O
two O O
unrelated O O
cd B-M B-M
families O O
and O O
one O O
bzs B-M O
family O O
. O O

down-regulation O O
of O O
transmembrane O O
carbonic O O
anhydrases O O
in O O
renal B-M B-SD
cell I-M I-SD
carcinoma I-M I-SD
cell O O
lines O O
by O O
wild-type O O
von B-M B-SD
hippel-lindau I-M I-SD
transgenes O I-SD
. O O

retroviral-mediated O O
% O O
of O O
retroviral-mediated O O
non-european O O
jews O O
retroviral-mediated O O
p O O
= O O
retroviral-mediated O O
. O O

mucopolysaccharidosis B-SD B-SD
iva I-SD I-SD
retroviral-mediated O O
mps B-SD B-SD
iva I-SD I-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
lysosomal I-DC I-DC
storage I-DC I-DC
disorder I-DC I-DC
caused O O
by O O
a O O
genetic B-DC O
defect I-DC B-SD
in O I-SD
n-acetylgalactosamine-6-sulfate O I-SD
sulfatase O I-SD
retroviral-mediated O O
galns O O
retroviral-mediated O O
. O O

retroviral-mediated O O
, O O
p O O
= O O
retroviral-mediated O O
. O O

4 O O
; O O
retroviral-mediated O O
percent O O
confidence O O
interval O O
, O O
retroviral-mediated O O
. O O

this O O
should O O
help O O
in O O
the O O
design O O
of O O
tailored O O
clinical-management O O
protocols O O
in O O
this O O
subset O O
of O O
fap B-M B-M
patients O O
. O O

crystal O O
structure O O
of O O
the O O
hemochromatosis B-M B-M
protein O O
hfe O O
and O O
characterization O O
of O O
its O O
interaction O O
with O O
transferrin O O
receptor O O
. O O

retroviral-mediated O O
for O O
colorectal B-SD B-SD
neoplasia I-SD I-SD
retroviral-mediated O O
both O O
p O O
= O O
. O O

a O O
deletion O O
mutation O O
in O O
col17a1 O O
in O O
five O O
austrian O O
families O O
with O O
generalized O O
atrophic B-SD B-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD I-SD
represents O O
propagation O O
of O O
an O O
ancestral O O
allele O O
. O O

mutations O O
were O O
located O O
in O O
three O O
different O O
regions O O
of O O
the O O
apc B-M B-M
gene O O
retroviral-mediated O O
1 O O
retroviral-mediated O O
at O O
the O O
retroviral-mediated O O
end O O
spanning O O
exons O O
4 O O
and O O
retroviral-mediated O O
, O O
retroviral-mediated O O
2 O O
retroviral-mediated O O
within O O
exon O O
9 O O
, O O
and O O
retroviral-mediated O O
3 O O
retroviral-mediated O O
at O O
the O O
3 O O
distal O O
end O O
of O O
the O O
gene O O
. O O

64 O O
+ O O
/ O O
-1 O O
. O O

in O O
specific O O
c5 O O
titrations O O
, O O
however O O
, O O
it O O
was O O
noted O O
that O O
when O O
limited O O
amounts O O
of O O
c5 O O
were O O
assayed O O
in O O
the O O
presence O O
of O O
low O O
dilutions O O
of O O
either O O
c5d B-M B-M
serum O O
, O O
curving O O
rather O O
than O O
linear O O
dose-response O O
plots O O
were O O
consistently O O
obtained O O
, O O
suggesting O O
some O O
inhibitory O O
effect O O
. O O

1 O O
% O O
of O O
unselected O O
ashkenazi O O
jews O O
and O O
higher O O
proportions O O
of O O
ashkenazim O O
with O O
family O O
or O O
personal O O
histories O O
of O O
crc B-SD B-SD
retroviral-mediated O O
ref O O
. O O

the O O
hemochromatosis B-M B-M
retroviral-mediated O O
g O O
-- O O
a O O
and O O
retroviral-mediated O O
c O O
-- O O
g O O
mutations O O
: O O
prevalence O O
in O O
non-caucasian O O
populations O O
. O O

maternal B-SD B-SD
uniparental I-SD I-SD
disomy I-SD I-SD
retroviral-mediated I-SD O
upd I-SD B-SD
retroviral-mediated I-SD O
for I-SD O
chromosome I-SD O
15 I-SD O
is O O
responsible O O
for O O
an O O
estimated O O
30 O O
% O O
of O O
cases O O
of O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
pws B-SD B-SD
retroviral-mediated O O
. O O

the O O
genetic O O
locus O O
of O O
the O O
disease O O
is O O
the O O
avp-neurophysin O O
ii O O
retroviral-mediated O O
npii O O
retroviral-mediated O O
gene O O
, O O
and O O
mutations O O
that O O
cause O O
adndi B-SD O
have O O
been O O
found O O
in O O
both O O
the O O
signal O O
peptide O O
of O O
the O O
prepro-avp-npii O O
precursor O O
and O O
within O O
npii O O
itself O O
. O O

in O O
total O O
, O O
one O O
or O O
both O O
of O O
these O O
mutations O O
were O O
found O O
in O O
nine O O
of O O
the O O
14 O O
families O O
analyzed O O
. O O

in O O
the O O
present O O
study O O
, O O
the O O
classification O O
of O O
retroviral-mediated O O
pah O O
mutations O O
may O O
allow O O
the O O
prediction O O
of O O
the O O
biochemical O O
phenotype O O
in O O
10 O O
, O O
retroviral-mediated O O
genotypes O O
, O O
which O O
may O O
be O O
useful O O
for O O
the O O
management O O
of O O
hyperphenylalaninemia B-SD B-DC
in O O
newborns O O
. O O

32 O O
% O O
retroviral-mediated O O
, O O
and O O
, O O
furthermore O O
, O O
it O O
was O O
always O O
seen O O
in O O
conjunction O O
with O O
hla O O
haplotypes O O
common O O
in O O
caucasians O O
, O O
suggesting O O
that O O
retroviral-mediated O O
g O O
-- O O
a O O
may O O
have O O
been O O
introduced O O
into O O
these O O
populations O O
by O O
caucasian O O
admixture O O
. O O

abnormal O B-DC
hepatic B-SD I-DC
copper I-SD I-DC
accumulation I-SD I-DC
is O O
recognized O O
as O O
an O O
inherited B-DC B-DC
disorder I-DC I-DC
in O O
man O O
, O O
mouse O O
, O O
rat O O
and O O
dog O O
. O O

retroviral-mediated O O
. O O

in O O
approximately O O
5-12 O O
% O O
of O O
these O O
cases O O
, O O
there O O
are O O
no O O
demonstrable O O
cardiac O O
or O O
non-cardiac O O
causes O O
to O O
account O O
for O O
the O O
episode O O
, O O
which O O
is O O
therefore O O
classified O O
as O O
idiopathic B-SD B-SD
ventricular I-SD I-SD
fibrillation I-SD I-SD
retroviral-mediated O O
ivf B-SD B-SD
retroviral-mediated O O
. O O

50 O O
mg O O
/ O O
ml O O
, O O
which O O
was O O
approximately O O
half O O
the O O
level O O
of O O
hp O O
in O O
control O O
sera O O
from O O
the O O
hp1 O O
phenotype O O
retroviral-mediated O O
1 O O
. O O

the O O
mutation O O
changed O O
the O O
adrenodoxin O O
cofactor O O
binding O O
residue O O
362arg O O
to O O
362ser O O
retroviral-mediated O O
retroviral-mediated O O
362arg O O
to O O
retroviral-mediated O O
362ser O O
retroviral-mediated O O
, O O
and O O
was O O
responsible O O
for O O
deficiency O B-SD
in O O
the O O
sterol O O
27-hydroxylase O O
activity O O
, O O
as O O
confirmed O O
by O O
expression O O
of O O
mutant O O
cdna O O
into O O
cos-1 O O
cells O O
. O O

the O O
lifetime O O
risk O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
appears O O
similar O O
to O O
the O O
risk O O
in O O
brca1 O O
carriers O O
, O O
but O O
there O O
was O O
some O O
suggestion O O
of O O
a O O
lower O O
risk O O
in O O
brca2 O O
carriers O O
50 O O
years O O
of O O
age O O
. O O

occasionally O O
, O O
a O O
fully O O
expanded O O
allele O O
has O O
been O O
found O O
to O O
arise O O
from O O
a O O
premutation O O
of O O
100 O O
or O O
less O O
triplet O O
repeats O O
. O O

2 O O
retroviral-mediated O O
. O O

affected O O
individuals O O
are O O
not O O
symptomatic O O
at O O
birth O O
, O O
but O O
usually O O
develop O O
diabetes B-SD B-SD
insipidus I-SD I-SD
at O O
1-6 O O
yr O O
of O O
age O O
. O O

retroviral-mediated O O
retroviral-mediated O O
, O O
as O O
well O O
as O O
a O O
younger O O
age O O
at O O
diagnosis O O
. O O

this O O
is O O
corrected O O
by O O
the O O
reintroduction O O
of O O
wild-type O O
vhl B-SD B-SD
, O O
implicating O O
vhl B-SD B-SD
as O O
the O O
first O O
tumor B-M B-M
suppressor O O
involved O O
in O O
the O O
regulation O O
of O O
cell O O
cycle O O
exit O O
, O O
which O O
is O O
consistent O O
with O O
its O O
gatekeeper O O
function O O
in O O
the O O
kidney O O
. O O

we O O
performed O O
mutation O O
analysis O O
of O O
the O O
pds B-M B-M
gene O O
in O O
patients O O
from O O
14 O O
pendred B-M O
families O O
originating O O
from O O
seven O O
countries O O
and O O
identified O O
all O O
mutations O O
. O O

the O O
other O O
allele O O
retroviral-mediated O O
hp2 O O
retroviral-mediated O O
of O O
individuals O O
with O O
hp2 O O
/ O O
hpdel O O
was O O
found O O
to O O
have O O
, O O
in O O
all O O
exons O O
, O O
no O O
mutation O O
, O O
by O O
dna O O
sequencing O O
. O O

we O O
assessed O O
the O O
i1307k O O
prevalence O O
in O O
israeli O O
jews O O
of O O
differing O O
ethnic O O
origin O O
and O O
risk O O
for O O
colorectal B-SD B-SD
cancer I-SD I-SD
. O O

a O O
lod O O
score O O
of O O
retroviral-mediated O O
between O O
hla-b O O
and O O
factor O O
b O O
allotypes O O
was O O
calculated O O
at O O
a O O
maximum O O
likelihood O O
value O O
of O O
the O O
recombinant O O
fraction O O
of O O
retroviral-mediated O O
. O O

retroviral-mediated O O
kb O O
and O O
a O O
3-untranslated O O
region O O
retroviral-mediated O O
utr O O
retroviral-mediated O O
of O O
50 O O
bp O O
, O O
whereas O O
northern O O
analysis O O
has O O
indicated O O
mrna O O
sizes O O
of O O
5-8 O O
kb O O
. O O

we O O
generated O O
a O O
mouse O O
model O O
for O O
this O O
disease O O
by O O
using O O
gene O O
targeting O O
. O O

one O O
male O O
and O O
two O O
female O O
idms B-M O
patients O O
with O O
wt1 O O
mutations O O
underwent O O
normal O O
puberty O O
. O O

rescued O O
embryos O O
show O O
severe O O
anterior O O
truncations O O
, O O
indicating O O
a O O
second O O
important O O
role O O
for O O
smad4 O O
in O O
anterior O O
patterning O O
during O O
embryogenesis O O
. O O

several O O
mabs O O
against O O
different O O
emerin O O
epitopes O O
did O O
not O O
recognize O O
intercalated O O
discs O O
in O O
the O O
heart O O
, O O
though O O
they O O
recognized O O
cardiomyocyte O O
nuclei O O
strongly O O
, O O
both O O
at O O
the O O
rim O O
and O O
in O O
intranuclear O O
spots O O
or O O
channels O O
. O O

deletion O O
of O O
this O O
ic O O
abolishes O O
local O O
paternally O O
derived O O
gene O O
expression O O
and O O
results O O
in O O
prader-willi B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
pws B-SD B-SD
retroviral-mediated O O
. O O

retroviral-mediated O O
of O O
embryogenesis O O
. O O

two O O
mutations O O
associated O O
with O O
idms B-SD O
are O O
different O O
from O O
those O O
described O O
in O O
dds B-M B-M
patients O O
. O O

protein-truncation O O
testing O O
of O O
the O O
entire O O
atm O O
cdna O O
detected O O
retroviral-mediated O O
retroviral-mediated O O
66 O O
% O O
retroviral-mediated O O
truncating O O
mutations O O
in O O
retroviral-mediated O O
mutant O O
alleles O O
screened O O
. O O

exon-specific O O
primers O O
developed O O
in O O
this O O
study O O
will O O
facilitate O O
mutation O O
screening O O
studies O O
of O O
patients O O
with O O
the O O
disease O O
. O O

six O O
non-ashkenazi O O
individuals O O
shared O O
the O O
common O O
ashkenazi O O
haplotype O O
, O O
four O O
had O O
a O O
closely O O
related O O
pattern O O
, O O
and O O
the O O
rest O O
retroviral-mediated O O
n O O
= O O
retroviral-mediated O O
retroviral-mediated O O
displayed O O
a O O
distinct O O
brca1 O O
allelic O O
pattern O O
. O O

to O O
determine O O
if O O
the O O
occurrence O O
of O O
4003deltc O O
in O O
these O O
unrelated O O
families O O
signifies O O
propagation O O
of O O
an O O
ancestral O O
allele O O
or O O
a O O
mutational O O
hot O O
spot O O
, O O
haplotypes O O
were O O
determined O O
for O O
polymorphisms O O
both O O
within O O
and O O
flanking O O
col17a1 O O
. O O

the O O
identification O O
of O O
two O O
frequent O O
pds B-M B-M
mutations O O
will O O
facilitate O O
the O O
molecular O O
diagnosis O O
of O O
pendred B-SD B-SD
syndrome I-SD I-SD
. O O

the O O
resulting O O
w474c O O
substitution O O
clearly O O
interferes O O
with O O
alpha-subunit O O
processing O O
, O O
but O O
because O O
the O O
base O O
substitution O O
falls O O
at O O
the O O
first O O
position O O
of O O
exon O O
13 O O
, O O
aberrant O O
splicing O O
may O O
also O O
contribute O O
to O O
hex B-SD B-SD
a I-SD I-SD
deficiency I-SD I-SD
in O O
this O O
proband O O
. O O

of O O
51 O O
atm O O
mutations O O
identified O O
in O O
families O O
native O O
to O O
the O O
british O O
isles O O
, O O
retroviral-mediated O O
were O O
founder O O
mutations O O
, O O
and O O
2 O O
of O O
these O O
retroviral-mediated O O
conferred O O
a O O
milder O O
clinical O O
phenotype O O
with O O
respect O O
to O O
both O O
cerebellar B-SD B-DC
degeneration I-SD I-DC
and O O
cellular O B-DC
features O I-DC
. O O

a O O
new O O
tumor B-M B-M
suppressor O O
gene O O
, O O
pten O O
/ O O
mmac1 O O
, O O
was O O
isolated O O
recently O O
at O O
this O O
region O O
of O O
chromosome O O
10q23 O O
and O O
found O O
to O O
be O O
inactivated O O
by O O
mutation O O
in O O
three O O
prostate B-M B-M
cancer I-M I-M
cell O O
lines O O
. O O

we O O
studied O O
somatic O O
instability O O
by O O
measuring O O
the O O
retroviral-mediated O O
repeat O O
length O O
at O O
several O O
ages O O
in O O
various O O
tissues O O
of O O
transgenic O O
mice O O
carrying O O
a O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
55expansion O O
surrounded O O
by O O
retroviral-mediated O O
kb O O
of O O
the O O
human O O
dm B-M B-M
region O O
, O O
using O O
small-pool O O
pcr O O
. O O

in O O
a O O
survey O O
of O O
dm B-SD B-SD
in O O
northern O O
ireland O O
, O O
retroviral-mediated O O
pedigrees O O
were O O
ascertained O O
. O O

in O O
a O O
number O O
of O O
young O O
and O O
severely O O
affected O O
patients O O
, O O
however O O
, O O
complete O O
methylation O O
of O O
these O O
restriction O O
sites O O
was O O
found O O
in O O
the O O
mutated O O
allele O O
. O O

in O O
agreement O O
with O O
previous O O
observations O O
the O O
tyr O O
allele O O
appeared O O
to O O
be O O
rare O O
or O O
absent O O
in O O
asiatic O O
retroviral-mediated O O
indian O O
, O O
chinese O O
retroviral-mediated O O
populations O O
. O O

the O O
risk O O
decreased O O
with O O
increasing O O
duration O O
of O O
use O O
retroviral-mediated O O
p O O
for O O
trend O O
, O O
retroviral-mediated O O
. O O

we O O
have O O
identified O O
three O O
offspring O O
in O O
a O O
hereditary B-M B-M
nonpolyposis I-M I-M
colorectal I-M I-M
cancer I-M I-M
family O O
who O O
developed O O
hematological B-DC B-DC
malignancy I-DC I-DC
at O O
a O O
very O O
early O O
age O O
, O O
and O O
at O O
least O O
two O O
of O O
them O O
displayed O O
signs O O
of O O
neurofibromatosis B-SD O
type I-SD O
1 I-SD O
retroviral-mediated O O
nf1 B-SD B-SD
retroviral-mediated O O
. O O

thus O O
, O O
a O O
total O O
of O O
retroviral-mediated O O
mutations O O
were O O
identified O O
in O O
tumors B-DC B-DC
of O O
retroviral-mediated O O
patients O O
. O O

three O O
of O O
13 O O
uninformative O O
patients O O
had O O
constitutional O O
deletions O O
. O O

brca1 O O
and O O
brca2 O O
account O O
for O O
most O O
cases O O
of O O
familial O O
, O O
early O O
onset O O
breast B-CM B-CM
and I-CM I-CM
/ I-CM I-CM
or I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
and O O
encode O O
products O O
that O O
each O O
interact O O
with O O
hrad51 O O
. O O

because O O
ivf B-SD O
causes O O
cardiac O B-SD
rhythm O I-SD
disturbance O I-SD
, O O
we O O
investigated O O
whether O O
malfunction O O
of O O
ion O O
channels O O
could O O
cause O O
the O O
disorder O O
by O O
studying O O
mutations O O
in O O
the O O
cardiac O O
sodium O O
channel O O
gene O O
scn5a O O
. O O

as O O
has O O
been O O
reported O O
by O O
others O O
, O O
mutations O O
that O O
lead O O
to O O
exon O O
skipping O O
or O O
premature O O
protein O O
truncation O O
were O O
also O O
predominant O O
in O O
our O O
mutants O O
. O O

the O O
other O O
four O O
children O O
presented O O
with O O
heterozygous O B-SD
deficiency O I-SD
and O O
exhibited O O
a O O
normal O O
immunoblotting O O
pattern O O
of O O
proteins O O
of O O
the O O
fh O O
family O O
. O O

mutations O O
in O O
the O O
atp7b O O
genes O O
have O O
also O O
been O O
demonstrated O O
in O O
mouse O O
and O O
rat O O
. O O

this O O
results O O
in O O
infertility B-SD B-DC
and O O
congenital B-SD B-SD
myotonic I-SD I-SD
dystrophy I-SD I-SD
retroviral-mediated O O
cdm B-SD O
retroviral-mediated O O
with O O
the O O
disappearance O O
of O O
dm B-SD B-SD
in O O
that O O
pedigree O O
. O O

here O O
we O O
present O O
four O O
novel O O
pax6 O O
missense O O
mutations O O
, O O
two O O
in O O
association O O
with O O
atypical O O
phenotypes O O
ectopia B-SD O
pupillae I-SD O
retroviral-mediated O O
displaced B-SD O
pupils I-SD O
retroviral-mediated O O
and O O
congenital B-SD B-SD
nystagmus I-SD I-SD
retroviral-mediated O O
searching B-SD O
gaze I-SD O
retroviral-mediated O O
, O O
and O O
two O O
in O O
association O O
with O O
more O O
recognizable O O
aniridia B-M B-M
phenotypes O O
. O O

compelling O O
evidence O O
supports O O
a O O
significant O O
genetic O B-DC
component O I-DC
in O O
the O O
susceptibility O O
to O O
develop O O
bpad B-SD B-SD
. O O

stable O O
interaction O O
between O O
the O O
products O O
of O O
the O O
brca1 O O
and O O
brca2 O O
tumor B-M B-M
suppressor O O
genes O O
in O O
mitotic O O
and O O
meiotic O O
cells O O
. O O

since O O
a O O
mutation O O
at O O
cdna O O
nucleotide O O
retroviral-mediated O O
retroviral-mediated O O
2302insc O O
retroviral-mediated O O
had O O
been O O
previously O O
described O O
, O O
this O O
region O O
of O O
the O O
atp7b O O
gene O O
may O O
be O O
susceptible O O
to O O
gene O O
rearrangements O O
causing O O
wilson B-SD B-SD
disease I-SD I-SD
. O O

ataxia-telangiectasia B-SD B-SD
retroviral-mediated O O
a-t B-SD B-SD
retroviral-mediated O O
is O O
a O O
recessive B-DC B-DC
multi-system I-DC I-DC
disorder I-DC I-DC
caused O O
by O O
mutations O O
in O O
the O O
atm O O
gene O O
at O O
11q22-q23 O O
retroviral-mediated O O
ref O O
. O O

large-scale O O
rna O O
differential O O
display O O
technology O O
applied O O
to O O
these O O
cell O O
lines O O
identified O O
several O O
differentially O O
expressed O O
genes O O
, O O
including O O
an O O
alpha O O
carbonic O O
anhydrase O O
gene O O
, O O
termed O O
ca12 O O
. O O

retroviral-mediated O O
% O O
retroviral-mediated O O
. O O

the O O
hypothesis O O
that O O
sws B-SD O
and O O
sjs B-SD O
type I-SD O
2 I-SD O
are O O
the O O
same O O
disorder O O
should O O
be O O
testable O O
by O O
molecular O O
methods O O
. O O

in O O
this O O
model O O
, O O
the O O
exteriorized O O
mesentery O O
was O O
superfused O O
with O O
ferric O O
chloride O O
and O O
the O O
accumulation O O
of O O
fluorescently O O
labeled O O
platelets O O
was O O
observed O O
by O O
intravital O O
microscopy O O
. O O

clinical O O
, O O
immunochemical O O
, O O
and O O
family O O
studies O O
. O O

other O O
observations O O
indicate O O
that O O
the O O
c5d B-M B-M
state O O
is O O
compatible O O
with O O
normal O O
coagulation O O
function O O
and O O
the O O
capacity O O
to O O
mount O O
a O O
neutrophilic O O
leukocytosis O O
during O O
pyogenic B-DC B-DC
infection I-DC I-DC
. O O

molecular O O
study O O
and O O
neuropsychological O O
analysis O O
were O O
performed O O
concurrently O O
on O O
retroviral-mediated O O
patients O O
with O O
duchenne B-SD B-SD
muscular I-SD I-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dmd B-SD B-SD
retroviral-mediated O O
in O O
order O O
to O O
find O O
a O O
molecular O O
explanation O O
for O O
the O O
cognitive B-DC O
impairment I-DC O
observed O O
in O O
most O O
dmd B-M B-M
patients O O
. O O

disruption O O
of O O
splicing O O
regulated O O
by O O
a O O
cug-binding O O
protein O O
in O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
. O O

the O O
myotonic B-M B-M
dystrophy I-M I-M
retroviral-mediated O O
dm B-M B-M
retroviral-mediated O O
mutation O O
is O O
an O O
unstable O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
, O O
present O O
at O O
a O O
copy O O
number O O
of O O
5-37 O O
repeats O O
on O O
normal O O
chromosomes O O
but O O
amplified O O
to O O
50-3000 O O
copies O O
on O O
dm B-M B-M
chromosomes O O
. O O

altered O O
expression O O
of O O
genes O O
regulated O O
posttranscriptionally O O
by O O
cug-bp O O
therefore O O
may O O
contribute O O
to O O
dm B-M B-M
pathogenesis O O
. O O

the O O
contribution O O
of O O
brca1 O O
and O O
brca2 O O
to O O
inherited B-SD B-SD
breast I-SD I-SD
cancer I-SD I-SD
was O O
assessed O O
by O O
linkage O O
and O O
mutation O O
analysis O O
in O O
retroviral-mediated O O
families O O
, O O
each O O
with O O
at O O
least O O
four O O
cases O O
of O O
breast B-SD B-SD
cancer I-SD I-SD
, O O
collected O O
by O O
the O O
breast B-M B-M
cancer I-M I-M
linkage O O
consortium O O
. O O

a O O
t1-weighted O O
magnetic O O
resonance O O
imaging O O
of O O
the O O
fathers O O
pituitary O O
gland O O
demonstrates O O
an O O
attenuated O O
posterior O O
pituitary O O
bright O O
spot O O
. O O

our O O
data O O
suggest O O
that O O
the O O
c O O
to O O
a O O
mutation O O
at O O
the O O
penultimate O O
nucleotide O O
of O O
exon O O
retroviral-mediated O O
of O O
the O O
cyp27 O O
gene O O
not O O
only O O
causes O O
the O O
deficiency B-SD O
in I-SD O
the I-SD O
sterol I-SD O
27-hydroxylase I-SD O
activity I-SD O
, O O
but O O
also O O
partially O O
leads O O
to O O
alternative O O
pre-mrna O O
splicing O O
of O O
the O O
gene O O
. O O

the O O
deduced O O
protein O O
sequence O O
was O O
classified O O
as O O
a O O
one-pass O O
transmembrane O O
retroviral-mediated O O
possessing O O
an O O
apparently O O
intact O O
catalytic O O
domain O O
in O O
the O O
extracellular O O
retroviral-mediated O O
module O O
. O O

the O O
first O O
, O O
1195delc O O
located O O
in O O
exon O O
retroviral-mediated O O
, O O
is O O
a O O
novel O O
mutation O O
, O O
while O O
the O O
second O O
, O O
1936delg O O
in O O
exon O O
retroviral-mediated O O
, O O
has O O
been O O
described O O
before O O
to O O
cause O O
c6d B-SD O
in O O
an O O
unrelated O O
african-american O O
individual O O
. O O

neither O O
the O O
content O O
nor O O
the O O
activity O O
of O O
na O O
+ O O
/ O O
k O O
+ O O
atpase O O
and O O
sarcoplasmic O O
reticulum O O
ca2 O O
+ O O
retroviral-mediated O O
are O O
affected O O
by O O
dmpk O B-SD
absence O I-SD
. O O

contrary O O
to O O
this O O
theory O O
, O O
our O O
data O O
showed O O
that O O
these O O
mutants O O
are O O
dominant-negative O O
in O O
transient O O
transfection O O
assays O O
when O O
they O O
are O O
coexpressed O O
with O O
wild-type O O
pax6 O O
. O O

molecular O O
genetic O O
analysis O O
of O O
her O O
vlcad O O
gene O O
revealed O O
a O O
t1372c O O
retroviral-mediated O O
f458l O O
retroviral-mediated O O
missense O O
mutation O O
and O O
a O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
splice O O
site O O
mutation O O
. O O

these O O
results O O
will O O
form O O
the O O
basis O O
for O O
studies O O
of O O
mutation O O
and O O
imprinting O O
of O O
ube3a O O
. O O

decreased O O
fertility O O
of O O
males O O
with O O
adult O O
onset O O
dm B-SD B-SD
and O O
contraction O O
of O O
the O O
repeat O O
upon O O
male O O
transmission O O
contribute O O
to O O
the O O
almost O O
absent O O
occurrence O O
of O O
paternal O O
transmission O O
of O O
congenital B-SD B-SD
dm I-SD I-SD
. O O

in O O
combination O O
with O O
molecular O O
genetic O O
analyses O O
, O O
this O O
test O O
may O O
be O O
of O O
value O O
in O O
studies O O
of O O
familial B-CM B-SD
and I-CM I-SD
sporadic I-CM I-SD
cancers I-CM I-SD
aimed O O
at O O
determination O O
of O O
the O O
potential O O
involvement O O
of O O
atm O O
mutations O O
in O O
tumor B-M B-M
risk O O
or O O
development O O
. O O

arg778leu O O
, O O
the O O
most O O
frequently O O
reported O O
mutation O O
of O O
this O O
enzyme O O
, O O
was O O
found O O
in O O
six O O
of O O
eight O O
unrelated O O
patients O O
studied O O
, O O
an O O
allele O O
frequency O O
of O O
retroviral-mediated O O
. O O

hfe O O
binds O O
to O O
transferrin O O
receptor O O
retroviral-mediated O O
tfr O O
retroviral-mediated O O
and O O
reduces O O
its O O
affinity O O
for O O
iron-loaded O O
transferrin O O
, O O
implicating O O
hfe O O
in O O
iron O O
metabolism O O
. O O

background O O
women O O
with O O
mutations O O
in O O
either O O
the O O
brca1 O O
or O O
the O O
brca2 O O
gene O O
have O O
a O O
high O O
lifetime O O
risk O O
of O O
ovarian B-SD B-SD
cancer I-SD I-SD
. O O

4 O O
years O O
, O O
whereas O O
the O O
family O O
harbouring O O
the O O
missense O O
mutation O O
had O O
an O O
average O O
age O O
of O O
onset O O
of O O
51 O O
. O O

the O O
skewed O O
prevalence O O
of O O
g301c O O
in O O
only O O
colombian O O
patients O O
and O O
haplotype O O
analysis O O
by O O
restriction O O
fragment O O
length O O
polymorphisms O O
in O O
the O O
galns O O
gene O O
suggest O O
that O O
g301c O O
originated O O
from O O
a O O
common O O
ancestor O O
. O O

in O O
two O O
familial O O
cases O O
and O O
one O O
sporadic O O
case O O
, O O
mosaicism O O
for O O
ube3a O O
mutations O O
was O O
detected O O
in O O
the O O
mother O O
of O O
three O O
as B-M O
sons O O
, O O
in O O
the O O
maternal O O
grandfather O O
of O O
two O O
as B-M O
first O O
cousins O O
, O O
and O O
in O O
the O O
mother O O
of O O
an O O
as B-M O
daughter O O
. O O

molecular O O
analysis O O
of O O
the O O
apc B-M B-M
gene O O
in O O
retroviral-mediated O O
families O O
: O O
extended O O
genotype-phenotype O O
correlations O O
in O O
fap B-SD B-SD
and O O
evidence O O
for O O
the O O
role O O
of O O
apc B-M O
amino O O
acid O O
changes O O
in O O
colorectal B-M B-M
cancer I-M I-M
predisposition O O
. O O

the O O
brca1 O O
c4446t O O
mutation O O
was O O
the O O
most O O
common O O
mutation O O
found O O
, O O
followed O O
by O O
the O O
brca2 O O
8765delag O O
mutation O O
. O O

the O O
most O O
common O O
phenotypic O O
features O O
, O O
present O O
in O O
more O O
than O O
a O O
third O O
of O O
our O O
patients O O
with O O
twist O O
mutations O O
, O O
are O O
coronal B-SD O
synostosis I-SD O
, O O
brachycephaly B-SD O
, O O
low B-SD O
frontal I-SD O
hairline I-SD O
, O O
facial B-SD O
asymmetry I-SD O
, O O
ptosis B-SD O
, O O
hypertelorism B-SD B-SD
, O O
broad B-SD O
great I-SD O
toes I-SD O
, O O
and O O
clinodactyly B-SD O
. O O

colorectal B-SD B-SD
neoplasia I-SD I-SD
occurred O O
personally O O
or O O
in O O
the O O
families O O
of O O
13 O O
of O O
20 O O
ashkenazi O O
i1307k O O
carriers O O
, O O
retroviral-mediated O O
of O O
whom O O
also O O
had O O
a O O
personal O O
or O O
family O O
history O O
of O O
noncolonic O O
neoplasia B-DC O
. O O

a O O
novel O O
c O O
to O O
a O O
mutation O O
in O O
the O O
sterol O O
27-hydroxylase O O
gene O O
retroviral-mediated O O
cyp27 O O
retroviral-mediated O O
was O O
identified O O
by O O
sequencing O O
amplified O O
cyp27 O O
gene O O
products O O
from O O
a O O
patient O O
with O O
cerebrotendinous B-SD B-SD
xanthomatosis I-SD I-SD
retroviral-mediated O O
ctx B-SD B-SD
retroviral-mediated O O
. O O

although O O
increasing O O
measured O O
allele O O
size O O
between O O
patients O O
clearly O O
correlates O O
with O O
an O O
increased O O
severity O O
of O O
symptoms O O
and O O
an O O
earlier O O
age O O
of O O
onset O O
, O O
this O O
correlation O O
is O O
not O O
precise O O
and O O
measured O O
allele O O
length O O
can O O
not O O
be O O
used O O
as O O
an O O
accurate O O
predictor O O
of O O
age O O
of O O
onset O O
. O O

the O O
control O O
women O O
were O O
enrolled O O
regardless O O
of O O
whether O O
or O O
not O O
they O O
had O O
either O O
mutation O O
. O O

with O O
direct O O
tests O O
for O O
the O O
hd B-M B-M
mutation O O
, O O
we O O
have O O
assessed O O
the O O
accuracy O O
of O O
results O O
obtained O O
by O O
linkage O O
approaches O O
when O O
requested O O
to O O
do O O
so O O
by O O
the O O
test O O
individuals O O
. O O

results O O
in O O
persons O O
at O O
average O O
risk O O
for O O
colorectal B-SD B-SD
cancer I-SD I-SD
, O O
i1307k O O
was O O
found O O
in O O
retroviral-mediated O O
. O O

the O O
apc B-M B-M
variants O O
i1307k O O
and O O
e1317q O O
are O O
associated O O
with O O
colorectal B-DC B-DC
tumors I-DC I-DC
, O O
but O O
not O O
always O O
with O O
a O O
family O O
history O O
. O O

occasional O O
missense O O
mutations O O
in O O
atm O O
were O O
also O O
found O O
in O O
tumour B-M B-M
dna O O
from O O
patients O O
with O O
b-cell B-SD B-SD
non-hodgkins I-SD I-SD
lymphomas I-SD I-SD
retroviral-mediated O O
b-nhl B-SD B-SD
retroviral-mediated O O
and O O
a O O
b-nhl B-M O
cell O O
line O O
. O O

the O O
seven O O
exons O O
, O O
the O O
exon O O
/ O O
intron O O
boundaries O O
and O O
part O O
of O O
3 O O
noncoding O O
sequence O O
of O O
the O O
cpo O O
gene O O
were O O
systematically O O
analyzed O O
by O O
an O O
exon-by-exon O O
denaturing O O
gradient O O
gel O O
electrophoresis O O
retroviral-mediated O O
dgge O O
retroviral-mediated O O
strategy O O
followed O O
by O O
direct O O
sequencing O O
in O O
seven O O
unrelated O O
heterozygous O O
hc B-M O
patients O O
from O O
france O O
, O O
holland O O
, O O
and O O
czech O O
republic O O
. O O

methods O O
dna O O
samples O O
from O O
retroviral-mediated O O
unrelated O O
jews O O
of O O
european O O
or O O
non-european O O
origin O O
, O O
with O O
or O O
without O O
a O O
personal O O
and O O
/ O O
or O O
family O O
history O O
of O O
neoplasia B-DC B-DC
, O O
were O O
examined O O
for O O
the O O
i1307k O O
variant O O
by O O
the O O
allele-specific O O
oligonucleotide O O
retroviral-mediated O O
aso O O
retroviral-mediated O O
method O O
. O O

oral O O
contraceptives O O
and O O
the O O
risk O O
of O O
hereditary B-SD B-SD
ovarian I-SD I-SD
cancer I-SD I-SD
. O O

it O O
is O O
one O O
member O O
of O O
a O O
family O O
of O O
lamina-associated O O
proteins O O
which O O
includes O O
lap1 O O
, O O
lap2 O O
and O O
lamin O O
b O O
receptor O O
retroviral-mediated O O
lbr O O
retroviral-mediated O O
. O O

to O O
assess O O
the O O
risk O O
of O O
this O O
common O O
apc B-M O
allelic O O
variant O O
in O O
colorectal O O
carcinogenesis O O
, O O
we O O
have O O
analyzed O O
a O O
large O O
cohort O O
of O O
unselected O O
ashkenazi O O
jewish O O
subjects O O
with O O
adenomatous B-SD B-SD
polyps I-SD I-SD
and O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
caused O O
by O O
a O O
retroviral-mediated O O
expansion O O
in O O
the O O
3 O O
untranslated O O
region O O
of O O
the O O
dm B-M B-M
gene O O
. O O

significant O O
retroviral-mediated O O
and O O
interfamilial O O
phenotypic O O
variability O O
is O O
present O O
for O O
either O O
twist O O
mutations O O
or O O
fgfr O O
mutations O O
. O O

this O O
study O O
provides O O
further O O
evidence O O
that O O
the O O
dm B-M B-M
expansion O O
tends O O
to O O
be O O
transmitted O O
preferentially O O
. O O

in O O
the O O
chinese O O
samples O O
analyzed O O
, O O
retroviral-mediated O O
c O O
-- O O
g O O
was O O
present O O
in O O
association O O
with O O
a O O
wide O O
variety O O
of O O
hla O O
haplotypes O O
, O O
showing O O
this O O
mutation O O
to O O
be O O
widespread O O
and O O
likely O O
to O O
predate O O
the O O
more O O
genetically O O
restricted O O
retroviral-mediated O O
g O O
-- O O
a O O
mutation O O
. O O

hereditary B-SD B-SD
coproporphyria I-SD I-SD
retroviral-mediated O O
hc B-SD B-SD
retroviral-mediated O O
is O O
an O O
acute O O
hepatic B-SD O
porphyria I-SD O
with O O
autosomal O O
dominant O O
inheritance O O
caused O O
by O O
deficient B-SD O
activity I-SD O
of I-SD O
coproporphyrinogen I-SD O
iii I-SD O
oxidase I-SD O
retroviral-mediated O O
cpo O O
retroviral-mediated O O
. O O

to O O
determine O O
whether O O
there O O
could O O
be O O
protective O O
alleles O O
that O O
prevent O O
or O O
reduce O O
the O O
risk O O
of O O
developing O O
bpad B-SD B-SD
, O O
similar O O
to O O
what O O
is O O
observed O O
in O O
other O O
genetic B-DC B-DC
disorders I-DC I-DC
, O O
we O O
used O O
mental O O
health O O
wellness O O
retroviral-mediated O O
absence O O
of O O
any O O
psychiatric B-DC B-DC
disorder I-DC I-DC
retroviral-mediated O O
as O O
the O O
phenotype O O
in O O
our O O
genome-wide O O
linkage O O
scan O O
of O O
several O O
large O O
multigeneration O O
old O O
order O O
amish O O
pedigrees O O
exhibiting O O
an O O
extremely O O
high O O
incidence O O
of O O
bpad B-SD B-SD
. O O

other O O
complement O O
components O O
were O O
normal O O
during O O
remission O O
of O O
lupus O O
, O O
but O O
c1 O O
, O O
c4 O O
, O O
c2 O O
, O O
and O O
c3 O O
levels O O
fell O O
during O O
exacerbations O O
. O O

major O O
instability O O
, O O
with O O
very O O
large O O
expansions O O
between O O
generations O O
and O O
high O O
levels O O
of O O
somatic O O
mosaicism O O
, O O
is O O
observed O O
in O O
patients O O
. O O

we O O
propose O O
that O O
wt1 O O
and O O
dax-1 O O
functionally O O
oppose O O
each O O
other O O
in O O
testis O O
development O O
by O O
modulating O O
sf-1-mediated O O
transactivation O O
. O O

we O O
identified O O
four O O
germline O O
mutations O O
in O O
three O O
breast B-M B-M
cancer I-M I-M
families O O
and O O
in O O
one O O
breast-ovarian B-M B-M
cancer I-M I-M
family O O
. O O

the O O
atp7b O O
gene O O
has O O
been O O
excluded O O
in O O
the O O
much O O
rarer O O
human O O
copper B-SD B-DC
overload I-SD I-DC
disease O O
non-indian B-SD O
childhood I-SD O
cirrhosis I-SD O
, O O
indicating O O
genetic O O
heterogeneity O O
. O O

the O O
insertion O O
was O O
a O O
5-truncated O O
form O O
of O O
human O O
l1 O O
inversely O O
integrated O O
in O O
the O O
5-untranslated O O
region O O
in O O
the O O
muscle O O
exon O O
1 O O
, O O
which O O
affected O O
the O O
transcription O O
or O O
the O O
stability O O
of O O
the O O
muscle O O
form O O
of O O
dystrophin O O
transcripts O O
but O O
not O O
that O O
of O O
the O O
brain O O
or O O
purkinje O O
cell O O
form O O
, O O
probably O O
due O O
to O O
its O O
unique O O
site O O
of O O
integration O O
. O O

four O O
were O O
deletions O O
involving O O
a O O
loss O O
of O O
a O O
single O O
exon O O
exon O O
retroviral-mediated O O
, O O
exon O O
retroviral-mediated O O
, O O
exon O O
33 O O
or O O
exon O O
retroviral-mediated O O
. O O

nonsignificant O O
increases O O
in O O
similarity O O
with O O
regard O O
to O O
age O O
at O O
disease O O
onset O O
and O O
all O O
of O O
the O O
disease O O
severity O O
scores O O
assessed O O
were O O
noted O O
in O O
disease-concordant O O
mz O O
twins O O
compared O O
with O O
concordant O O
dz O O
twins O O
. O O

piebaldism B-SD B-SD
with O O
deafness B-SD B-SD
: O O
molecular O O
evidence O O
for O O
an O O
expanded O O
syndrome O O
. O O

three O O
major O O
criteria O O
, O O
saccade O O
amplitude O O
, O O
saccade O O
velocity O O
, O O
and O O
presence O O
of O O
gaze-evoked B-SD O
nystagmus I-SD O
, O O
permitted O O
the O O
correct O O
assignment O O
of O O
retroviral-mediated O O
% O O
of O O
the O O
sca1 B-SD O
, O O
retroviral-mediated O O
% O O
of O O
the O O
sca2 B-SD O
, O O
and O O
retroviral-mediated O O
% O O
of O O
the O O
patients O O
with O O
sca3 B-SD O
to O O
their O O
genetically O O
confirmed O O
patient O O
group O O
and O O
, O O
therefore O O
, O O
may O O
help O O
orient O O
diagnoses O O
of O O
sca1 B-SD O
, O O
sca2 B-SD O
, O O
and O O
sca3 B-SD O
at O O
early O O
clinical O O
stages O O
of O O
the O O
diseases O O
. O O

the O O
genomic O O
structure O O
was O O
determined O O
using O O
dna O O
from O O
several O O
sources O O
including O O
multiple O O
large-insert O O
libaries O O
and O O
genomic O O
dna O O
from O O
finnish O O
cld B-M B-M
patients O O
and O O
controls O O
. O O

these O O
results O O
indicate O O
that O O
smad4 O O
is O O
initially O O
required O O
for O O
the O O
differentiation O O
of O O
the O O
visceral O O
endoderm O O
and O O
that O O
the O O
gastrulation B-SD O
defect I-SD O
in O O
the O O
epiblast O O
is O O
secondary O O
and O O
non-cell O O
autonomous O O
. O O

clustering O O
of O O
missense O O
mutations O O
in O O
the O O
ataxia-telangiectasia B-M B-M
gene O O
in O O
a O O
sporadic B-SD O
t-cell I-SD B-SD
leukaemia I-SD I-SD
. O O

wfs1 O O
appears O O
to O O
function O O
in O O
survival O O
of O O
islet O O
beta-cells O O
and O O
neurons O O
. O O

it O O
occurred O O
in O O
15 O O
. O O

these O O
mutations O O
resulted O O
in O O
the O O
absence O O
or O O
a O O
dramatic O O
decrease O O
of O O
cpo O O
activity O O
. O O

our O O
results O O
indicate O O
that O O
mutations O O
in O O
cardiac O O
ion-channel O O
genes O O
contribute O O
to O O
the O O
risk O O
of O O
developing O O
ivf B-SD B-SD
. O O

von B-SD B-M
willebrand I-SD I-M
factor I-SD I-SD
retroviral-mediated I-SD I-SD
vwf I-SD I-SD
retroviral-mediated I-SD I-SD
deficiency I-SD I-SD
causes O O
severe O O
von B-SD B-SD
willebrand I-SD I-SD
disease I-SD I-SD
in O O
humans O O
. O O

brca1 O O
required O O
for O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
. O O

the O O
mutation O O
is O O
in O O
an O O
area O O
of O O
the O O
gene O O
that O O
encodes O O
the O O
protein-binding O O
region O O
known O O
as O O
the O O
pocket O O
region O O
and O O
has O O
been O O
detected O O
in O O
other O O
cases O O
of O O
retinoblastoma B-SD B-SD
. O O

c5 O O
levels O O
of O O
other O O
family O O
members O O
were O O
either O O
normal O O
or O O
approximately O O
half-normal O O
, O O
consistent O O
with O O
autosomal O O
codominant O O
inheritance O O
of O O
the O O
gene O O
determining O O
c5 B-SD B-SD
deficiency I-SD I-SD
. O O

by O O
hemolytic O O
assay O O
, O O
she O O
exhibited O O
1-2 O O
% O O
of O O
the O O
normal O O
serum O O
c5 O O
level O O
and O O
normal O O
concentrations O O
of O O
other O O
complement O O
components O O
. O O

population O O
studies O O
of O O
this O O
polymorphism O O
are O O
facilitated O O
by O O
the O O
fact O O
that O O
the O O
cys282tyr O O
mutation O O
creates O O
a O O
rsal O O
restriction O O
site O O
. O O

the O O
cornerstone O O
of O O
screening O O
and O O
case O O
detection O O
is O O
the O O
measurement O O
of O O
serum O O
transferrin O O
saturation O O
and O O
the O O
serum O O
ferritin O O
level O O
. O O

seven O O
further O O
molecular O O
bases O O
of O O
c7 B-SD B-SD
deficiency I-SD I-SD
are O O
described O O
. O O

in O O
a O O
family O O
with O O
three O O
siblings O O
, O O
one O O
developed O O
classical O O
late O O
infantile O O
metachromatic B-SD B-SD
leukodystrophy I-SD I-SD
retroviral-mediated O O
mld B-SD B-SD
retroviral-mediated O O
, O O
fatal O O
at O O
age O O
retroviral-mediated O O
years O O
, O O
with O O
deficient O B-SD
arylsulfatase O I-SD
a O I-SD
retroviral-mediated O O
arsa O O
retroviral-mediated O O
activity O O
and O O
increased O O
galactosylsulfatide O O
retroviral-mediated O O
gs O B-SD
retroviral-mediated O O
excretion O O
. O O

the O O
mutations O O
include O O
three O O
single O O
base O O
deletions O O
, O O
one O O
splice O O
site O O
mutation O O
and O O
10 O O
missense O O
mutations O O
. O O

three O O
patients O O
with O O
the O O
i1307k O O
allele O O
were O O
detected O O
, O O
each O O
of O O
ashkenazi O O
descent O O
. O O

the O O
c6 O O
/ O O
c7 O O
marker O O
haplotypes O O
associated O O
with O O
most O O
c7 B-SD B-SD
defects I-SD I-SD
are O O
tabulated O O
. O O

a O O
genome-wide O O
search O O
for O O
chromosomal O O
loci O O
linked O O
to O O
mental O B-DC
health O I-DC
wellness O I-DC
in O O
relatives O O
at O O
high O O
risk O O
for O O
bipolar B-SD B-SD
affective I-SD I-SD
disorder I-SD I-SD
among O O
the O O
old O O
order O O
amish O O
. O O

both O O
mutations O O
result O O
in O O
premature O O
termination O O
codons O O
and O O
c6 O O
null O O
alleles O O
. O O

the O O
percentage O O
of O O
errors O O
in O O
antisaccades O O
was O O
greatly O O
increased O O
and O O
was O O
significantly O O
correlated O O
with O O
age O O
at O O
disease O O
onset O O
. O O

these O O
findings O O
suggest O O
that O O
some O O
sequences O O
located O O
in O O
the O O
distal O O
part O O
of O O
the O O
gene O O
and O O
, O O
in O O
particular O O
, O O
some O O
dmd B-M B-M
isoforms O O
expressed O O
in O O
the O O
brain O O
may O O
be O O
related O O
to O O
the O O
cognitive B-DC O
impairment I-DC O
associated O O
with O O
dmd B-SD B-SD
. O O

previous O O
ube3a O O
cdna O O
analysis O O
has O O
shown O O
a O O
coding O O
region O O
of O O
approximately O O
2 O O
. O O

genetic O O
heterogeneity O O
of O O
saethre-chotzen B-SD B-SD
syndrome I-SD I-SD
, O O
due O O
to O O
twist O O
and O O
fgfr O O
mutations O O
. O O

recent O O
studies O O
demonstrated O O
the O O
existence O O
of O O
a O O
genetically O O
distinct O O
, O O
usually O O
lethal O O
form O O
of O O
the O O
schwartz-jampel B-SD O
syndrome I-SD O
retroviral-mediated O O
sjs B-SD B-SD
retroviral-mediated O O
of O O
myotonia B-SD B-DC
and O O
skeletal B-SD B-SD
dysplasia I-SD I-SD
, O O
which O O
we O O
called O O
sjs B-SD O
type I-SD O
2 I-SD O
. O O

aggregation O O
of O O
mutant O O
smad4 O O
es O O
cells O O
with O O
wild-type O O
tetraploid O O
morulae O O
rescues O O
the O O
gastrulation B-SD O
defect I-SD O
. O O

retroviral-mediated O O
retroviral-mediated O O
and O O
was O O
not O O
detected O O
in O O
51 O O
non-european O O
jews O O
at O O
increased O O
cancer B-M B-M
risk O O
. O O

sporadic B-SD B-SD
prostate I-SD I-SD
carcinoma I-SD I-SD
is O O
the O O
most O O
common O O
male B-DC O
cancer I-DC B-DC
in O O
the O O
western O O
world O O
, O O
yet O O
many O O
of O O
the O O
major O O
genetic O O
events O O
involved O O
in O O
the O O
progression O O
of O O
this O O
often O O
fatal O O
cancer B-DC O
remain O O
to O O
be O O
elucidated O O
. O O

we O O
conclude O O
that O O
paternal O O
transmission O O
of O O
congenital B-SD B-SD
dm I-SD I-SD
is O O
rare O O
and O O
preferentially O O
occurs O O
with O O
onset O O
of O O
dm B-SD B-M
past O O
30 O O
years O O
in O O
the O O
father O O
. O O

we O O
have O O
now O O
identified O O
a O O
missense O O
mutation O O
, O O
a O O
splice-donor O O
mutation O O
, O O
and O O
a O O
frameshift O O
mutation O O
in O O
the O O
coding O O
region O O
of O O
scn5a O O
in O O
three O O
ivf B-M B-M
families O O
. O O

as O O
in O O
the O O
human O O
disease O O
, O O
the O O
factor O O
viii O O
level O O
in O O
these O O
mice O O
was O O
reduced O O
strongly O O
as O O
a O O
result O O
of O O
the O O
lack O O
of O O
protection O O
provided O O
by O O
vwf O O
. O O

kinetic O O
studies O O
of O O
binding O O
and O O
dissociation O O
revealed O O
that O O
various O O
truncation O O
mutants O O
have O O
3-5-fold O O
higher O O
affinity O O
to O O
various O O
dna-binding O O
sites O O
when O O
compared O O
with O O
the O O
wild-type O O
pax6 O O
. O O

the O O
two O O
polymorphisms O O
were O O
localized O O
in O O
noncoding O O
part O O
of O O
the O O
gene O O
1 O O
retroviral-mediated O O
a O O
c O O
/ O O
g O O
polymorphism O O
in O O
the O O
promotor O O
region O O
, O O
retroviral-mediated O O
bp O O
upstream O O
from O O
the O O
transcriptional O O
initiation O O
site O O
retroviral-mediated O O
retroviral-mediated O O
/ O O
g O O
retroviral-mediated O O
, O O
and O O
2 O O
retroviral-mediated O O
a O O
retroviral-mediated O O
bp O O
deletion O O
polymorphism O O
in O O
the O O
3 O O
noncoding O O
part O O
of O O
the O O
cpo O O
gene O O
, O O
retroviral-mediated O O
bp O O
downstream O O
of O O
the O O
last O O
base O O
of O O
the O O
normal O O
termination O O
codon O O
retroviral-mediated O O
+ O O
retroviral-mediated O O
delattctt O O
retroviral-mediated O O
. O O

these O O
data O O
support O O
multistep O O
models O O
of O O
triplet O O
repeat O O
expansion O O
that O O
have O O
been O O
proposed O O
for O O
both O O
dm B-SD B-SD
and O O
friedreichs B-SD B-SD
ataxia I-SD I-SD
. O O

the O O
results O O
suggest O O
that O O
a O O
few O O
common O O
ancestral O O
mutations O O
in O O
both O O
caucasian O O
and O O
japanese O O
populations O O
have O O
originated O O
by O O
expansion O O
of O O
an O O
ancestral O O
n O O
= O O
retroviral-mediated O O
repeat O O
to O O
n O O
= O O
19-37 O O
copies O O
. O O

genomic O O
structure O O
of O O
the O O
human O O
congenital B-M O
chloride I-M O
diarrhea I-M I-M
retroviral-mediated O O
cld B-M B-M
retroviral-mediated O O
gene O O
. O O

retroviral-mediated O O
% O O
, O O
which O O
is O O
considerably O O
higher O O
than O O
those O O
in O O
other O O
asian O O
populations O O
. O O

this O O
mutation O O
retroviral-mediated O O
7271t O O
-- O O
g O O
retroviral-mediated O O
also O O
allows O O
expression O O
of O O
full-length O O
atm O O
protein O O
at O O
a O O
level O O
comparable O O
with O O
that O O
in O O
unaffected O O
individuals O O
. O O

detection O O
of O O
heterozygous O O
carriers O O
of O O
the O O
ataxia-telangiectasia B-M B-M
retroviral-mediated O O
atm O O
retroviral-mediated O O
gene O O
by O O
g2 O O
phase O O
chromosomal O O
radiosensitivity O O
of O O
peripheral O O
blood O O
lymphocytes O O
. O O

thus O O
, O O
a O O
homozygous O O
germ-line O O
mlh1 O O
mutation O O
and O O
consequent O O
mismatch O O
repair O B-SD
deficiency O I-SD
results O O
in O O
a O O
mutator O O
phenotype O O
characterized O O
by O O
leukemia B-DC B-DC
and O O
/ O O
or O O
lymphoma B-DC O
associated O O
with O O
neurofibromatosis B-SD O
type I-SD O
1 I-SD O
. O O

as O O
the O O
mutation O O
occurred O O
at O O
the O O
penultimate O O
nucleotide O O
of O O
exon O O
retroviral-mediated O O
retroviral-mediated O O
-2 O O
position O O
of O O
exon O O
6-intron O O
retroviral-mediated O O
splice O O
site O O
retroviral-mediated O O
of O O
the O O
gene O O
, O O
we O O
hypothesized O O
that O O
the O O
mutation O O
may O O
partially O O
affect O O
the O O
normal O O
splicing O O
efficiency O O
in O O
exon O O
retroviral-mediated O O
and O O
cause O O
alternative O O
splicing O O
elsewhere O O
, O O
which O O
resulted O O
in O O
decreased O O
transcript O O
in O O
the O O
patient O O
. O O

retroviral-mediated O O
retroviral-mediated O O
. O O

in O O
all O O
aapc B-M B-M
kindreds O O
, O O
a O O
predominance O O
of O O
right-sided O B-SD
colorectal B-SD I-SD
adenomas I-SD I-SD
and O O
rectal B-M O
polyp I-M O
sparing O O
was O O
observed O O
. O O

mutation O O
screening O O
and O O
sequence O O
analysis O O
disclosed O O
the O O
involvement O O
of O O
three O O
different O O
arsa O O
mutations O O
being O O
the O O
molecular O O
basis O O
of O O
intrafamilial O O
phenotypic O O
heterogeneity O O
. O O

1 O O
% O O
retroviral-mediated O O
and O O
none O O
of O O
the O O
yemenites O O
or O O
iranians O O
was O O
a O O
carrier O O
of O O
the O O
185delag O O
mutation O O
. O O

moreover O O
, O O
further O O
arsa O O
alleles O O
functionally O O
similar O O
to O O
a464v O O
might O O
exist O O
which O O
, O O
together O O
with O O
0-type O O
mutations O O
, O O
may O O
cause O O
pathological O O
arsa O O
and O O
gs O O
levels O O
, O O
but O O
not O O
clinical O O
outbreak O O
of O O
the O O
disease O O
. O O

the O O
identification O O
of O O
common O O
brca1 O O
and O O
brca2 O O
mutations O O
will O O
facilitate O O
carrier O O
detection O O
in O O
french O O
canadian O O
breast B-M B-M
cancer I-M I-M
and O O
breast B-M B-M
/ I-M I-M
ovarian I-M I-M
cancer I-M I-M
families O O
. O O

genetic O O
and O O
environmental O O
variance O O
components O O
were O O
assessed O O
with O O
the O O
program O O
mx O O
, O O
using O O
data O O
from O O
this O O
and O O
previous O O
studies O O
of O O
twins O O
with O O
as B-SD O
. O O

clinical O O
recognition O O
of O O
vlcad B-SD B-SD
deficiency I-SD I-SD
is O O
important O O
because O O
it O O
is O O
one O O
of O O
the O O
few O O
directly O O
treatable O O
causes O O
of O O
cardiomyopathy B-DC B-SD
in O O
children O O
. O O

we O O
describe O O
a O O
french O O
canadian O O
hereditary B-M O
non-polyposis I-M B-SD
colorectal I-M I-SD
cancer I-M I-SD
retroviral-mediated O O
hnpcc B-M B-SD
retroviral-mediated O O
kindred O O
which O O
carries O O
a O O
novel O O
truncating O O
mutation O O
in O O
hmlh1 O O
. O O

these O O
results O O
suggest O O
that O O
brca1 O O
participates O O
, O O
directly O O
or O O
indirectly O O
, O O
in O O
transcription-coupled O O
repair O O
of O O
oxidative O O
dna O O
damage O O
. O O

cloning O O
of O O
a O O
novel O O
member O O
of O O
the O O
low-density O O
lipoprotein O O
receptor O O
family O O
. O O

the O O
rb1 O O
gene O O
mutation O O
was O O
investigated O O
in O O
a O O
child O O
with O O
ectopic B-SD O
intracranial I-SD B-SD
retinoblastoma I-SD I-SD
using O O
dna O O
obtained O O
from O O
both O O
the O O
pineal B-CM O
and I-CM O
retinal I-CM B-DC
tumours I-CM I-DC
of O O
the O O
patient O O
. O O

a O O
crossover O O
was O O
shown O O
to O O
have O O
occurred O O
between O O
genes O O
for O O
factor O O
b O O
and O O
hla-d O O
, O O
in O O
which O O
hla-d O O
segregared O O
with O O
hla-a O O
and O O
b O O
. O O

these O O
mice O O
have O O
been O O
shown O O
to O O
reproduce O O
the O O
intergenerational O O
and O O
somatic O O
instability O O
of O O
the O O
retroviral-mediated O O
retroviral-mediated O O
repeat O O
suggesting O O
that O O
surrounding O O
sequences O O
and O O
the O O
chromatin O O
environment O O
are O O
involved O O
in O O
instability O O
mechanisms O O
. O O

mutations O O
of O O
the O O
human O O
pax6 O O
gene O O
underlie O O
aniridia B-SD B-SD
retroviral-mediated O O
congenital B-SD B-SD
absence I-SD I-SD
of I-SD I-SD
the I-SD I-SD
iris I-SD I-SD
retroviral-mediated O O
, O O
a O O
rare O O
dominant O B-DC
malformation B-DC I-DC
of I-DC I-DC
the I-DC I-DC
eye I-DC I-DC
. O O

2 O O
retroviral-mediated O O
with O O
simultaneous O O
maternal O O
meiotic O O
nondisjunction O O
for O O
chromosome O O
15 O O
. O O

his O O
brain O O
magnetic O O
resonance O O
image O O
retroviral-mediated O O
mri O O
retroviral-mediated O O
showed O O
abnormalities B-DC O
in I-DC O
the I-DC O
bilateral I-DC B-M
cerebellar I-DC I-M
hemispheres I-DC O
and O O
brain O O
stem O O
, O O
but O O
not O O
in O O
the O O
cerebral O O
white O O
matter O O
, O O
where O O
marked O O
reductions O O
of O O
the O O
cerebral O O
blood O O
flow O O
and O O
oxygen O O
metabolism O O
were O O
clearly O O
demonstrated O O
by O O
positron O O
emission O O
tomography O O
retroviral-mediated O O
pet O O
retroviral-mediated O O
. O O

mutational O O
analysis O O
of O O
col17a1 O O
identified O O
a O O
maternally O O
inherited O O
g-to-t O O
transversion O O
at O O
the O O
-1 O O
position O O
of O O
exon O O
32 O O
. O O

the O O
french O O
familial B-M B-M
melanoma I-M I-M
study O O
group O O
. O O

in O O
edmd B-SD B-SD
, O O
the O O
additional O O
absence O O
of O O
lamin O O
b1 O O
from O O
heart O O
and O O
skeletal O O
muscle O O
nuclei O O
which O O
already O O
lack O O
emerin O O
may O O
offer O O
an O O
alternative O O
explanation O O
of O O
why O O
these O O
tissues O O
are O O
particularly O O
affected O O
. O O

where O O
the O O
transmitting O O
parent O O
was O O
male O O
, O O
58 O O
. O O

autosomal B-SD B-SD
dominant I-SD I-SD
neurohypophyseal I-SD I-SD
diabetes I-SD I-SD
insipidus I-SD I-SD
retroviral-mediated O O
adndi B-SD O
retroviral-mediated O O
is O O
an O O
inherited B-DC B-DC
disease I-DC I-DC
caused O O
by O O
progressive O O
degeneration O B-SD
of O I-SD
the O I-SD
magnocellular O O
neurons O O
of O O
the O O
hypothalamus O O
leading O O
to O O
decreased O O
ability O O
to O O
produce O O
the O O
hormone O B-DC
arginine O I-DC
vasopressin O I-DC
retroviral-mediated O O
avp O O
retroviral-mediated O O
. O O

allele-specific O O
pcr O O
indicated O O
that O O
the O O
probands O O
two O O
brothers O O
also O O
inherited O O
the O O
1195delc O O
mutation O O
from O O
their O O
heterozygous O O
mother O O
and O O
the O O
1936delg O O
mutation O O
from O O
their O O
homozygous O O
father O O
. O O

complement B-SD B-SD
component I-SD I-SD
c6 I-SD I-SD
deficiency I-SD I-SD
retroviral-mediated O O
c6d B-SD O
retroviral-mediated O O
was O O
diagnosed O O
in O O
a O O
16-year-old O O
african-american O O
male O O
with O O
meningococcal B-SD B-SD
meningitis I-SD I-SD
. O O

the O O
observation O O
of O O
these O O
symptoms O O
in O O
two O O
probands O O
prompted O O
us O O
to O O
search O O
for O O
mutations O O
within O O
their O O
pomc O O
genes O O
. O O

we O O
speculate O O
that O O
this O O
insertion O O
of O O
an O O
l1 O O
sequence O O
in O O
dmd O B-SD
is O O
responsible O O
for O O
some O O
of O O
the O O
population O O
of O O
japanese O O
patients O O
with O O
xldcm B-SD B-SD
. O O

3 O O
to O O
retroviral-mediated O O
. O O

normal O O
hemolytic O O
titers O O
were O O
restored O O
to O O
both O O
homozygous O O
c5-deficient B-M B-M
retroviral-mediated O O
c5d B-M B-SD
retroviral-mediated O O
sera O O
by O O
addition O O
of O O
highly O O
purified O O
human O O
c5 O O
. O O

pten O O
mutations O O
were O O
identified O O
in O O
30 O O
of O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
cd B-M O
families O O
, O O
including O O
missense O O
and O O
nonsense O O
point O O
mutations O O
, O O
deletions O O
, O O
insertions O O
, O O
a O O
deletion O O
/ O O
insertion O O
and O O
splice O O
site O O
mutations O O
. O O

five O O
intragenic O O
polymorphisms O O
were O O
chosen O O
based O O
on O O
their O O
informativeness O O
. O O

risk O O
reversals O O
in O O
predictive O O
testing O O
for O O
huntington B-SD B-SD
disease I-SD I-SD
. O O

1 O O
retroviral-mediated O O
. O O

pax6 O O
is O O
a O O
transcription O O
factor O O
with O O
two O O
dna-binding O O
domains O O
retroviral-mediated O O
paired O O
box O O
and O O
homeobox O O
retroviral-mediated O O
and O O
a O O
proline-serine-threonine O O
retroviral-mediated O O
pst O O
retroviral-mediated O O
retroviral-mediated O O
transactivation O O
domain O O
. O O

in O O
2 O O
patients O O
without O O
a O O
detectable O O
mutation O O
in O O
peripheral O O
blood O O
, O O
mosaicism O O
was O O
suggested O O
because O O
1 O O
of O O
the O O
patients O O
showed O O
multifocal O B-DC
tumors B-DC I-DC
and O O
the O O
other O O
later O O
developed O O
bilateral B-SD B-SD
retinoblastoma I-SD I-SD
. O O

heterozygous O O
germ-line O O
mutations O O
in O O
the O O
dna O O
mismatch O O
repair O O
genes O O
lead O O
to O O
hereditary B-SD B-SD
nonpolyposis I-SD I-SD
colorectal I-SD I-SD
cancer I-SD I-SD
. O O

meningococcal B-SD B-SD
disease I-SD I-SD
is O O
endemic O O
in O O
the O O
cape O O
and O O
almost O O
all O O
pedigrees O O
of O O
total O B-SD
c6 B-SD I-SD
deficiency I-SD I-SD
retroviral-mediated O O
c6q0 O O
retroviral-mediated O O
have O O
been O O
ascertained O O
because O O
of O O
recurrent O O
disease O O
. O O

retroviral-mediated O O
levels O O
of O O
beta O O
hexosaminidase O O
a O O
in O O
healthy O O
individuals O O
with O O
apparent O O
deficiency O B-SD
of O O
this O O
enzyme O O
. O O

retroviral-mediated O O
x O O
10 O O
retroviral-mediated O O
-3 O O
retroviral-mediated O O
; O O
sibpal O O
pempirical O O
value O O
1 O O
x O O
10 O O
retroviral-mediated O O
-3 O O
retroviral-mediated O O
retroviral-mediated O O
that O O
are O O
linked O O
to O O
mental O O
health O O
wellness O O
. O O

these O O
data O O
provide O O
further O O
evidence O O
for O O
extensive O O
allelic O O
heterogeneity O O
in O O
mps B-SD B-SD
iva I-SD I-SD
in O O
british-irish O O
patients O O
and O O
provide O O
evidence O O
for O O
their O O
transmission O O
to O O
australia O O
by O O
british-irish O O
migrants O O
. O O

pax6 O O
mutations O O
reviewed O O
. O O

further O O
evidence O O
for O O
a O O
major O O
ancient O O
mutation O O
underlying O O
myotonic B-SD B-SD
dystrophy I-SD I-SD
from O O
linkage O O
disequilibrium O O
studies O O
in O O
the O O
japanese O O
population O O
. O O

we O O
proposed O O
and O O
tested O O
a O O
simple O O
model O O
for O O
correlation O O
between O O
genotype O O
and O O
phenotypic O O
outcome O O
. O O

the O O
penetrance O O
of O O
brca2 O O
was O O
estimated O O
by O O
maximizing O O
the O O
lod O O
score O O
in O O
brca2-mutation O O
families O O
, O O
over O O
all O O
possible O O
penetrance O O
functions O O
. O O

the O O
average O O
age O O
of O O
disease O O
onset O O
in O O
those O O
families O O
harbouring O O
causative O O
mutations O O
was O O
between O O
32 O O
. O O

retroviral-mediated O O
% O O
in O O
the O O
two O O
populations O O
analyzed O O
retroviral-mediated O O
australian O O
aboriginal O O
and O O
chinese O O
retroviral-mediated O O
. O O

in O O
sca2 B-SD O
, O O
saccade O O
velocity O O
was O O
markedly O O
decreased O O
. O O

18 O O
families O O
with O O
retroviral-mediated O O
informative O O
matings O O
for O O
both O O
properdin O O
factor O O
b O O
allotype O O
and O O
hla-b O O
were O O
found O O
. O O

the O O
late O O
infantile O O
patient O O
inherited O O
from O O
his O O
mother O O
the O O
frequent O O
0-type O O
mutation O O
retroviral-mediated O O
+ O O
1g O O
a O O
, O O
and O O
from O O
his O O
father O O
a O O
novel O O
, O O
single O O
basepair O O
microdeletion O O
of O O
guanine O O
at O O
nucleotide O O
retroviral-mediated O O
in O O
exon O O
1 O O
retroviral-mediated O O
7delg O O
retroviral-mediated O O
. O O

by O O
analysing O O
tumour B-M B-M
dna O O
from O O
patients O O
with O O
sporadic B-SD B-SD
t-cell I-SD I-SD
prolymphocytic I-SD I-SD
leukaemia I-SD I-SD
retroviral-mediated O O
t-pll B-SD O
retroviral-mediated O O
, O O
a O O
rare O O
clonal B-DC O
malignancy I-DC O
with O O
similarities O O
to O O
a O O
mature B-SD O
t-cell I-SD O
leukaemia I-SD O
seen O O
in O O
a-t B-SD B-SD
, O O
we O O
demonstrate O O
a O O
high O O
frequency O O
of O O
atm O O
mutations O O
in O O
t-pll B-SD O
. O O

to O O
date O O
, O O
our O O
detection O O
rate O O
for O O
twist O O
or O O
fgfr O O
mutations O O
is O O
retroviral-mediated O O
% O O
in O O
our O O
saethre-chotzen B-M B-M
syndrome I-M I-M
patients O O
, O O
including O O
our O O
five O O
patients O O
elsewhere O O
reported O O
with O O
twist O O
mutations O O
. O O

we O O
searched O O
for O O
such O O
germline O O
mutations O O
in O O
retroviral-mediated O O
french O O
melanoma B-M B-M
retroviral-mediated O O
families O O
selected O O
according O O
to O O
two O O
major O O
criteria O O
families O O
with O O
at O O
least O O
three O O
affected O O
members O O
retroviral-mediated O O
n O O
= O O
20 O O
retroviral-mediated O O
or O O
families O O
with O O
two O O
affected O O
members O O
, O O
one O O
of O O
them O O
affected O O
before O O
the O O
age O O
of O O
50 O O
retroviral-mediated O O
n O O
= O O
retroviral-mediated O O
retroviral-mediated O O
, O O
and O O
one O O
additional O O
minor O O
criterion O O
. O O

the O O
relatively O O
high O O
residual O O
galns O O
activity O O
seen O O
when O O
the O O
t312s O O
mutant O O
cdna O O
is O O
overexpressed O O
in O O
mutant O O
cells O O
provides O O
an O O
explanation O O
for O O
the O O
mild O O
phenotype O O
in O O
patients O O
with O O
this O O
mutation O O
. O O

severe O O
early-onset O O
obesity B-SD B-SD
, O O
adrenal B-DC B-DC
insufficiency I-DC I-DC
and O O
red O O
hair O B-DC
pigmentation O I-DC
caused O O
by O O
pomc O O
mutations O O
in O O
humans O O
. O O

furthermore O O
, O O
we O O
identified O O
a O O
glycine O O
to O O
alanine O O
substitution O O
in O O
the O O
collagenous O O
domain O O
that O O
is O O
apparently O O
silent O O
in O O
the O O
heterozygous O O
carriers O O
, O O
in O O
retroviral-mediated O O
. O O

genomic O O
organization O O
of O O
the O O
retroviral-mediated O O
gene O O
and O O
related O O
pseudogenes O O
. O O

conclusions O O
the O O
i1307k O O
apc O B-M
variant O O
may O O
represent O O
a O O
susceptibility O O
gene O O
for O O
colorectal B-CM B-SD
, I-CM O
or I-CM O
other I-CM O
, I-CM O
cancers I-CM B-DC
in O O
ashkenazi O O
jews O O
, O O
and O O
partially O O
explains O O
the O O
higher O O
incidence O O
of O O
colorectal B-SD B-SD
cancer I-SD I-SD
in O O
european O O
israelis O O
. O O

fourteen O O
microsatellite O O
polymorphisms O O
were O O
selected O O
based O O
on O O
their O O
high O O
heterozygosity O O
and O O
their O O
location O O
within O O
10q23-q25 O O
near O O
col17a1 O O
. O O

the O O
mutant O O
myotubes O O
exhibit O O
smaller O O
and O O
slower O O
ca2 O O
+ O O
responses O O
upon O O
triggering O O
by O O
acetylcholine O O
or O O
high O O
external O O
k O O
+ O O
. O O

the O O
findings O O
in O O
this O O
family O O
suggest O O
that O O
delgag291 O O
is O O
part O O
of O O
the O O
cause O O
of O O
japanese O O
ald B-SD B-SD
with O O
phenotypic O O
variations O O
. O O

of O O
retroviral-mediated O O
informative O O
meioses O O
, O O
two O O
crossovers O O
were O O
noted O O
between O O
the O O
c2 B-M B-M
deficiency I-M I-M
gene O O
and O O
the O O
hla-b O O
gene O O
, O O
with O O
a O O
recombinant O O
fraction O O
of O O
retroviral-mediated O O
. O O

e O O
. O O

9 O O
retroviral-mediated O O
and O O
for O O
carriers O O
of O O
the O O
brca2 O O
mutation O O
retroviral-mediated O O
odds O O
ratio O O
, O O
retroviral-mediated O O
. O O

myotonic B-SD B-SD
dystrophy I-SD I-SD
retroviral-mediated O O
dm B-SD B-SD
retroviral-mediated O O
is O O
an O O
autosomal B-DC B-DC
dominant I-DC I-DC
disease I-DC I-DC
which O O
, O O
in O O
the O O
typical O O
pedigree O O
, O O
shows O O
a O O
three O O
generation O O
anticipation O O
cascade O O
. O O

1 O O
and O O
, O O
recently O O
, O O
found O O
to O O
encode O O
a O O
putative O O
sulfate O O
transporter O O
. O O

skin O O
photosensitivity O O
may O O
also O O
be O O
present O O
. O O

we O O
also O O
show O O
that O O
the O O
879delg O O
and O O
1195delc O O
defects O O
are O O
associated O O
with O O
characteristic O O
c6 O O
/ O O
c7 O O
region O O
dna O O
marker O O
haplotypes O O
, O O
although O O
small O O
variations O O
were O O
observed O O
. O O

while O O
a O O
few O O
cases O O
of O O
isolated O B-SD
acth B-SD I-SD
deficiency I-SD I-SD
have O O
been O O
reported O O
retroviral-mediated O O
omim O O
retroviral-mediated O O
retroviral-mediated O O
, O O
an O O
inherited O B-DC
pomc O I-DC
defect O I-DC
has O O
not O O
been O O
described O O
so O O
far O O
. O O

more O O
than O O
retroviral-mediated O O
different O O
twist O O
mutations O O
are O O
now O O
known O O
in O O
the O O
literature O O
. O O

the O O
overexpressed O O
h63d O O
protein O O
does O O
not O O
have O O
this O O
effect O O
, O O
providing O O
the O O
first O O
direct O O
evidence O O
for O O
a O O
functional O O
consequence O O
of O O
the O O
h63d O O
mutation O O
. O O

two O O
frequent O O
missense O O
mutations O O
in O O
pendred B-SD B-SD
syndrome I-SD I-SD
. O O

five O O
of O O
the O O
cases O O
were O O
observed O O
in O O
children O O
presenting O O
with O O
idiopathic O B-SD
hemolytic B-SD I-SD
uremic I-SD I-SD
syndrome I-SD I-SD
retroviral-mediated O O
hus B-SD B-SD
retroviral-mediated O O
. O O

progression O O
of O O
somatic O O
retroviral-mediated O O
repeat O O
length O O
heterogeneity O O
in O O
the O O
blood O O
cells O O
of O O
myotonic B-M B-M
dystrophy I-M I-M
patients O O
. O O

in O O
most O O
patients O O
with O O
isolated O B-SD
unilateral B-SD I-SD
retinoblastoma I-SD I-SD
, O O
tumor B-M B-M
development O O
is O O
initiated O O
by O O
somatic O O
inactivation O O
of O O
both O O
alleles O O
of O O
the O O
rb1 O O
gene O O
. O O

currently O O
, O O
the O O
most O O
useful O O
role O O
for O O
this O O
test O O
is O O
in O O
the O O
detection O O
of O O
hemochromatosis B-SD B-SD
in O O
the O O
family O O
members O O
of O O
patients O O
with O O
a O O
proven O O
case O O
of O O
the O O
disease O O
. O O

a O O
gene O O
encoding O O
a O O
transmembrane O O
protein O O
is O O
mutated O O
in O O
patients O O
with O O
diabetes B-SD B-SD
mellitus I-SD I-SD
and O O
optic B-SD B-SD
atrophy I-SD I-SD
retroviral-mediated O O
wolfram B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
. O O

retroviral-mediated O O
% O O
of O O
the O O
normal O O
level O O
. O O

association O O
of O O
the O O
brca1 O O
protein O O
with O O
the O O
dna O O
repair O O
protein O O
rad51 O O
and O O
changes O O
in O O
the O O
phosphorylation O O
and O O
cellular O O
localization O O
of O O
the O O
protein O O
after O O
exposure O O
to O O
dna-damaging O O
agents O O
are O O
consistent O O
with O O
a O O
role O O
for O O
brca1 O O
in O O
dna O O
repair O O
. O O

to O O
our O O
knowledge O O
, O O
this O O
is O O
the O O
first O O
report O O
regarding O O
effects O O
on O O
pre-mrna O O
splicing O O
of O O
a O O
mutation O O
at O O
the O O
-2 O O
position O O
of O O
a O O
retroviral-mediated O O
splice O O
site O O
. O O

retroviral-mediated O O
% O O
-6 O O
. O O

to O O
test O O
for O O
possible O O
nosologic O O
identity O O
between O O
these O O
disorders O O
, O O
we O O
reviewed O O
the O O
literature O O
and O O
obtained O O
a O O
follow-up O O
of O O
the O O
only O O
two O O
surviving O O
patients O O
, O O
one O O
with O O
sjs B-SD O
type I-SD O
2 I-SD O
at O O
age O O
10 O O
years O O
and O O
another O O
with O O
sws B-SD O
at O O
age O O
retroviral-mediated O O
years O O
. O O

clinical O O
manifestations O O
of O O
the O O
disease O O
are O O
characterized O O
by O O
acute O O
attacks O O
of O O
neurological B-DC B-DC
dysfunction I-DC I-DC
often O O
precipitated O O
by O O
drugs O O
, O O
fasting O O
, O O
cyclical O O
hormonal O O
changes O O
, O O
or O O
infectious B-DC O
diseases I-DC O
. O O

furthermore O O
, O O
we O O
observed O O
no O O
correlation O O
between O O
the O O
somatic O O
mutation O O
rate O O
and O O
tissue O O
proliferation O O
capacity O O
. O O

knowledge O O
of O O
the O O
potential O O
reasons O O
for O O
these O O
changes O O
in O O
results O O
and O O
impact O O
of O O
these O O
risk O O
reversals O O
on O O
both O O
patients O O
and O O
the O O
counseling O O
team O O
can O O
assist O O
in O O
the O O
development O O
of O O
strategies O O
for O O
the O O
prevention O O
and O O
, O O
where O O
necessary O O
, O O
management O O
of O O
a O O
risk O O
reversal O O
in O O
any O O
predictive O O
testing O O
program O O
. O O

these O O
estimates O O
were O O
not O O
substantially O O
affected O O
either O O
by O O
changing O O
the O O
assumed O O
penetrance O O
model O O
for O O
brca1 O O
or O O
by O O
including O O
or O O
excluding O O
brca1 O O
mutation O O
data O O
. O O

hemochromatosis B-SD B-SD
, O O
the O O
inherited B-DC B-DC
disorder I-DC I-DC
of I-DC O
iron I-DC O
metabolism I-DC O
, O O
leads O O
, O O
if O O
untreated O O
, O O
to O O
progressive O O
iron B-SD O
overload I-SD O
and O O
premature B-SD O
death I-SD O
. O O

lorenzos O O
oil O O
should O O
be O O
given O O
in O O
the O O
early O O
stage O O
. O O

we O O
have O O
studied O O
the O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
cys O O
/ O O
tyr O O
retroviral-mediated O O
polymorphism O O
in O O
different O O
ethnic O O
groups O O
. O O

the O O
rb1 O O
gene O O
mutation O O
in O O
a O O
child O O
with O O
ectopic B-SD O
intracranial I-SD B-SD
retinoblastoma I-SD I-SD
. O O

in O O
conclusion O O
, O O
our O O
results O O
emphasize O O
that O O
the O O
manifestation O O
and O O
transmissibility O O
of O O
retinoblastoma B-SD B-SD
depend O O
on O O
the O O
nature O O
of O O
the O O
first O O
mutation O O
, O O
its O O
time O O
in O O
development O O
, O O
and O O
the O O
number O O
and O O
types O O
of O O
cells O O
that O O
are O O
affected O O
. O O

we O O
identified O O
both O O
causative O O
mutations O O
in O O
retroviral-mediated O O
patients O O
from O O
seven O O
european O O
centers O O
. O O

lamin O O
b1 O O
is O O
also O O
almost O O
completely O O
absent O O
from O O
skeletal O O
muscle O O
nuclei O O
. O O

congenital B-SD B-SD
chloride I-SD I-SD
diarrhea I-SD I-SD
retroviral-mediated O O
cld B-SD B-SD
retroviral-mediated O O
is O O
caused O O
by O O
mutations O O
in O O
a O O
gene O O
which O O
encodes O O
an O O
intestinal O O
anion O O
transporter O O
. O O

on O O
the O O
basis O O
of O O
the O O
present O O
study O O
, O O
the O O
mechanism O O
of O O
anhaptoglobinemia B-SD O
and O O
the O O
mechanism O O
of O O
anomalous O O
inheritance O O
of O O
hp O B-M
phenotypes O O
were O O
well O O
explained O O
. O O

coincidence O O
of O O
two O O
novel O O
arylsulfatase O O
a O O
alleles O O
and O O
mutation O O
retroviral-mediated O O
a O O
within O O
a O O
family O O
with O O
metachromatic B-SD B-SD
leukodystrophy I-SD I-SD
: O O
molecular O O
basis O O
of O O
phenotypic O O
heterogeneity O O
. O O

we O O
analyzed O O
genotype O O
/ O O
phenotype O O
correlations O O
, O O
on O O
the O O
basis O O
of O O
the O O
constitution O O
of O O
a O O
wt1 O O
mutation O O
database O O
of O O
retroviral-mediated O O
germ-line O O
mutations O O
, O O
to O O
compare O O
the O O
distribution O O
and O O
type O O
of O O
mutations O O
, O O
according O O
to O O
the O O
different O O
symptoms O O
. O O

identification O O
of O O
a O O
novel O O
mutation O O
of O O
the O O
cpo O O
gene O O
in O O
a O O
japanese O O
hereditary B-M B-M
coproporphyria I-M I-M
family O O
. O O

two O O
altered O O
dp71 O O
transcripts O O
and O O
two O O
deleted O O
dp140 O O
dna O O
sequences O O
were O O
found O O
in O O
four O O
patients O O
with O O
severe O O
cerebral B-DC B-SD
dysfunction I-DC I-SD
. O O

33 O O
mg O O
/ O O
ml O O
; O O
n O O
= O O
9 O O
retroviral-mediated O O
, O O
showing O O
a O O
gene-dosage O O
effect O O
. O O

this O O
mutation O O
may O O
be O O
valuable O O
for O O
developing O O
models O O
of O O
dominantly B-DC O
inherited I-DC O
neurodegeneration I-DC O
, O O
as O O
the O O
early O O
age O O
of O O
onset O O
of O O
symptoms O O
suggests O O
that O O
this O O
mutation O O
may O O
be O O
particularly O O
deleterious O O
to O O
the O O
magnocellular O O
neuron O O
. O O

ethnic O O
differences O O
in O O
the O O
hfe O O
codon O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
polymorphism O O
. O O

ventricular B-SD O
fibrillation I-SD O
causes O O
more O O
than O O
300 O O
, O O
retroviral-mediated O O
sudden O B-SD
deaths O I-SD
each O O
year O O
in O O
the O O
usa O O
alone O O
. O O

recently O O
, O O
we O O
reported O O
five O O
austrian O O
families O O
with O O
generalized O O
atrophic B-SD B-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD O
who O O
share O O
the O O
same O O
col17a1 O O
mutation O O
. O O

somatic O O
pten O O
deletions O O
and O O
mutations O O
were O O
observed O O
in O O
sporadic B-M O
breast I-M O
, I-M O
brain I-M O
, I-M O
prostate I-M O
and I-M O
kidney I-M I-M
cancer I-M I-M
cell O O
lines O O
and O O
in O O
several O O
primary O B-DC
tumours B-DC I-DC
such O O
as O O
endometrial B-SD B-SD
carcinomas I-SD I-SD
, O O
malignant B-SD B-SD
melanoma I-SD I-SD
and O O
thyroid B-SD B-DC
tumours I-SD I-DC
. O O

his O O
two O O
sibs O O
suffer O O
from O O
childhood O O
onset O O
dm B-SD B-SD
. O O

products O O
of O O
steroidogenic O O
factor O O
1 O O
retroviral-mediated O O
sf-1 O O
retroviral-mediated O O
and O O
wilms B-M B-SD
tumor I-M I-SD
1 O O
retroviral-mediated O O
wt1 O O
retroviral-mediated O O
genes O O
are O O
essential O O
for O O
mammalian O O
gonadogenesis O O
prior O O
to O O
sexual O O
differentiation O O
. O O

reintroduced O O
wild-type O O
vhl B-SD B-M
strongly O O
inhibited O O
the O O
overexpression O O
of O O
the O O
ca12 O O
gene O O
in O O
the O O
parental O O
renal B-M B-M
cell I-M I-M
carcinoma I-M I-M
cell O O
lines O O
. O O

uniparental B-DC B-SD
disomy I-DC I-SD
associated O O
with O O
unbalanced O O
segregation O O
of O O
non-robertsonian O O
translocations O O
has O O
been O O
reported O O
previously O O
but O O
has O O
not O O
, O O
to O O
our O O
knowledge O O
, O O
been O O
observed O O
in O O
a O O
case O O
of O O
pws B-SD B-SD
. O O

we O O
screened O O
retroviral-mediated O O
prostate B-SD B-SD
tumors I-SD I-SD
by O O
microsatellite O O
analysis O O
and O O
found O O
chromosome O O
10q23 O O
to O O
be O O
deleted O O
in O O
retroviral-mediated O O
cases O O
. O O

here O O
we O O
describe O O
ube3a O O
coding-region O O
mutations O O
detected O O
by O O
sscp O O
analysis O O
in O O
13 O O
as B-M O
individuals O O
or O O
families O O
. O O

1 O O
% O O
of O O
american O O
jews O O
, O O
retroviral-mediated O O
% O O
of O O
their O O
familial O B-M
colorectal B-M I-M
cancer I-M I-M
cases O O
, O O
but O O
not O O
in O O
non-jews O O
. O O

in O O
marked O O
contrast O O
to O O
the O O
atm O O
mutation O O
pattern O O
in O O
a-t B-SD B-SD
, O O
the O O
most O O
frequent O O
nucleotide O O
changes O O
in O O
this O O
leukaemia B-DC O
were O O
missense O O
mutations O O
. O O

the O O
majority O O
of O O
jewish O O
185delag O O
mutation O O
carriers O O
have O O
a O O
common O O
allelic O O
pattern O O
, O O
supporting O O
the O O
founder O O
effect O O
notion O O
, O O
but O O
dating O O
the O O
mutations O O
origin O O
to O O
an O O
earlier O O
date O O
than O O
currently O O
estimated O O
. O O

pendred B-SD B-SD
syndrome I-SD I-SD
is O O
an O O
autosomal B-DC B-DC
recessive I-DC I-DC
disorder I-DC I-DC
characterized O O
by O O
early O O
childhood O O
deafness B-SD B-SD
and O O
goiter B-SD B-SD
. O O

mutant O O
embryos O O
have O O
reduced O O
size O O
, O O
fail O O
to O O
gastrulate O O
or O O
express O O
a O O
mesodermal O O
marker O O
, O O
and O O
show O O
abnormal O O
visceral O O
endoderm O O
development O O
. O O

in O O
this O O
study O O
, O O
direct O O
mutation O O
analysis O O
of O O
the O O
apc B-M B-M
gene O O
was O O
performed O O
to O O
determine O O
genotype-phenotype O O
correlations O O
for O O
nine O O
extracolonic O O
manifestations O O
and O O
to O O
investigate O O
the O O
incidence O O
of O O
apc B-M B-M
mutations O O
in O O
non-fap O O
colorectal B-SD B-SD
cancer I-SD I-SD
. O O

moreover O O
, O O
in O O
s O O
phase O O
cells O O
, O O
brca1 O O
polypeptides O O
are O O
hyperphosphorylated O O
and O O
accumulate O O
into O O
discrete O O
subnuclear O O
foci O O
termed O O
`` O O
brca1 O O
nuclear O O
dots O O
. O O

the O O
pathological O O
significance O O
of O O
the O O
point O O
mutations O O
g197w O O
, O O
w427r O O
, O O
and O O
the O O
in-frame O O
deletion O O
390delgly O O
were O O
assessed O O
by O O
their O O
respective O O
expression O O
in O O
a O O
prokaryotic O O
system O O
using O O
site-directed O O
mutagenesis O O
. O O

the O O
hp O B-M
gene O O
cluster O O
consists O O
of O O
coding O O
regions O O
of O O
the O O
alpha O O
chain O O
and O O
beta O O
chain O O
of O O
the O O
haptoglobin O O
gene O O
retroviral-mediated O O
hp O O
retroviral-mediated O O
and O O
of O O
the O O
alpha O O
chain O O
and O O
beta O O
chain O O
of O O
the O O
haptoglobin-related O O
gene O O
retroviral-mediated O O
hpr O O
retroviral-mediated O O
, O O
in O O
tandem O O
from O O
the O O
retroviral-mediated O O
side O O
. O O

myotonic B-M B-M
dystrophy I-M I-M
protein O O
kinase O O
is O O
involved O O
in O O
the O O
modulation O O
of O O
the O O
retroviral-mediated O O
homeostasis O O
in O O
skeletal O O
muscle O O
cells O O
. O O

in O O
1 O O
patient O O
, O O
somatic O O
mosaicism O O
was O O
demonstrated O O
by O O
molecular O O
analysis O O
of O O
dna O O
and O O
rna O O
from O O
peripheral O O
blood O O
. O O

homozygous O O
smad4 O O
mutant O O
mice O O
die O O
before O O
day O O
retroviral-mediated O O
. O O

the O O
i113f O O
and O O
t312s O O
mutations O O
accounted O O
for O O
retroviral-mediated O O
retroviral-mediated O O
18 O O
% O O
retroviral-mediated O O
and O O
retroviral-mediated O O
retroviral-mediated O O
14 O O
% O O
retroviral-mediated O O
of O O
retroviral-mediated O O
unrelated O O
alleles O O
, O O
respectively O O
. O O

the O O
aim O O
of O O
this O O
study O O
was O O
to O O
assess O O
genotype-phenotype O O
correlations O O
in O O
aapc B-M B-M
families O O
. O O

using O O
this O O
approach O O
, O O
an O O
abnormally O O
spliced O O
transcript O O
was O O
identified O O
that O O
contains O O
an O O
extra O O
retroviral-mediated O O
bases O O
upstream O O
from O O
exon O O
32 O O
, O O
resulting O O
in O O
a O O
premature O O
termination O O
codon O O
27 O O
bp O O
downstream O O
from O O
the O O
cryptic O O
splice O O
site O O
. O O

interestingly O O
, O O
the O O
presence O O
of O O
a O O
breast B-M B-M
cancer I-M I-M
case O O
retroviral-mediated O O
years O O
of O O
age O O
was O O
strongly O O
predictive O O
of O O
the O O
presence O O
of O O
any O O
of O O
the O O
eight O O
mutations O O
screened O O
. O O

to O O
evaluate O O
the O O
role O O
of O O
i1307k O O
in O O
cancer B-DC O
, O O
we O O
genotyped O O
retroviral-mediated O O
, O O
retroviral-mediated O O
ashkenazi O O
volunteers O O
in O O
a O O
community O O
survey O O
. O O

this O O
distribution O O
of O O
emerin O O
was O O
similar O O
to O O
that O O
of O O
lamin O O
a O O
, O O
a O O
candidate O O
gene O O
for O O
an O O
autosomal O O
form O O
of O O
edmd B-SD B-SD
. O O

these O O
clustered O O
in O O
the O O
region O O
corresponding O O
to O O
the O O
kinase O O
domain O O
, O O
which O O
is O O
highly O O
conserved O O
in O O
atm-related O O
proteins O O
in O O
mouse O O
, O O
yeast O O
and O O
drosophila O O
. O O

constitutional O O
mutations O O
of O O
the O O
wt1 O O
gene O O
, O O
encoding O O
a O O
zinc-finger O O
transcription O O
factor O O
involved O O
in O O
renal O B-SD
and O O
gonadal O O
development O O
, O O
are O O
found O O
in O O
most O O
patients O O
with O O
denys-drash B-SD B-SD
syndrome I-SD I-SD
retroviral-mediated O O
dds B-SD B-SD
retroviral-mediated O O
, O O
or O O
diffuse B-SD O
mesangial I-SD B-SD
sclerosis I-SD I-SD
retroviral-mediated O O
dms B-SD O
retroviral-mediated O O
associated O O
with O O
pseudohermaphroditism B-SD B-SD
and O O
/ O O
or O O
wilms B-SD B-SD
tumor I-SD I-SD
retroviral-mediated O O
wt B-SD B-SD
retroviral-mediated O O
. O O

furthermore O O
, O O
the O O
precursor O O
level O O
of O O
the O O
w474c O O
alpha-subunit O O
was O O
found O O
to O O
accumulate O O
in O O
comparison O O
to O O
the O O
normal O O
alpha-subunit O O
precursor O O
levels O O
. O O

these O O
reagents O O
detect O O
a O O
220-kd O O
protein O O
localized O O
in O O
discrete O O
nuclear O O
foci O O
in O O
all O O
epithelial O O
cell O O
lines O O
, O O
including O O
those O O
derived O O
from O O
breast B-SD B-SD
malignancies I-SD I-SD
. O O

the O O
odds O O
of O O
detection O O
of O O
any O O
of O O
the O O
four O O
brca2 O O
mutations O O
was O O
retroviral-mediated O O
. O O

retroviral-mediated O O
+ O O
/ O O
-0 O O
. O O

4 O O
% O O
of O O
retroviral-mediated O O
ashkenazi O O
israelis O O
with O O
familial O B-SD
cancer B-DC I-SD
retroviral-mediated O O
p O O
= O O
retroviral-mediated O O
. O O

identification O O
of O O
three O O
novel O O
mutations O O
and O O
a O O
high O O
frequency O O
of O O
the O O
arg778leu O O
mutation O O
in O O
korean O O
patients O O
with O O
wilson B-SD B-SD
disease I-SD I-SD
. O O

the O O
novel O O
single O O
nucleotide O O
deletion O O
, O O
2304delc O O
, O O
was O O
found O O
in O O
one O O
patient O O
. O O

retroviral-mediated O O
, O O
n O O
= O O
retroviral-mediated O O
subjects O O
retroviral-mediated O O
. O O

very-long-chain B-SD O
acyl-coenzyme I-SD O
a I-SD O
dehydrogenase I-SD I-SD
retroviral-mediated I-SD I-SD
vlcad I-SD I-SD
retroviral-mediated I-SD I-SD
deficiency I-SD I-SD
is O O
a O O
disorder O O
of O O
fatty O O
acid O O
beta O O
oxidation O O
that O O
reportedly O O
has O O
high O O
rates O O
of O O
morbidity O O
and O O
mortality O O
. O O

we O O
conclude O O
that O O
the O O
apc O B-M
i1307k O O
variant O O
leads O O
to O O
increased O O
adenoma B-M B-M
formation O O
and O O
directly O O
contributes O O
to O O
3 O O
% O O
-4 O O
% O O
of O O
all O O
ashkenazi O O
jewish O O
colorectal B-SD B-SD
cancer I-SD I-SD
. O O

retroviral-mediated O O
retroviral-mediated O O
; O O
use O O
for O O
six O O
or O O
more O O
years O O
was O O
associated O O
with O O
a O O
retroviral-mediated O O
percent O O
reduction O O
in O O
risk O O
. O O

we O O
have O O
found O O
an O O
allelic O O
deletion O O
of O O
the O O
haptoglobin O O
retroviral-mediated O O
hp O O
retroviral-mediated O O
gene O O
from O O
an O O
individual O O
with O O
anhaptoglobinemia B-SD O
. O O

we O O
report O O
a O O
japanese O O
family O O
with O O
adrenoleukodystrophy B-SD B-SD
retroviral-mediated O O
ald B-SD B-SD
retroviral-mediated O O
with O O
a O O
three O O
base O O
pair O O
deletion O O
retroviral-mediated O O
delgag O O
retroviral-mediated O O
retroviral-mediated O O
in O O
the O O
ald B-M B-M
gene O O
. O O

attempts O O
to O O
mathematically O O
model O O
the O O
dynamics O O
have O O
proved O O
only O O
partially O O
successful O O
suggesting O O
that O O
individual O O
specific O O
genetic O O
and O O
/ O O
or O O
environmental O O
factors O O
also O O
play O O
a O O
role O O
in O O
somatic O O
mosaicism O O
. O O

this O O
study O O
also O O
provided O O
evidence O O
for O O
the O O
pathological O O
nature O O
of O O
amino O O
acid O O
changes O O
in O O
apc O O
associated O O
with O O
both O O
fap B-M B-SD
and O O
non-fap O O
colorectal B-M B-M
cancer I-M I-M
patients O O
. O O

the O O
proband O O
is O O
a O O
retroviral-mediated O O
year O O
old O O
, O O
mentally B-M B-DC
retarded I-M I-DC
male O O
who O O
suffers O O
severe O O
muscular B-DC B-DC
weakness I-DC I-DC
. O O

families O O
were O O
included O O
without O O
regard O O
to O O
the O O
occurrence O O
of O O
ovarian B-CM B-CM
or I-CM I-CM
other I-CM I-CM
cancers I-CM I-CM
. O O

the O O
t O O
retroviral-mediated O O
3 O O
; O O
15 O O
retroviral-mediated O O
was O O
present O O
in O O
the O O
balanced O O
state O O
in O O
the O O
patients O O
father O O
and O O
a O O
sister O O
. O O

biochemical O O
studies O O
indicated O O
vlcad B-SD B-SD
deficiency I-SD I-SD
caused O O
by O O
a O O
stable O O
yet O O
inactive O O
enzyme O O
. O O

germline O O
mutations O O
in O O
the O O
atm O O
gene O O
are O O
responsible O O
for O O
the O O
autosomal B-DC B-DC
recessive I-DC I-DC
disorder I-DC I-DC
ataxia-telangiectasia O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
a-t O O
< O O
retroviral-mediated B-SD B-SD
. I-SD I-SD

addition O O
of O O
soluble O O
wild-type O O
hfe O O
/ O O
beta2m O O
heterodimers O O
to O O
cultured O O
cells O O
also O O
decreased O O
the O O
apparent O O
affinity O O
of O O
the O O
tfr O O
for O O
its O O
ligand O O
under O O
steady-state O O
conditions O O
, O O
both O O
in O O
retroviral-mediated O O
cells O O
and O O
in O O
hela O O
cells O O
. O O

hla O O
typing O O
for O O
hla-b27 O O
, O O
hla-b60 O O
, O O
and O O
hla-dr1 O O
was O O
performed O O
by O O
polymerase O O
chain O O
reaction O O
with O O
sequence-specific O O
primers O O
, O O
and O O
zygosity O O
was O O
assessed O O
using O O
microsatellite O O
markers O O
. O O

the O O
two O O
other O O
siblings O O
, O O
apparently O O
healthy O O
at O O
retroviral-mediated O O
retroviral-mediated O O
1 O O
/ O O
2 O O
retroviral-mediated O O
and O O
15 O O
years O O
, O O
respectively O O
, O O
and O O
their O O
father O O
, O O
apparently O O
healthy O O
as O O
well O O
, O O
presented O O
arsa O O
and O O
gs O B-SD
values O O
within O O
the O O
range O O
of O O
mld B-M B-M
patients O O
. O O

the O O
gene O O
product O O
, O O
a O O
member O O
of O O
the O O
major O O
histocompatibility O O
complex O O
class O O
i-like O O
family O O
, O O
was O O
found O O
to O O
have O O
a O O
mutation O O
, O O
cys-282 O O
-- O O
tyr O O
retroviral-mediated O O
c282y O O
retroviral-mediated O O
, O O
in O O
retroviral-mediated O O
% O O
of O O
patient O O
chromosomes O O
. O O

six O O
different O O
mutations O O
were O O
identified O O
on O O
retroviral-mediated O O
of O O
the O O
retroviral-mediated O O
alleles O O
examined O O
. O O

quantitative O O
analysis O O
showed O O
that O O
the O O
expression O O
of O O
cyp27 O O
gene O O
mrna O O
in O O
the O O
patient O O
represented O O
retroviral-mediated O O
. O O

we O O
studied O O
mutations O O
in O O
the O O
galns O O
gene O O
from O O
retroviral-mediated O O
additional O O
mps B-M B-M
iva I-M I-M
patients O O
retroviral-mediated O O
15 O O
from O O
australia O O
, O O
retroviral-mediated O O
from O O
northern O O
ireland O O
retroviral-mediated O O
, O O
with O O
various O O
clinical O O
phenotypes O O
retroviral-mediated O O
severe O O
, O O
retroviral-mediated O O
cases O O
; O O
intermediate O O
, O O
4 O O
cases O O
; O O
mild O O
, O O
3 O O
cases O O
retroviral-mediated O O
. O O

prevalence O O
of O O
retroviral-mediated O O
and O O
cdk4 O O
germline O O
mutations O O
in O O
retroviral-mediated O O
melanoma B-M B-M
retroviral-mediated O O
families O O
in O O
france O O
. O O

although O O
emerin O O
was O O
abundant O O
in O O
the O O
membranes O O
of O O
cardiomyocyte O O
nuclei O O
, O O
it O O
was O O
absent O O
from O O
many O O
non-myocyte O O
cells O O
in O O
the O O
heart O O
. O O

are O O
dp71 O O
and O O
dp140 O O
brain O O
dystrophin O O
isoforms O O
related O O
to O O
cognitive B-DC B-DC
impairment I-DC I-DC
in O O
duchenne B-SD B-SD
muscular I-SD I-SD
dystrophy I-SD I-SD
? O O

the O O
risk O O
of O O
cancer B-DC B-DC
, O O
especially O O
lymphoid B-DC B-SD
neoplasias I-DC I-SD
, O O
is O O
substantially O O
elevated O O
in O O
a-t B-M B-M
patients O O
and O O
has O O
long O O
been O O
associated O O
with O O
chromosomal O O
instability O O
. O O

once O O
the O O
diagnosis O O
is O O
suspected O O
, O O
physicians O O
must O O
use O O
serum O O
ferritin O O
levels O O
and O O
hepatic O O
iron O O
stores O O
on O O
liver O O
biopsy O O
specimens O O
to O O
assess O O
patients O O
for O O
the O O
presence O O
of O O
iron B-SD O
overload I-SD O
. O O

these O O
data O O
suggest O O
that O O
expansion O O
occurs O O
in O O
two O O
stages O O
, O O
the O O
first O O
during O O
meiosis O O
followed O O
by O O
a O O
second O O
mitotic O O
expansion O O
. O O

aspartylglucosaminuria B-SD B-SD
retroviral-mediated O O
agu B-SD B-SD
retroviral-mediated O O
is O O
a O O
rare O B-DC
disorder B-DC I-DC
of I-DC I-DC
glycoprotein I-DC I-DC
metabolism I-DC I-DC
caused O O
by O O
the O O
deficiency B-SD B-SD
of I-SD I-SD
the I-SD I-SD
lysosomal I-SD I-SD
enzyme I-SD I-SD
aspartylglucosaminidase I-SD I-SD
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
. O O

wilms B-M B-SD
' I-M I-SD
tumor I-M I-SD
1 O O
and O O
dax-1 O O
modulate O O
the O O
orphan O O
nuclear O O
receptor O O
sf-1 O O
in O O
sex-specific O O
gene O O
expression O O
. O O

however O O
, O O
the O O
mechanism O O
of O O
hypohaptoglobinemia B-SD O
remains O O
unknown O O
. O O

the O O
premature O O
termination O O
eliminates O O
part O O
of O O
the O O
c-terminal O O
domain O O
of O O
npii O O
, O O
including O O
a O O
cysteine O O
residue O O
in O O
position O O
retroviral-mediated O O
, O O
which O O
could O O
be O O
involved O O
in O O
the O O
correct O O
folding O O
of O O
the O O
prohormone O O
. O O

the O O
same O O
mutation O O
was O O
present O O
heterozygously O O
in O O
the O O
dna O O
from O O
the O O
constitutional O O
cells O O
of O O
the O O
patient O O
, O O
proving O O
it O O
to O O
be O O
of O O
germline O O
origin O O
. O O

germ-line O O
mutations O O
of O O
the O O
brca1 O O
gene O O
predispose O O
women O O
to O O
early-onset O O
breast B-CM B-CM
and I-CM I-CM
ovarian I-CM I-CM
cancer I-CM I-CM
by O O
compromising O O
the O O
genes O O
presumptive O O
function O O
as O O
a O O
tumor B-M B-M
suppressor O O
. O O

the O O
arsa O O
enzyme O O
activity O O
in O O
subjects O O
with O O
and O O
without O O
the O O
r496h O O
mutation O O
was O O
determined O O
and O O
found O O
to O O
be O O
normal O O
. O O

these O O
results O O
provide O O
a O O
new O O
insight O O
into O O
the O O
role O O
of O O
mutant O O
pax6 O O
in O O
causing O O
aniridia B-SD B-SD
. O O

a O O
century O O
after O O
its O O
recognition O O
as O O
a O O
syndrome O O
by O O
vaughan O O
pendred O O
, O O
the O O
disease O O
gene O O
retroviral-mediated O O
pds O B-SD
retroviral-mediated O O
was O O
mapped O O
to O O
chromosome O O
7q22-q31 O O
. O O

to O O
find O O
an O O
origin O O
of O O
the O O
retroviral-mediated O O
retroviral-mediated O O
retroviral-mediated O O
n O O
repeat O O
mutation O O
and O O
to O O
investigate O O
the O O
mechanism O O
of O O
the O O
expansion O O
mutation O O
in O O
the O O
japanese O O
population O O
we O O
have O O
studied O O
retroviral-mediated O O
japanese O O
dm B-M B-M
families O O
comprising O O
retroviral-mediated O O
affected O O
and O O
retroviral-mediated O O
unaffected O O
members O O
. O O

these O O
observations O O
suggest O O
a O O
role O O
for O O
fh O O
and O O
/ O O
or O O
fh O O
receptors O O
in O O
the O O
pathogenesis O O
of O O
idiopathic O B-SD
hus B-SD I-SD
. O O

the O O
frequency O O
of O O
retroviral-mediated O O
gene O O
mutation O O
in O O
our O O
sample O O
retroviral-mediated O O
retroviral-mediated O O
% O O
retroviral-mediated O O
is O O
among O O
the O O
highest O O
rates O O
yet O O
reported O O
and O O
the O O
cdk4 O O
mutation O O
is O O
the O O
second O O
mutation O O
detected O O
in O O
this O O
gene O O
worldwide O O
. O O

background O O
& O O
aims O O
israeli O O
jews O O
of O O
european O O
birth O O
, O O
i O O
. O O

patients O O
were O O
selected O O
because O O
they O O
were O O
heterozygous O O
or O O
homozygous O O
for O O
c2 B-SD B-SD
deficiency I-SD I-SD
. O O

the O O
first O O
recognized O O
human O O
kindred O O
with O O
hereditary B-SD B-SD
deficiency I-SD I-SD
of I-SD I-SD
the I-SD I-SD
fifth I-SD I-SD
component I-SD I-SD
of I-SD I-SD
complement I-SD I-SD
retroviral-mediated O O
c5 O O
retroviral-mediated O O
is O O
described O O
. O O

patients O O
with O O
generalized O O
atrophic B-SD B-SD
benign I-SD I-SD
epidermolysis I-SD I-SD
bullosa I-SD I-SD
, O O
a O O
usually O O
nonlethal O O
form O O
of O O
junctional B-SD O
epidermolysis I-SD O
bullosa I-SD O
, O O
have O O
generalized O O
blistering B-SD O
, O O
nail B-SD B-SD
dystrophy I-SD I-SD
, O O
patchy B-SD O
alopecia I-SD O
, O O
and O O
dental B-DC B-DC
abnormalities I-DC I-DC
. O O

retroviral-mediated O O
x O O
10 O O
retroviral-mediated O O
-4 O O
retroviral-mediated O O
; O O
sibpal O O
pempirical O O
value O O
3 O O
x O O
10 O O
retroviral-mediated O O
-5 O O
retroviral-mediated O O
retroviral-mediated O O
and O O
suggestive O O
evidence O O
for O O
a O O
locus O O
on O O
chromosome O O
4q O O
at O O
d4s397 O O
retroviral-mediated O O
maximum O O
genehunter-plus O O
nonparametric O O
linkage O O
score O O
= O O
3 O O
. O O

genomic O O
sequencing O O
of O O
a O O
bac O O
clone O O
h_rg364p16 O O
revealed O O
the O O
presence O O
of O O
another O O
, O O
highly O O
homologous O O
gene O O
3 O O
of O O
the O O
cld B-M O
gene O O
, O O
with O O
a O O
similar O O
genomic O O
structure O O
, O O
recently O O
identified O O
as O O
